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Summary 
Research on probiotics has increased over the past years, which led to commercialization of a 
number of probiotic supplements and functional foods.  In vitro assays such as tolerance to acid 
and bile, adhesion to mucus and epithelial cells, antimicrobial activity and antibiotic resistance 
tests are performed to screen lactic acid bacteria for probiotic properties. 
 
Enterococcus mundtii ST4SA produces an antimicrobial peptide (peptide ST4SA) with activity 
against Gram-positive and Gram-negative bacteria.  Lactobacillus plantarum 423 produces 
plantaricin 423, a typical class II bacteriocin, active against a number of Gram-positive bacteria.   
 
A gastro-intestinal model (GIM) simulating the gastro-intestinal tract (GIT) of infants, was 
developed to study the survival of E. mundtii ST4SA and L. plantarum 423 and evaluate them as 
possible probiotics.  Growth of the two strains in the GIM was compared to the growth of 
commercially available probiotics.  Infant milk formulations were used as growth medium. 
Changes in pH, the addition of bile salt and pancreatic juice, and intestinal flow rates were 
controlled by peristaltic pumps linked to a computer with specifically designed software. 
 
Strain ST4SA was sensitive to low pH and high concentrations of bile salts.  Growth of strain 
ST4SA was repressed in the first part of the GIM, however, the cells recovered in the ileum.  
Strain 423 was also sensitive to acidic conditions.  However, the cells withstood the presence of 
bile and pancreatin in the first part of the GIT.  Neither of the two strains displayed bile salt 
hydrolase (BSH) activity.  Both strains were resistant to amoxicillin, ampicillin, 
chloramphenicol, cefadroxil, roxithromycin, meloxicam, doxycycline, erythromycin, novobiocin, 
rifampicin, tetracyclin, bacitracin, oflaxacin and cephazolin, anti-inflammatory drugs Na+-
diklofenak and ibuprofen, and painkillers codeine terprim hydrate aminobenzoic acid, 
metamizole aspirin and paracetamol.  Strain 423 was resistant to ciprofloxacin.  Genes encoding 
cytolysin, non-cytolysin β-hemolysin and cell aggregation substances were detected on the 
genome of strain ST4SA but they were not expressed.  L. plantarum 423 does not contain genes 
encoding gelatinase, cell aggregation, enterococcus surface protein, hemolysin, non-cytolysin β-
hemolysin and enterococcus endocarditis antigen.  Both strains inhibited the growth of Listeria 
monocytogenes ScottA in the GIM.  Survival of the strains improved when used in combination 
and compared well with the survival of commercially available probiotics.  
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Adhesion to epithelial cells is an important prerequisite for bacterial colonization in the GIT.  The 
adhesion of E. mundtii ST4SA and L. plantarum 423 was studied using Caco-2 (human colon 
carcinoma epithelial) cells.  Both strains revealed good adhesion compared to other probiotic 
strains.  No correlation was found between hydrophobicity, auto-aggregation and adhesion to 
Caco-2 cells. Antibiotics and anti-inflammatory medicaments had a negative effect on adhesion.  
Different combinations of proteins were involved in the adhesion of E. mundtii ST4SA and L. 
plantarum 423 to Caco-2 cells.  E. mundtii ST4SA, L. plantarum 423 and L. monocytogenes 
ScottA were stained with fluorescent dyes to visualize adhesion to Caco-2 cells.  Adhesion of L. 
monocytogenes ScottA to Caco-2 cells was not reduced in the presence of strains ST4SA and 
423.  Cell-free culture supernatants of both strains inhibited the invasion of L. monocytogenes 
ScottA.  The cell structure of Caco-2 cells changed in the presence of L. monocytogenes ScottA.  
Strains ST4SA and 423 protected Caco-2 cells from deforming. 
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Opsomming 
Navorsing op probiotika het die afgelope tyd drasties toegeneem en aanleiding gegee tot die  
kommersialisering van ‘n groot hoeveelheid probiotiese supplemente en funksionele 
voedselsoorte.  In vitro studies, soos bv. weerstand teen suur en gal, vashegting aan mukus en 
epiteelselle, antimikrobiese aktiwiteit en weerstand teen antibiotika word uitgevoer om te bepaal 
of melksuurbakteriëe aan probiotiese standaarde voldoen. 
 
Enterococcus mundtii ST4SA produseer ’n peptied met antimikrobiese werking teen Gram-
positiewe en Gram-negatiewe bakteriëe.  Lactobacillus plantarum 423 produseer ‘n tipiese klas II 
bakteriosien, plantarisien 423, met aktiwiteit teen sekere Gram-positiewe bakteriëe. 
 
’n Gastro-intestinale model (GIM)  wat die spysverteringskanaal (SVK) van babas simuleer, is 
ontwikkel om die oorlewing van E. mundtii ST4SA en L. plantarum 423 te bepaal en hul 
eienskappe met dié van kommersiële probiotiese stamme te vergelyk.  Babamelk formules is as 
groeimedium gebruik. Verandering in pH, byvoeging van galsoute en pankreassappe, en 
intestinale vloei is met behulp van peristaltiese pompe gereguleer wat seine vanaf ‘n spesiaal 
ontwikkelde rekenaarprogram ontvang. 
 
E. mundtii ST4SA was sensitief vir lae pH en hoë galsoutkonsentrasies en groei is in die eerste 
deel van die GIM onderdruk.  Selgetalle het wel in die ileum herstel.  Stam 423 was ook sensitief 
vir lae pH, maar het die galsout- en pankreatienvlakke in die laer deel van die SVK weerstaan.  
Geen galsout-hidrolase aktiwiteit is by enige van die twee stamme gevind nie. 
 
Beide stamme het weerstand getoon teen amoksillien, ampisillien, chloramfenikol, cefadroksiel, 
roksitromisien, meloksikam, doksisiklien, eritromisien, novobiosien, rifampisien, tetrasiklien, 
basitrasien, oflaksasien, kefazolien, die anti-inflammatoriese medikamente Na+-diklofenak en 
ibuprofen, en die pynstillers kodeïenterprimhidraataminobensoësuur, metamisoolaspirien en 
parasetamol.  L. plantarum 423 was bestand teen ciprofloksasien.  Gene wat kodeer vir sitolisien, 
nie-sitolisien β-hemolisien III en sel-aggregasie is op die genoom van E. mundtii ST4SA gevind, 
maar word nie uitgedruk nie.  L. plantarum 423 besit nie die gene wat vir gelatinase, sel-
aggregasie substansies, enterokokkus selwandproteïen, hemolise, nie-sitolisien β-hemolisien en 
enterokokkus endokarditis antigeen kodeer nie.  Albei stamme inhibeer die groei van Listeria 
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monocytogenes ScottA in die GIM.  Die twee stamme in kombinasie het tot beter oorlewing in 
die GIM gelei.  Stamme ST4SA en 423 vergelyk goed met kommersieël beskikbare probiotika. 
 
Vashegting van probiotiese stamme aan epiteelselle is belangrik vir kolonisering in die SVK.  
Vashegting van E. mundtii ST4SA en L. plantarum 423 is bestudeer deur van Caco-2 (kolon 
epiteel) selle van die mens gebruik te maak.  Die aanhegting van beide stamme aan Caco-2 selle 
het goed vergelyk met kommersieël beskikbare probiotiese stamme.  Geen korrelasie is gevind 
tussen hidrofobisiteit, aggregasie en vashegting aan Caco-2 selle nie.  Antibiotika en anti-
inflammatoriese medikamente het ‘n negatiewe effek op vashegting gehad.  Verskillende 
kombinasies van proteïene is betrokke in die vashegting van E. mundtii ST4SA en L. plantarum 
423 aan Caco-2 selle.  E. mundtii ST4SA, L. plantarum 423 en L. monocytogenes ScottA is met 
fluoreserende kleurstowwe gemerk om vashegting aan Caco-2 selle te monitor.  Vashegting van 
L. monocytogenes ScottA aan Caco-2 selle is nie deur die teenwoordigheid van stamme ST4SA 
en 423 beïnvloed nie.  Sel-vrye kultuursupernatante van beide stamme het die binnedring van L. 
monocytogenes ScottA verhoed.  Die selstruktuur van Caco-2 selle het in die teenwoordigheid 
van L. monocytogenes ScottA van vorm verander.  E. mundtii ST4SA en L. plantarum 423 het 
die Caco-2 selle teen vervorming beskerm. 
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CHAPTER 1 
 
Introduction 
 
 
This chapter is written according to the style of International Journal of Food Microbiology. 
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Introduction 
 
Lactic acid bacteria (LAB) are generally regarded as safe (GRAS) and form part of the probiotic 
concept which received considerable attention over the past years (Salminen et al., 1998).  The 
concept of eating or applying live bacteria for a health benefit goes back a hundred years 
(Metchnikoff, 1907).  Probiotics are defined as “Living microorganisms which upon ingestion in 
certain numbers exert health benefits beyond inherent general nutrition” (Gorbach, 2002) and 
play a role in the prevention or treatment of infectious diseases, irritable bowel syndrome, 
allergies, lactose intolerance, colon cancer and chronically high cholesterol levels (Andersson et 
al., 2001).  
 
Criteria for selection of probiotic strains have only recently been formulated by the Food and 
Agriculture Organization of the United Nations and the World Health Organization (FAO/WHO). 
Some of the most important criteria are gastric and bile acid resistance, adhesion to mucus and/or 
human epithelial cells, competition with pathogens for adhesion sites, growth inhibition of 
potentially pathogenic bacteria, bile salt hydrolase activity and, in the case of vaginal 
applications, resistance to spermicides (FAO/WHO, 2002). 
 
Several in vitro techniques are used to evaluate probiotic strains.  Survival in the presence of 
acid, bile, enzymes and pancreatic juice is studied under conditions simulating the gastro-
intestinal tract (Conway et al., 1987; Fernándes et al., 2003; Lin et al., 2006; Pinto et al., 2006).  
These in vitro tests are time consuming and are not a true representation of conditions in vivo.  In 
vitro models, simulating human gastro-intestinal conditions, were later developed. The SHIME, 
described by Molly and co-workers (1993), consisted of five reactors that represented the small 
and large intestine. Different in vitro gastro-intestinal models followed, e.g. an upper-gastro-
intestinal model, a three-stage compound continuous culture system representing the proximal 
colon, and a model simulating the stomach and duodenum (Macfarlane et al., 1998; Mainville et 
al., 2005; Minekus et al., 1995).  These models are based on a “fill and draw” system with 
reactors representing sections of the intestine.  Each vessel is equipped with pH and temperature 
probes and entry ports for solutions such as medium, HCl, NaOH and oxbile (Mainville et al., 
2005; Marfarlane et al., 1998; Minekus et al., 1995; Molly et al., 1993).  The advantage of an in 
vitro model lies in the evaluation of all components in one system.  
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After surviving the harsh conditions in the stomach, probiotic bacteria are encountered by the 
mucus and epithelial cells in the small intestine.  Physico-chemical properties of probiotic 
bacteria draw them closer to the mucus and they may come in close contact to adhesion sites on 
epithelial cells (Guiemonde & Salminen, 2006).  Adhesion is facilitated by cell-surface proteins 
(including S-layer proteins), carbohydrates, hemagglutins and lipoteichoic acids (Adlerberth et 
al., 1996; Andreu et al., 1995; Bernet et al., 1994; Frece et al., 2005; Granato et al., 1999; Greene 
& Klaenhammer, 1994; Roos & Jonsson, 2002; Satoh et al., 1999; Vidal et al., 2002).  Adhesion 
increases the retention time of probiotic cells to the intestine, which in turn prevents colonization 
of pathogens and modulates the immune system of the host (Guiemonde & Salminen, 2006). 
Several in vitro epithelial cell models have been developed to study adhesion.  Caco-2 cells, a 
human colonic adenocarcinoma cell line, differentiate spontaneously and grow as cylindrical 
polarized cells, with microvilli on the apical side and tight junctions between adjacent cells. 
These cells produce hydrolases similar to levels encountered in normal epithelial cells (Sambuy 
et al., 2005).  Such in vitro models are useful to select probiotics with adhesion properties and to 
calculate predicted dose-responses in clinical trials (Tuomola & Salminen, 1998). 
 
Fluorescent staining has recently been used to study bacterial adhesion (Fuller et al., 2000).  
Lectin binds specifically to N-acetylglucosamine in the peptidoglycan layer of Gram-positive 
bacteria.  Cell-permeating nucleic acid stains, e.g. intercalating dyes such as ethidium bromide 
and propidium iodide and minor-groove binders such as DAPI and Hoechst dyes, stain Gram-
negative bacteria (Mason et al., 1998).  Fluorescent staining is more specific and is used to detect 
specific strains in a complex environment such as the GIT. 
 
Lactobacilli compete with pathogens for adhesion sites, as observed for Lactobacillus rhamnosus 
GG and Lactobacillus casei Shirota (Lee et al., 2003).  Competitive exclusion might also involve 
bacteriocins produced by LAB (Klaenhammer, 1988; Tagg et al., 1976).  These peptides are 
antimicrobial and could be used in combination with other antibiotics (Ouwehand & Vesterlund, 
2004). Bacteriocins of LAB (including the enterocins) have been divided into three major classes 
i.e. lantibiotics, small heat-stable peptides and large heat-labile proteins.  Another mechanism of 
probiotic bacteria to compete with pathogenic bacteria is co-aggregation (Reid et al., 1988). Co-
aggregation delays the removal of probiotic bacteria from the intestinal epithelium and prevents 
colonization by pathogenic bacteria (Collado et al., 2007; Reid et al., 1988; Schachtsiek et al., 
2004; Schellenberg et al., 2006). 
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The use of probiotics as health supplements and as natural alternatives to therapeutic antibiotics 
is increasing. However, a few cases of bacteremia caused by LAB have been reported (Cannon et 
al., 2005; Donohue and Salminen, 1996; Gasser, 1994; Husni et al., 1997; Vesterlund et al., 
2007).  Probiotic strains should be assessed for safety by conducting studies on their intrinsic 
properties and pharmacokinetics and interactions with the host (Salminen et al., 1998; Saxelin et 
al., 2005).  Systemic infections, deleterious metabolic activity, excessive immune stimulation and 
risk of gene transfer are four examples of adverse side-effects (Salminen et al., 1998).  Bacteria 
causing these side-effects are mostly characteristic for the host’s own micro-flora and are not 
associated with lactobacilli and bifidobacteria in comparison to other bacteria (Salminen et al., 
1998).  The greatest risk for safety is the use of multi-drug resistant probiotics and the spread of 
antibiotic resistance genes to pathogenic bacteria.  Lactic acid bacteria, like all other bacteria, 
exchange antibiotic resistance genes to enhance their own resistance (Courvalin, 2006).  
Enterococci are known to harbor virulence factors that may contribute to pathogenesis (Franz & 
Holzapfel, 2004). Examples of these are aggregation substances encoded by pheromone-
responsive plasmids (observed for E. faecalis), sex pheromones, β-haemolysin/bacteriocin or 
cytolysin, enterococcus surface proteins, enterococcus endocarditis antigen (observed for E. 
faecalis and E. faecium), gelatinase, extracellular metallo-endopeptidase, hyaluronidase and 
capsules (Chow et al., 1993; Clewell et al., 2000; Franz et al., 2003; Franz & Holzapfel, 2004; 
Gilmore et al., 1994; Huebner et al., 1999; Ike et al., 1984; Jett et al., 1992; 1994; Su et al., 1991; 
Toledo-Arana et al., 2001).  
 
Enterococcus mundtii ST4SA isolated from soybeans, produces an antimicrobial peptide active 
against various Gram-positive and Gram-negative bacteria. Lactobacillus plantarum 423, isolated 
from sorghum beer, produces a typical class II bacteriocin active against Gram-positive bacteria. 
Preliminary studies have indicated that both strains have probiotic properties.  In this study the 
probiotic properties of E. mundtii ST4SA and L. plantarum 423 are evaluated and compared to 
those of commercially available probiotics. 
 
The following objectives were formulated: 
Survival properties 
• To develop a computerized model simulating the gastro-intestinal tract of infants.   
• To determine the survival of E. mundtii ST4SA and L. plantarum 423 in the gastro-
intestinal model (GIM) and compare the strains to commercially available probiotics. 
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• To assess the safety of strains ST4SA and 423 in terms of antibiotic resistance and 
presence of virulence factors. 
 
Adhesion properties 
• To determine the hydrophobicity, auto- and co-aggregation properties of strains ST4SA 
and 423. 
• To determine the adhesion of strains ST4SA and 423 to Caco-2 cells and compare them to 
commercially available probiotic strains. 
• To determine if E. mundtii ST4SA and L. plantarum 423 are able to compete with other 
cells for binding to epithelial cells. 
• To determine the effect of bile, pancreatin and antibiotics on the adhesion of strains 
ST4SA and 423 to epithelial cells. 
• Visualization of E. mundtii ST4SA, L. plantarum 423 and L. monocytogenes ScottA 
adhesion to Caco-2 cells by fluorescent staining.  
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1. Introduction 
A hundred years have passed since Metchnikoff described the health benefits of milk fermented 
with specific strains (Metchnikoff, 1907).  Since then, many lactic acid bacteria with probiotic 
properties have been isolated from plants, animals and fermented foods.  Many claims relating to 
probiotic properties have been made, which varies from the prevention of infectious diseases 
(Rolfe, 2000), curing of irritable bowel syndrome, alleviation of allergies, digestion of lactose 
and lowering of serum cholesterol levels (Andersson et al., 2001) to prevention of cancer (Gibson 
& Macfarlane, 1994; Morotomi et al., 1990).  It is thus not surprising that over the years many 
definitions for probiotics have been proposed.  Marteau et al. (2002) defined probiotics as 
“microbial cell preparations or components of microbial cells that have a beneficial effect on 
health and well-being”.  Gorbach (2002) defined probiotics as “living microorganisms which 
upon ingestion in certain numbers exert health benefits beyond inherent general nutrition”.  
Recent definitions tend to focus more on specific effects, in particular stimulation of the immune 
system by well-defined strains (Isolauri et al., 2004).  This posed the question whether any given 
micro-organism that adheres to any one or more of these definitions is considered a probiotic 
(Fioramonti et al., 2003).  To fuel the debate further, a number of recently published papers have 
suggested that probiotics may cause side-effects such as systemic infections, deleterious 
metabolic activities and excessive immune stimulation in susceptible individuals.  Reports on 
virulence and the possible exchange of genes encoding antibiotic resistance (Marteau, 2002) have 
emphasized the importance of having the correct safety precautions in place when selecting a 
probiotic.  
 
Regulatory guidelines were implemented in 2002 (FAO/WHO) to ensure safe and reliable 
products.  A probiotic should be (a) resistant to gastric and bile acid, (b) adhere to mucus and/or 
human epithelial cells, (c) inhibit the growth and colonization of pathogens, and if used 
intravaginally, (d) be resistant to spermicides (FAO/WHO, 2002).  Most of these tests are 
performed in vitro (Conway et al., 1987; Floch, 2002; Lin et al., 2006).  Studies with human cell 
lines such as Caco-2, HT-29 and HT29-MTX provide an opportunity to study adhesion to mucus, 
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glycoproteins and epithelial cells (Gopal et al., 2001; Kirjavainen et al., 1998; Ouwehand et al., 
1999; Sambuy et al., 2005).  Adhesion to epithelial cells differ with the use of different cell lines, 
e.g. bacterial strains have a higher affinity to HT29-MTX cells than Caco-2 cells (Shillinger et 
al., 2005).  Other factors of importance are cell-surface proteins (Adlerberth et al., 1996; Bernet 
et al., 1994; Roos & Jonsson, 2002; Satoh et al., 1999), carbohydrates (Granato et al., 1999; Vidal 
et al., 2002), hemagglutins (Andreu et al., 1995), S-layer proteins (Frece et al., 2005) and 
lipoteichoic acids (Greene and Klaenhammer, 1994).  In vitro studies on cell lines are important 
in that they bridge the gap between “test-tube” research and animal or human studies.  However, 
in vivo trials have to be conducted in final evaluations (Charteris et al., 1998; Jacobsen et al., 
1999; Mishra & Prasad, 2005). 
 
Genomic analyses have proved valuable in probiotic studies.  Examples are the  F1F0-ATPase 
system, encoded by the atp operon, ornithine decarboxylase (La996) and the role it plays in  acid 
tolerance of Lactobacillus acidophilus NCFM (Alterman et al., 2005), bile salt hydrolase (BSH) 
and  bile transport by Lactobacillus johnsonii NCC 533 (Pridmore et al., 2004).  Bron and co-
workers (2004) described fourteen genes and gene clusters encoding cytoplasmic membrane and 
cell-wall-associated functions involved in bile tolerance of Lactobacillus plantarum WCFS1. 
 
This review focuses on the properties of probiotic lactic acid bacteria, the gastro-intestinal tract, 
mode of action, safety of probiotics, and methods used to study these organisms. 
 
2. Digestion of food in the gastro-intestinal tract  
Food enters the stomach and forms concentric circles in the body and fundus so that the latest 
food is closest to the esophagus and the oldest food nearest the wall of the body of the stomach.  
Digestive juices, secreted from glands on the surface of the stomach wall (Table 1), come into 
contact with stored food and the mucosa.  Contractions towards the antrum blend secretions with 
the food, resulting in a murky, milky semi- fluid or paste known as chime. Peristaltic constrictor 
rings force the stomach contents towards the pylorus and into the duodenum.  Lyzozyme in the 
saliva weakens the cell wall of bacteria and facilitates the entering of thiocyanate ions into cells 
(Guyton, 1991).   
 
The surface of the stomach is lined with mucus-secreting cells.  The mucus, composed of water, 
electrolytes and several glycoproteins, acts as a lubricant that spreads food and other particles 
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across the intestinal surface. Mucus is not easily digested by gastro-intestinal enzymes and serves 
as a buffer against acids and alkalis.  Oxyntic glands in the mucosa secrete hydrochloric acid, 
pepsinogen, intrinsic factor and mucus.  Pyloric glands, also positioned in the mucosa, secrete 
mucus, pepsinogen and the hormone gastrin, which in turn regulates antral peristalsis and thus 
emptying of the stomach. Feedback signals from the duodenum, i.e. enterogastric feedback 
reflexes and hormonal feedback, help to force the chime through the small intestine at 0.5 to 2 
cm/sec.  Chime takes three to five hours to pass from the pylorus valve to the ileocecal valve 
(Guyton, 1991). 
 
Table 1 
Volumes and pH values of intestinal juices secreted daily (obtained from Guyton, 1991) 
 Daily volume (ml) pH 
Saliva 1000 6.0-7.0 
Gastric secretion 1500 1.0-3.5 
Pancreatic secretion 1000 8.0-8.3 
Bile 1000 7.8 
Small intestine secretion 1800 7.5-8.0 
Brunner’s gland secretion 200 8.0-8.9 
Large intestine secretion 200 7.5-8.0 
Total 6700  
Pancreatic juice composed of digestive enzymes and sodium bicarbonate is secreted in response 
to the presence of chime in the upper sections of the small intestine.  Bicarbonate levels increase 
to 145 milli equivalents of solute per liter (mEq/liter) and provide more alkali to neutralize the 
acid chime.  The presence of chime in the small intestine stimulates secretion of cholecystokinin 
and secretin.  Cholecystokinin stimulates contractions of the gallbladder and common bile duct 
and delivers bile to the duodenum.  Secretin simulates biliary duct cells to secrete bicarbonate 
and water.  This expands the volume of bile and increases its flow to the intestine (Guyton, 
1991).  Bile is secreted by the liver, stored in the gallbladder and released in the duodenum 
(Taranto et al., 2006).  The combination of bile salts, bilirubin, cholesterol, lecithin and 
electrolytes (Table 2) renders bile amphipathic and bactericidal (Guyton, 1991; Hofmann, 1994). 
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Table 2 
Composition of bile (obtained from Guyton, 1991) 
 Liver bile Gallbladder bile 
Water 97.5 g/dl 92 g/dl 
Bile salts 1.1 g/dl 6 g/dl 
Bilirubin 0.04 g/dl 0.3 g/dl 
Cholesterol 0.10 g/dl 0.3-0.9 g/dl 
Fatty acids 0.12 g/dl 0.3-1.2 g/dl 
Lecithin 0.04 g/dl 0.3 g/dl 
Na+ 145 mEq/liter 130  mEq/liter 
K+ 5 mEq/liter 12 mEq/liter 
Ca++ 5 mEq/liter 23 mEq/liter 
Cl- 100 mEq/liter 25 mEq/liter 
HCO3- 28 mEq/liter 10 mEq/liter 
 
Absorption of nutrients does not take place in the stomach, as it lacks the typical villous-type 
membrane.  The intestinal mucosa has many folds (folds of Kerckring) which increase the surface 
area of the mucosa by approximately three-fold.  These folds extend circularly along most of the 
intestine and are well developed in the duodenum and jejunum.  Small villi that project 
approximately 1 millimeter from the surface of the mucosa cover the entire surface of the small 
intestine (Fig. 1).  The villi are situated adjacent to each other in the upper small intestine and are 
almost completely in contact with each other.  Villi in the distal small intestine are less compact.  
Each epithelial cell is characterized by brush border, consisting of about 600 microvilli, 1 
micrometer in length and 0.1 micrometer in diameter, protruding into the intestinal chime.  The 
folds of Kerckring, villi and microvilli increase the absorptive area of the mucosa up to 600-fold. 
 
Once in the colon, the chime migrates with the help of sluggish contractions.  Water and 
electrolytes are absorbed from the chime in the proximal half of the colon and fecal material is 
stored in the distal half.  The mucosa in the large intestine is similar to the mucosa in the small 
intestine, but does not have villi.  Epithelial cells of the large intestine secrete very few enzymes 
and are almost entirely covered by mucous cells.  Large numbers of mucous cells are dispersed 
among other epithelial cells.  Mucus contains high concentrations of bicarbonate ions to protect 
the intestinal wall from harmful faecal bacteria (Guyton, 1991).  Protection is important, since 
more than 1011 bacteria per gram dry matter has been reported in the colon (Guyton, 1991).  
Several hundred bacterial species have been isolated from faeces (Guyton, 1991).  Approximately 
40 of these species are grouped into six genera and account for 99 %  
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Fig. 1.  A longitudinal section of the small intestine, showing the surface of mucosa covered by 
villi (www.colorado.edu). 
 
of the faecal biomass.  Asporogenous anaerobes such as Bacteroides, Bifidobacterium and 
Eubacterium spp. predominate the colon.  The micro-aerophilic species include streptococci, 
enterobacteria and lactobacilli. Facultative anaerobic cocci are represented by Peptostreptococcus 
spp., Ruminococcus spp., Megasphaera elsdenii, Sarcina ventriculi, Enterococcus faecalis, 
Streptococcus bovis, Streptococcus equines and Streptococcus salivarius. Veillonella and 
Acidaminococcus spp. present the Gram-negative anaerobic cocci (Cummings, 1997). 
 
3. Survival of microorganisms in the gastro-intestinal tract 
3.1 Acid and bile tolerance 
Physiological stress of bacteria begins in the stomach, where the pH may reach 1.5 (Lankaputhra 
and Shah, 1995).  Bile secreted in the small intestine reduces the survival of bacteria by changing 
the composition of lipids and fatty acids in their cell membranes.  These modifications may affect 
interactions between the membrane and the environment, thus permeability (Gilliland et al., 
1977).  Acid and bile tolerance are therefore considered key criteria in the selection of a probiotic 
(Lankaputhra and Shah, 1995).  In vitro methods used to simulate gastro-intestinal conditions and 
select probiotic strains are listed in Table 3. 
 
 
 
Mucosa 
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Table 3 
In vitro methods used to evaluate potential probiotic strains. 
Simulation of Stomach acid:  
Growth medium or sterilized phosphate-buffered saline (PBS, 6.0 mM Na2HPO4, 1.5 mM 
KH2PO4, 0.14 M NaCl, 3.0 mM KCl, pH 7.3) with pH values adjusted between 2.0 and 3.2 
(Conway et al., 1987; Lin et al., 2006). 
Electrolyte solution (6.2 g/l NaCl, 2.2 g/l KCl, 0.22 g/l CaCl2 and 1.2 g/l NaHCO3), adjusted to 
pH 2.5 (Pinto et al., 2006). 
Gastric juice withdrawn from humans (Del Piano et al., 2006).  
Gastro-intestinal enzymes: 
Lysozyme (100ppm) and pepsin (0.3% w/v) added to acidic buffers (Pinto et al., 2006).  Strains 
are incubated for 1 h to 3 h in acidic buffers and plated onto specific growth media. 
Bile acids: 
Different preparations of porcine and bovine bile are used, based on the presence of conjugated 
and unconjugated bile salts (Floch, 2002).  
Duodenum secretions: 
Artificial duodenum secretion (pH 7.2): 6.4 g/l NaHCO3, 0.239 g/l KCl, 1.28 g/l NaCl, 5 g/l bile 
salts and 1 g/l pancreatin (Fernándes et al., 2003; Pinto et al., 2006; Zárate et al., 2000). 
Cells are collected after exposure to the acidic buffers, incubated in 3 g/l (w/v) bile for 36 h and 
plated onto specific growth media (Gilliland & Walker, 1990; Lin et al., 2006; Yu & Tsen, 1993).  
 
In vitro studies with human and simulated gastric juice revealed between 15 % and 45 % survival 
of microbial cells (strains of L. plantarum) in human gastric juice and 20 % survival of the same 
strains in simulated gastric juice (Del Piano et al., 2006).  Viability is strain dependant and 
influenced by pH and exposure time.  Food intake also protects bacteria during gastric passage 
(Del Piano et al., 2006).  Milk has a protective effect on bacteria and the presence of pepsin and 
lysozyme increases inhibition (Fig. 2; Pinto et al., 2006).  Bacterial strains isolated from the 
human gut revealed higher levels of acid resistance in simulated gastric juice (Conway, 1987).  
Strains with good colonizing properties were less resistant to low pH in in vitro studies (Charteris 
et al., 1998; Jacobsen et al., 1999; Mishra & Prasad, 2005).  Strains of Lactobacillus paracasei 
showed low resistance to gastric acid in vitro, although survival in the gastro-intestinal tract was 
excellent (Charteris et al., 1998; Mishra & Prasad, 2005).  Although in vitro assays may provide 
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information on acid tolerance, the method should be refined to correlate with in vivo tests, or 
validated by human clinical trials. 
 
 
Run 1 2 3 4 5 6 7 8 
Milk + + + - + - - - 
Medium 
Composition 
MRS Electrolyte 
solution 
Electrolyte 
solution 
Electrolyte 
solution 
MRS Electrolyte 
solution 
MRS MRS 
Lysozyme - - + + + - + - 
pH 3 2.5 2.5 3 3 3 2.5 2.5 
Pepsin + - + - - + + - 
 
Fig. 2. Effect of different variables (presence of milk, lysosyme and pepsin, medium composition 
and pH) on L. johnsonii LA1 after 1 h in the presence of artificial gastric juice determined in 
eight experiments (Pinto et al., 2006).   One milliliter samples were taken at the beginning of the 
each assay (T0) and 1 h later (T60).  The response was calculated as the difference between the 
log units of the initial and final counts (inhibition: log CFU/mlT0 - log CFU/mlT60).  The 
symbols + and - refer respectively to the presence and absence of milk, lysozyme and pepsin. 
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Multiple factors such as stress response systems and transcriptional regulators, elements involved 
in the maintenance of the cell envelope, energy metabolism, amino acid transport (putative role in 
pH homogenesis) and fatty acid or isoprenoid biosynthesis play a role in survival of bacteria in 
bile-rich environments (Begley et al., 2000; Breton et al., 2002).  Cholic acid and deoxycholic 
acid (DCA) have a stronger inhibitory effect on intestinal aerobic and anaerobic bacteria 
compared to conjugated bile acids (Floch et al., 1972).  The first evidence of DCA toxicity in 
lactic acid bacteria was reported by Taranto et al. (2006).  DCA is more hydrophobic and toxic 
than taurodeoxycholate (TCDA).  Electron microscopy showed severe distortion of the cell 
envelope, complete permeabilization of cells and prevention of glucose uptake by Lactobacillus 
reuteri CRL 1098.  The lipid composition of the membrane, including the ratio of phospholipids 
to glycolipids, changed significantly.  This can be explained by the improved physico-chemical 
properties of the membrane after a rapid adaptive response to bile by viable cells.  However, 
sugar transport and permeability assays revealed changes in the integrity of the cell wall, leading 
to death (Taranto et al., 2006).  Lactobacillus spp. differ significantly in bile tolerance and are 
less sensitive to human bile than bovine bile (Fig. 3; Del Piano et al., 2006). 
 
Bile salt hydrolase (BSH) activity is a controversial subject.  The phenomenon was initially 
associated with natural tolerance to bile salts (De Smet et al., 1994; Moser and Savage, 2001). 
However, recent studies have shown that bile salt resistance of lactobacilli could not be 
associated with the presence of BSH (Gilliland and Speck, 1977; Moser and Savage, 2001; 
Schmidt et al., 2001).  
 
3.2 Mechanisms of survival in the gastro-intestinal tract 
The reaction of bacteria to intestinal conditions is not fully understood (De Vriese et al., 2006).  
Genome sequencing could be a new resolution and therefore the complete genome sequences of 
probiotic bacteria such as L. plantarum WCFS1, L. acidophilus NCFM and L. johnsonii NCC 
533 were determined (Alterman et al., 2005; Kleerebezem et al., 2003; Pridmore et al., 2004).  
Genomic analysis together with studies done on their behavior in the gastro-intestinal tract could 
give more insight into the mechanisms behind probiotic functions (De Vos et al., 2004). 
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Fig. 3.  Gastro-intestinal resistance of different strains of L. plantarum to 0.3% human bile and 
bovine bile salts (Del Piano et al., 2006). 
 
Mechanisms used by Gram-positive bacteria in resistance to acid include proton pumps, amino 
acid decarboxylation, electrogenic transport systems, chaperones involved in repair/degradation 
of damaged proteins, incremental expression of regulators promoting local or global responses 
and changes in the structure of the cell envelope (Cotter & Hill, 2003). The F1F0-system encoded 
by the atp operon and ornithine decarboxylase (La996) was studied for L. acidophilus NCFM 
(Azcarate-Peril et al., 2004).  A thioredoxin system and genes encoding glutathione reductase, 
NADH-oxidase and NADH-peroxidase were also identified (Altermann et al., 2005).  L. 
johnsonii NCC 533 has three genes encoding BSH, one less than L. plantarum WCFS1 (Pridmore 
et al., 2004).  The large number of BSH-encoding genes emphasizes the importance of this 
characteristic to survival of strains in the gastro-intestinal tract (Dambekodi & Gilliland, 1998; 
Pridmore et al., 2004).  
 
Genes that are switched on under conditions simulating the gastro-intestinal tract were detected in 
several in vitro studies.  Fragments of the L. plantarum WCFS1 genome were cloned upstream of 
a promoterless alanine racemace (alr) gene of Lactococcus lactis in a low copy number plasmid.  
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The plasmid library, which covered 98 % of the genome, was introduced into a alr deletion 
mutant (L. plantarum∆alr) (Bron, Meijer et al., 2004).  Clones that could complement the D-
alanine auxotroph phenotype in the presence of 0.8 M NaCl were screened.  Significantly higher 
production of alr in eight clones was detected that contained L. plantarum promoters preceding 
genes coding for different functions.  These functions included an integral membrane protein, 
glycerate kinase, permease, short chain dehydrogenase and different hypothetical proteins.  A 
specific regulation of genes was indicated by four promoters with the same conserved motive, not 
present on the chromosome (Bron, Meijer et al., 2004).  Thirty-one genes, including 11 
membrane- and cell wall-associated functions, five functions involved in redox reactions and five 
regulatory factors were induced in the presence of 0.1 % porcine bile (Bron, Molenaar et al., 
2004).  Growth of L. plantarum WCF1 on MRS agar, with or without 0.1% porcine bile, was 
compared by using DNA micro-arrays.  Stress proteins, cell-envelope located proteins and 
proteins involved in redox reactions were up-regulated (Bron, Hoffer et al., 2004; Bron, Molenaar 
et al., 2004). These studies showed alterations in the cell wall that could protect the cell from 
harsh conditions (Bron, Hoffer et al., 2004).  Genes involved in redox reactions which are up-
regulated might be explained by different metabolic reactions under intestinal conditions. 
 
A resolvase-based in vivo expression technology (R-IVET) was used to switch on the genes of L. 
plantarum WCFS1 in the intestinal tract of mice (Bron, Grangette et al., 2004).  The genes coded 
for sugar-related functions, acquisition and synthesis of amino acids, nucleotides, cofactors, 
vitamins and stress-related functions (Fig. 4).  Deletion of these genes resulted in reduced 
survival of L. plantarum WCFS1 in the gastro-intestinal tract.  This indicated that L. plantarum 
WCFS1 adapts to different environmental conditions and that the series of functions are 
concentrated in a defined genomic region (Kleerebezem et al., 2003). 
 
DNA micro-arrays were used to determine gene expression of L. plantarum 299v in surgically 
removed intestinal segments of potential colon cancer patients (De Vriese et al., 2006).  The 
patients were fed a fermented oatmeal drink with L. plantarum 299v.  Genes encoding sugar 
uptake and metabolism, amino acid biosynthesis, cell division and stress were up regulated. This 
indicated survival, metabolic activity and growth of L. plantarum attached to the human intestine 
(De Vriese et al., 2006).  DNA micro-arrays combined with clinical studies may provide insight 
and new perspectives on in vivo host-microbe interactions (De Vriese et al., 2006).  
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4. Adhesion 
4.1 Adhesion to mucus 
Ingested micro-organisms are exposed to mucus in the small intestine after surviving through the 
stomach.  Adhesion to mucus prevents flushing out of cells, especially in the small intestine with 
relatively high flow rates (Kirjavainen et al., 1998; Sanford, 1992).  The in vitro models that are 
used to study adhesion of probiotic bacteria to mucus are listed in Table 4. 
 
Kirjavainen and co-workers (1998) were the first to study the interaction between probiotic 
bacteria and glycoproteins.  They found that adhesion of LAB to human intestinal tissue and 
mucus is strain dependent and reported the best adhesion with Lactobacillus rhamnosus GG 
(LGG).  In a similar study, Tuomola et al. (1999) have shown that adhesion is concentration-
dependent of adhesion sites.   In another study, strains adhered stronger to the mucus of adults 
compared to the mucus of newborns (Kirjavainen et al., 1998).  Less significant differences in the 
bacterial adhesion were recorded among infants of different ages.  A positive correlation between 
increasing age and increased degradation of mucin exists between birth and 1 month, and 
between 6 and 9 months and complete degradation of mucin starts during the first and  
Hypothetical  
proteins 
Transport and 
binding proteins 
Cell envelope 
Energy metabolism 
Cellular processes 
Regulatory functions 
Protein synthesis
Fatty acid metabolism 
Central intermediary metabolism 
DNA metabolism 
Amino acid biosynthesis 
Biosynthesis of cofactors NucleotidesProtein fate 
Other 
factors 
 
Fig. 4.  Functional classes of genes of L. plantarum induced in the intestinal tract of 
rats, determined by using resolve-based in vivo expression technology (R-IVET) 
(Bron, Grangette et al., 2004). 
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Table 4 
In vitro methods used to study adhesion of probiotic bacteria to mucus 
Sources: 
Mucus or mucus glycoproteins extracted from human faeces (Kirjavainen et al., 1998; Ouwehand 
et al., 1999), ileostomy glycoproteins (Ouwehand et al., 2001), or pig small intestine (Jonsson et 
al., 2001).  
Adhesion determination: 
Radioactive labeling of micro-organisms (Cohen & Laux, 1995). 
Immobilized mucus in microtiter wells (Jonsson et al., 2001).  
Scanning electron microscopy (Sarem-Damerdji et al., 1995).  
Fluorescent-tagged bacteria (Vesterlund et al., 2005). 
In vivo fluorescence imaging (Francis et al., 2001). 
 
second year of life (Midvedt et al., 1994; Norin et al., 1988). Adhesion may also be reduced by 
exposure to low pH, suggesting that adherence may be reduced after passage through the  
stomach (Ouwehand et al., 2001).  The health status of an individual also plays an important role.  
Composition of mucus differs in patients with rectal carcinoma, diverticulitis and irritable bowel 
syndrome (IBD) (Ouwehand et al., 2003).  It is thus safe to assume that the availability of 
adhesion sites will differ.  A decrease in viable cell numbers of lactobacilli and bifidobacteria has 
been reported in patients with IBD and colon cancer (Salminen et al., 1995).  Treatment of these 
patients with probiotics that have good adhesion properties may alleviate symptoms (Ouwehand 
et al., 2003).  LGG showed better adhesion to tissue from IBD patients than tissue from 
diverticulitis or rectal carcinoma, whereas Lactobacillus breve adhered best to mucus from 
patients with rectal carcinoma.  This study suggested the use of selected strains for specific 
intestinal diseases.  Many other studies (Tables 5-7) show the adhesion of probiotic bacteria to 
mucus.   
 
No competitive exclusion of Salmonella typhimurium or Escherichia coli SfaII was observed in 
the presence of L. brevis PEL1, L. reuteri ING1, L. rhamnosus VTT E-800 and L. rhamnosus 
LC-705 (Ouwehand et al., 2001).  Adhesion of S-fimbriated E. coli to mucus was relatively high 
and was slightly reduced by LGG, L. rhamnosus LC-705 and L. rhamnosus isolated from human 
faeces.  Adhesion of S. typhimurium was significantly inhibited by L. johnsonii LJ1 and L. casei 
Shirota.  However, adhesion of S. typhimurium strengthened in the presence of L. rhamnosus GG 
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and L. rhamnosus (human isolate), suggesting an interaction between cells (Tuomola et al., 
1999). 
 
Table 5 
Adhesion of probiotic bacteria to human colonic tissue (obtained from Sarem-Damerdji et al., 
1995)  
Probiotic bacteria Adhesion 
Bacilli per 1 mm2 of tissue/ 
(adhesion evaluation) 
Control  
L. acidophilus NCFB 1748 
L. acidophilus Ki 
L. rhamnosus GG 
L. casei 212.3 
L. plantarum 43364 
0.12 ± 0.06 x 105    (-) 
12.96 ± 6.29 x 105  (+) 
0.15 ± 0.09 x 105    (-) 
14.32 ± 1.82 x 105  (+) 
33.46 ± 8.25 x 105 (++) 
24.75 ± 2.14 x 105 (++) 
 
 
More than 60 % of probiotic preparations on the market contain strains of enterococci (Franz et 
al., 1999).  Little research has been done on the adhesion of these strains to mucus and their 
competitive exclusion of pathogens (Franz et al., 1999).  The adhesion of Enterococcus faecium 
M74 and E. faecium SF68 to mucus was 3 % and 18 %, respectively (Pultz et al., 2006).  The 
adhesion was classified low when compared to 9.2 % adhesion recorded for strain LGG.  
Approximately 9 % of Enterococcus faecium 18C23 cells adhered to small intestine mucus of 
piglets and effectively inhibited the adhesion of E. coli K88ac and K88MB to the mucus.  
Adhesion of more than 90 % of E. coli K88 was inhibited by the addition of 109 CFU/ml or 
higher cell numbers of E. faecium 18C23 or pH-neutralized supernatant to mucus. Treatment of 
mucus with pronase and proteinase reduced the adhesion of E. coli K88ac and increased the 
adhesion E. faecium 18C23.  The mucus receptors of the two strains may be different and 
inhibition of E. coli K88ac is possibly through steric hindrance (Jin et al., 2000a; 2000b). 
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Table 6 
Adhesion of probiotic bacteria to human ileostomy glycoproteins (obtained from Tuomola et al., 
1999, Ouwehand et al., 2001) 
Probiotic bacteria         Adhesion (%) 
L. rhamnosus  
L. rhamnosus GG 
L. acidophilus LC1 
L. plantarum ATCC 8014 
L. casei (Fyos®) 
L. rhamnosus ATCC 7469 
L. casei Immunitas  
L. casei 01 (Starter culture 
Chr. Hansen) 
L. casei var. rhamnosus 
(Lactophilus®) 
L. rhamnosus LC-705 
L. casei (BIO®, Danone) 
L. casei Shirota (Yakult®) 
Lact. lactis subsp. cremoris 
ARH 74 
L. brevis PEL1 
L. reuteri ING1 
L. rhamnosus E-800 
L. rhamnosus LC-705 
L. rhamnosus GG 
31.6 
28.7 
5.6 
1.7 
1.2 
0.74 
0.53 
              0.45 
 
0.43 
 
0.41 
0.36 
0.35 
0.51 
 
19.3 
36.5 
34.0 
0.79 
35.0 
 
Table 7 
Adhesion of probiotic bacteria to mucus of adult humans (obtained from Kirjavainen et al., 1998; 
Ouwehand et al., 1999) 
Probiotic bacteria      Adhesion (%) 
L. crispatus Mu5 
L. crispatus M247 
L. rhamnosus GG 
L. johnsonii La1 
L. paracasei F19 
L. salivarius LM2-118 
L. rhamnosus (faecal isolate) 
L. bulgaricus 
L. johnsonii LJ1 
Lc lactis cremoris 
Enterococcus 
L. rhamnosus 744 
L. rhamnosus ATCC 7469 
L. plantarum ATCC 8014 
2.1 
10.4 
46.0 
14.4 
9.7 
7.7 
48.0 
33.0 
30.0 
23.0 
8.0 
8.0 
6.0 
6.0 
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4.2 Adhesion to epithelial cells 
A collection of cell lines was established in the 1970’s with the aim of performing studies on 
cancer mechanisms and related cytostatic therapies (Fogh et al., 1977).  Specific intestinal 
properties of these tumoral cell lines were studied.  Addition of synthetic or biological factors 
induced partial differentiation (Pinto et al., 1983).  Caco-2 cells showed a spontaneous 
differentiation pathway in long-term culture.  During differentiation these cells express several 
morphological and biochemical characteristics of small intestine enterocytes (Pinto et al., 1983).  
Caco-2 cells have a cylindrical polarized morphology, microvilli on the apical side, tight junction 
between adjacent cells and express low levels of hydrolase when grown  
in a monolayer.  Expression of these enzymes leads to the selection of prominent sub-populations 
of cells.  Several clonal cell lines have been isolated from the parental line that expresses a 
homogenous collection of differentiation traits.  Results obtained with Caco-2 cell lines in 
different laboratories are often difficult to compare (Sambuy et al., 2005).  Over the past 25 years 
the Caco-2 cell lines were used extensively in experiments to determine adhesion properties of 
probiotic bacteria (Sambuy et al., 2005).  An alternative in vitro adhesion model is the colonic 
cell line HT-29 which also shows typical characteristics of enterocytic differentiation (Gopal et 
al., 2001).  Other cell lines include fetal I-407 (Gork et al., 1999) and the more recently 
developed IPEC-J2 isolated from the jejunum of piglets (Schierack et al., 2005).  The HT29-
MTX cell line from the small intestine of humans was developed to simulate a mucus-secreting 
environment (Lesuffleur et al., 1990).   
 
Conventional and microscopic methods are used to determine the adhesion of probiotic bacteria 
to epithelial cell lines (Table 8). 
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Table 8 
In vitro methods used to determine the adhesion of probiotic cells to epithelial cell lines 
Conventional and microscopic methods:  
Plate counting after treatment with Triton-X 100 (Bertazzoni-Minelli et al., 2004; Forestier et al., 
2001; Shillinger et al., 2005) 
Microscopic counting of fixed bacteria after Gram-staining (Tuomola & Salminen, 1998) or 
Giemsa-staining (Forestier et al., 2001).  
Adhesion is calculated as the percentage of bacteria adhered, or adhered bacteria per cell 
(Shillinger et al., 2005). (These techniques are laborious and bacteria have to remain culturable 
when released).  
Real-time PCR (Candela et al., 2005).  
In vivo fluorescence imaging (Francis et al., 2001). 
Analysing of adhered bacteria: 
Liquid scintillation counting of radio-labeled bacteria (Gopal et al., 2001).  
Fluorescent staining of bacteria and subsequent spectro-fluorimetric detection (Bianchi et al., 
2004), especially when using mixed cultures.  
Fluorochromes are used to replace the radiolabels because of better safety and cost concerns, but 
may alter the surface properties of bacteria and affect their viability (Fuller et al., 2000). 
 
Several strains of L. casei, L. paracasei, L. acidophilus and L. rhamnosus, isolated from dairy 
products, were studied for adhesion to cell lines (Baccigalupi et al., 2005; Bertazzoni et al., 2004; 
Forestier et al., 2001; Gopal et al., 2001; Pennacchia et al., 2006; Shillinger et al., 2005; Tuomola 
& Salminen, 1998).  Adhesion to Caco-2 cells is strain specific and varies from 9.7 % recorded 
for L. rhamnosus GG (Tuomola & Salminen, 1998) to between 3 % and 14 % recorded for other 
strains of Lactobacillus spp. (Tuomola & Salminen, 1998).  In the case of mucus-producing 
HT29 MTX cells, adhesion increased to between 20 % and 40 % (Shillinger et al., 2005).  Caco-2 
cells have less adhesion sites compared to HT29-MTX cells (Blum et al., 1999).  Cell wall 
structures are expressed from the onset of stationary growth (Blum et al., 1999) and secretion of 
adhesion promoting factors reach optimal levels towards the end of stationary growth.  Structures 
involved in binding to carbohydrate moieties in mucus are different from structures implicated in 
adhesion to Caco-2 cells and the process is not influenced by growth phase (Blum et al., 1999).  
Acetate buffer (pH 5.0) promoted the adhesion of L. johnsonii La1, although difference in pH 
values did not affect the adhesion of L. rhamnosus GG (Blum et al., 1999).  A study conducted 
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by Tuomola and Salminen (1998) have shown that commercial probiotic strains with reported 
health effects such as L. casei Shirota did not adhere more effectively than other strains.  The 
authors suggested that cells other than Caco-2 should also be used in adhesion studies.  
Preliminary studies with Caco-2 cell lines are, however, useful for dose-response studies (Saxelin 
et al., 1991; 1993; Saxelin, 1997). 
 
Several in vivo studies with mice and pigs were conducted to study the adhesion of probiotic 
strains.  Gnotobiotic mice were orally fed with L. rhamnosus GG and L. johnsonii La1 and the 
bacteria were established in all segments of the gut (Bernet-Camard et al., 1997).  L. salivarius 
and L. plantarum strain 299v colonized the gut of gnotobiotic mice (Kabir et al., 1997; 
Matsumoto et al., 2001).  Lactobacillus spp. orally administrated to gnotobiotic pigs colonized 
the jejunum and ileum (Bomba et al., 1996).  In a few well-designed human trials, colonization of 
L. rhamnosus GG in the intestinal tract was proved by colonic biopsies from patients who 
consumed a whey drink fermented with the strain (Alander et al., 1997; 1999; Isolauri et al., 
1994; Sarem-Damerdji et al., 1995).  L. johnsonii La1 and L. casei Shirota also survived 
intestinal transit in adults (Donnet-Hughes et al., 1999).  All of these studies showed that 
probiotics have to be taken on a daily basis to provide a continuous exogenous probiotic effect 
(Bezkorovainy, 2001). 
 
Intestinal pathogens adhere to the surface of epithelial cells (Alam et al., 1996; Scaletsky et al., 
2002; Weinstein et al., 1998).  Cell line models have been used to study the mechanisms 
pathogenic micro-organisms use to cross the intestinal epithelium and infect the host (Chauviére 
et al., 1992; Forestier et al., 2001; Lee et al., 2003).  Lactobacilli have adhesins on their cell 
surfaces, similar to those on the surface of bacterial pathogens (Neesler et al. 2000).  Probiotic 
strains such as L. rhamnosus GG and L. casei Shirota may thus compete with intestinal pathogens 
for adhesion sites in the intestinal tract (Lee et al., 2003).  Lactobacilli have the ability to displace 
gastro-intestinal bacteria.  L. rhamnosus GG adheres to epithelial cells via hydrophobic 
interaction and displace a pathogen by steric hindrance.  Once bound to the epithelial cells, the 
bacterial cell is displaced only when it detaches from the enterocytic receptor.  L. rhamnosus GG 
inhibited the re-attachment of the bacterium by binding to the enterocytic receptor (Lee et al., 
2003).  Another example of steric hindrance is the adhesion of heat-killed cells of L. acidophilus 
LB to Caco-2 cells.  This inhibited the adhesion of diarrheogenic E. coli (Chauviére et al., 1992).  
Multiple surface adhesins were found on L. casei Shirota.  Four of these adhesins bound to the 
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mucosal surface (Lee et al., 2002) and affected competition and exclusion interactions with 
pathogens.  One cell of L. casei rhamnosus could out-compete as many as four pathogen cells 
(Lee et al., 2003).  In another study by Forestier et al. (2001) the presence of L. rhamnosus 
(Lcr35) decreased adhesion of three pathogens, enteropathogenic and enterotoxigenic E. coli and 
Klebsiella pneumoniae.  The access of pathogens to receptor sites was possibly impeded by the 
addition of Lcr35.  A second explanation is the interaction of Lcr35 with the level of mucins 
produced by Caco-2 cells.  Although Caco-2 cells express significant levels of mucins, 
expression is further elicited in the presence of a probiotic (Mack et al., 1999).  Bacteriocins, 
produced by lactobacilli may also play a role in the competitive exclusion of pathogens.  L. 
johnsonii La1 inhibited the growth of Giardia intestinalis and its attachment to Caco-2 cells. The 
factors involved were heat-labile peptides of low molecular mass (Perez et al., 2001).  Spent 
culture supernatant of LB blocked the intracellular life cycle of S. enterica serovar. Typhimurium 
SL1344 and inhibited cell damage induced by Salmonella and E. coli (Coconnier et al., 2000). 
 
Milk with a high fat content reduces the adhesion of probiotic bacteria. Care should therefore be 
taken during the selection of different fats and fatty acids in the developing of new probiotic food 
products (Ouwehand et al., 2001).  A calcium level of 10 mM, which corresponds to the calcium 
content in milk, increased the adhesion of lactobacilli (Larsen et al., 2007).  Adhesion levels of 
poorly adhesive strains increased when probiotic formulations were supplemented with calcium 
(Larsen et al., 2007). Polyunsaturated fatty acids possess antimicrobial activities that modulate 
the action of probiotics in the gut (Kankaanpää et al., 2001).  Cellular growth and adhesion of 
LGG, L. casei Shirota and L. bulgaricus to mucus were reduced in the presence of high levels (10 
- 40 µg PUFA ml-1) of polyunsaturated fatty acids (PUFU).  The adhesion sites on Caco-2 cells 
were also altered by PUFA.  However, low concentrations of γ-linolenic acid and arachidonic 
acid promoted growth and adhesion of L. casei Shirota to mucus.  Adhesion of L. casei Shirota to 
Caco-2 cells improved in the presence of α-linolenic acid (Kankaanpää et al., 2001). 
 
4.3 Mechanisms of adhesion 
Mechanisms involved in the binding of probiotic bacteria to epithelial cells and mucus have been 
studied to understand the balance of intestinal microflora and to provide a basis for rational 
design of probiotic bacteria (Greene & Klaenhammer, 1994).  
Physico-chemical properties of bacteria, which facilitates the first contact between the 
microorganism and intestinal mucus or epithelial cells, include cell surface hydrophobicity, 
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passive forces, electrostatic interactions and steric forces, (Schillinger et al., 2005; Wadström et 
al., 1987).  These properties precede the adhesion process mediated by specific mechanisms and 
are therefore weak and reversible.  In contrast to the reports of Wadström et al. (1987), no 
correlation between hydrophobicity and adhesion to mucus or epithelial cells was observed in 
subsequent studies (Ouwehand et al., 1999; Savage, 1992; Shillinger et al., 2005).  These 
discrepancies can be explained by the use of different methods (Ouwehand et al., 1999; Savage, 
1992; Shillinger et al. 2005). Although hydrophobicity might assist adhesion, it is not a 
prerequisite for strong binding to mucus and epithelial cells (Shillinger et al., 2005).  
 
Greene and Klaenhammer (1994) pre-treated Lactobacillus spp. with proteases of the human 
gastro-intestinal tract and periodate to examine variations in proteins and carbohydrate adhesion 
cites on the cell walls.  The adhesion process involves specific mechanisms that include cell-
surface proteins (Adlerberth et al., 1996; Bernet et al., 1994; Roos & Jonsson, 2002; Satoh et al., 
1999), carbohydrates (Granato et al., 1999; Vidal et al., 2002), hemagglutins (Andreu et al., 
1995), aggregation promoting factors (Ventura et al., 2002), S-layer proteins (Frece et al., 2005) 
and lipoteichoic acids (Greene & Klaenhammer, 1994).  Various proteins involved in adhesion of 
Lactobacillus spp. have been isolated and characterized (Table 9). 
 
Many bacteria have a crystalline layer on their cell surface, which changes with the environment 
(Boot & Powels, 1996).  This layer consists of single protein or glycoprotein species with relative 
molecular weights of 40 000 to 200 000, representing 10-15 % of the total protein of the bacterial 
cell (Sára & Sleytr, 2000).  Bacteria have efficient expression of genes, synthesis and secretion of 
S-layer proteins (Boot & Pouwels, 1996).  The S-layer structure contains pores of identical size 
and morphology that comprise up to 70 % of the lattice surface area (Sleytr & Beveridge, 1999).  
S-layer proteins are involved in cell protection, adhesion, trapping molecules and ions, and 
virulence (Åvall-Jääskeläinen & Palva, 2005; Sleytr & Jacobsen, 1983).  S-layer proteins isolated 
from L. acidophilus, L. amylovofus, L. brevis, L. buchneri, L. casei, L. crispatus, L. fermentum, L. 
gallinarum, L. helveticus, L. kefir, L. parakefir vary from 25 to 71kDa in size (Ǻvall-Jääskeläinen 
et al., 2002; Barker &; Boot et al., 1993; 1995; 1996; Callegari et al., 1998; Jakava-Viljanen et 
al., 2002; Kos et al., 2003; Lortal et al., 1992; Masuda & Ka-wata, 1981; 1983; Sillanpää et al., 
2000; Thorne, 1970; Vidgrén et al., 1992).    
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Table 9 
Adhesion factors isolated from Lactobacillus spp. 
Bacterial strains Adhesion factors Characterization Molecular 
mass (kDa)
References 
L. plantarum 
299, L. 
plantarum 
299v 
Mannose-
specific adhesin 
Cell-surface 
protein 
- Adlerberth et al. 
(1996) 
L. johnsonii 
NCC533 (La1) 
LTA Cell Surface-
Associated 
lipoteichoic acid 
46 Granato et al. (1999) 
L. gasseri 
SBT267 
L. gasseri 
LA187 
L. gasseri LA2 
SLP Cell-surface lectin 50 
30 
25 
30 
60 
Matsumura et al. 
(1999) 
L. reuteri 104R MapA Cell-surface 
protein, mucus 
adhesion 
promoting protein 
26 Satoh et al. (1999) 
L. reuteri 1063 Mub Cell-surface 
protein 
358 Roos & Jonsson, 
(2002) 
L. gasseri VPI 
11759 
L. gasseri ATCC 
19992 
L. johnsonii 
ATCC 332, 
ATCC 533(La1) 
 
ATCC 33200 
 
ATCC 20553 
 
DSM 11506 
 
Apf1 
Apf2  
Apf1 
Apf2 
Apf1 
Apf2 
Apf1 
Apf2 
Apf1 
Apf2 
Apf1 
Apf2 
Apf1 
Apf2 
Aggregation 
promoting factor 
29.8 
29.8 
26.3 
26.3 
27.45 
31.0 
26.3 
32.0 
25.39 
29.77 
28.69 
32.38 
28.69 
32.38 
Ventura et al. (2002) 
 
 
L. johnsonii 
NCC533 (La1) 
EF-Tu Cell Surface-
Associated 
Elongation factor 
Tu 
50 Granato et al. (2004) 
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Many of the genes encoding these proteins have been sequenced (Table 10).  S-layer proteins in 
lactobacilli function in adhesion to epithelial cells (Frece et al., 2005; Schneitz et al., 1993) and 
mammalian extracellular matrix (stable macromolecular structure underlying epithelial and 
endothelial cells) (Hynonen et al., 2002; Sillanpää et al., 2000; Toba et al., 1995).  S-layer 
proteins of L. crispatus ZJ001 are involved in adhesion to epithelial cells and competitive 
exclusion of pathogens such as Escherichia coli O157:H7 and Salmonella typhimurium (Chen et 
al., 2007).  However, removal of the S-layer proteins by treatment with LiCl revealed that they 
are not involved in the adhesion of lactobacilli to Caco-2 cells (Greene & Klaenhammer, 1994). 
 
Table 10 
Sequenced S-layer protein genes, isolated from Lactobacillus species (obtained from Åvall-
Jääskeläinen & Palva, 1995) 
Bacterial species Strain GenBank accession 
number 
L. acidophilus ATCC 4356 
 
 
AF250229 
L. crispatus JCM 5810 
 
 
LMG 12003 
 
 
AB110090 
AB110091 
AJ007839 
AF253043 
AF253044 
 
L. helveticus GCL1001 
JCM1003 
ATCC 12046 
ATCC 15009 
CNRZ 303 
CNRZ 35 
IMPC i60 
IMPC M696 
IMPC HLMI 
AB061775 
AB061776 
AJ388558 
AJ388559 
AJ388560 
AJ388561 
AJ388562 
AJ388563 
AJ388564 
 
 
5. In vitro and in vivo fluorescent imaging 
Fluorescent staining is a safe and cost-effective technique to visualize bacteria in vitro (Fuller et 
al., 2000).  Lectin binds specifically to N-acetylglucosamine in the peptidoglycan layer of Gram-
positive bacteria.  Cell-permeating nucleic acid stains, e.g. intercalating dyes such as ethidium 
bromide and propidium iodide and minor-groove binders such as DAPI and Hoechst dyes, stain 
Gram-negative bacteria (Mason et al., 1998). 
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Vesterlund and co-workers (2005) described a new model which involves the use of resected 
human intestinal tissue, fluorescent-tagged bacteria and confocal laser scanning microscopy 
(CLSM), as well as human intestinal mucus and bioluminescent-tagged bacteria.  Fluorescent 
protein encoding genes are transformed into bacteria to ensure minimal background fluorescence.  
Fluorescent-tagged bacteria can be detected in an environment where other bacteria are present. 
 
Animal models are used in preclinical tests to evaluate therapeutic agents.  These tests are time 
consuming and do not always give a true prediction of the outcome of human clinical trials.  
Real-time in vivo imaging requires fewer test animals and less time than other animal testing 
models. Only one animal is needed to collect temporal and spatial data over different time points 
(Sadikot & Blackwell, 2005). 
 
A bioluminescent or fluorescent reporter gene is expressed in a living organism and real-time in 
vivo imaging utilizes the light emitted.  The strength of the signal is analyzed and allows 
extensive three-dimensional modeling in the live animal.  Cellular or genetic activity is 
monitored to track gene expression, the spread of a disease or the effect(s) of a new potential 
drug in vivo (Sadikot & Blackwell, 2005).   
 
A few studies have been done using in vivo fluorescence imaging.  A novel Gram-positive lux 
transposon cassette, Tn4001 luxABCDE Kmr allows random integration of lux genes onto the 
genome of bacteria.  Clinical Streptococcus pneumoniae isolates were transformed with plasmid 
Tn4001 luxABCDE Kmr, in a pneumococcal lung infection model for drug development.  The 
outcome of antibiotic treatment could be monitored in real time in living animals.  Strong 
bioluminescent signals were seen in the lungs of the infected animals and corresponded with 
recovered bacteria (Francis et al., 2001).  The effectiveness of amoxicillin treatment in infection 
of mice was determined by transforming strains of Staphylococcus aureus with plasmid DNA 
containing a Photorhabdus luminescens lux operon (luxABCDE).  The light signal decreased after 
8 h and no signal was detected after 24 h, which indicated that the antibiotic was effective 
(Francis et al., 2000).  Three different antibiotics were evaluated for antimicrobial activity in a 
mouse model.  The metabolic activity of rifampin was dose-dependent and the disappearance of 
light emission correlated with decrease in colony counts (Kadrugamuwa et al., 2003).  These 
studies are examples of successful in vivo fluorescence imaging.  In vivo monitoring has 
numerous other applications.  Probiotic bacteria can be monitored in the gastro-intestinal tract to 
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determine their survival, adhesion and competitive exclusion of pathogens causing infection and 
application of these techniques will ensure high quality probiotic research in the future.  
 
6. Characterization of antimicrobial agents produced by LAB 
Fermentation of carbohydrates by LAB leads to the production of antimicrobial compounds 
including organic acids, diacetyl, hydrogen peroxide or other low molecular weight compounds 
such as reuterin (Piard & Desmazeaud, 1992a; 1992b; Vandenberg, 1993). Antimicrobial activity 
of LAB could also be due to the production of bacteriocins, a family of antimicrobial peptides 
that have gained increasing interest.  These substances exert in some cases a narrow, or in other 
cases, a relatively broad spectrum of antimicrobial activity (Rodríguez et al., 2003). 
 
6.1 Organic acids 
Lactic acid is produced during homofermentation of hexoses and a combination of lactic acid, 
acetic acid/ethanol and CO2 by heterofermentation (Ouwehand & Vesterlund, 2004).  Acetic and 
propionic acid have a wide spectrum of inhibitory activity, which includes yeasts, molds, and 
bacteria (Ouwehand & Vesterlund, 2004).  In a mixture, the lactic acid reduces the pH, 
permeabilizes membranes and hereby enhances the activity of the propionic and acetic acids 
which become undissociated and act as antimicrobial agents (Alakomi et al., 2000).  The acid 
diffuses across the cell membrane, dissociates in the neutral cytoplasm, releasing protons and 
anions which lead to growth inhibition (Cherrington et al., 1991; Padan et al., 1981; Slonczewski 
et al., 1981). 
 
6.2 Hydrogen peroxide 
LAB generate hydrogen peroxide that may scavenge oxygen and create an anaerobic 
environment that is unfavorable for certain microorganisms (Ouwehand & Vesterlund, 2004). 
Gram-negative bacteria are rapidly killed, whereas the growth of Gram-positive bacteria 
including LAB is inhibited (Blom & Mörtvedt, 1991; Condon, 1987; Lindgren & Dobrogosz, 
1990).  Hydrogen peroxide has a strong oxidizing effect on the bacterial cell, sulfhydryl groups of 
cell proteins and membrane lipids (Morris, 1976; Schlegel, 1985; Lindgren & Dobrogosz, 1990).  
Lactobacilli, which colonize the urogenital tract, produce hydrogen peroxide and decrease the 
acquisition of human immune deficiency virus (HIV) infection, gonorrhea and urinary tract 
infections (Vallor et al., 2001).  The main antimicrobial effect is the blocking of glycolysis.  
Glucose transport, hexokinase activity, and glyceraldehyde-3-phosphate dehyrogenase activity 
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are inhibited due to the oxidation of sulfhydryl groups in metabolic enzymes (Carlsson et al., 
1983).   
 
6.3 Carbon dioxide 
Production of carbon dioxide (CO2) during lactic acid fermentation creates a micro-aerophilic 
environment.  The accumulation of enzymatic decarboxylations in the lipid bilayer is inhibited 
which causes dysfunction in membrane permeability (Lindgren & Dobrogosz, 1990; King et al., 
1975).  Gram-negative bacteria are more sensitive to CO2 than Gram-positive bacteria 
(Devlieghere & Debevre, 2000). 
 
6.4 Diacetyl 
Diacetyl (2,3-butanedione) produced by Lactobacillus, Leuconostoc, Pediococus and 
Streptococcus spp. is not only the aroma and flavor component in butter but has antimicrobial 
activity (Jay, 1982; Lemoigne, 1927).  Diacetyl reacts with the arginine-binding protein of Gram-
negative bacteria and interferes with arginine utilization (Jay, 1982).  Diacetyl is more active 
against Gram-negative bacteria, yeasts and molds than against Gram-positive bacteria (Jay, 
1982). 
 
6.5 Reuterin 
Lactobacillus reuteri produces a low molecular-weight antimicrobial substance, reuterin, when 
grown anaerobically in the presence of glucose and glycerol or glyceraldehydes (Axelsson, 
1989).  When in contact with target cells, L. reuteri is stimulated to produce reuterin which is 
active against bacteria, fungi, protozoa and viruses (Axelsson, 1989; Chung et al., 1989; 
Dobrogosz et al., 1989).  Reuterin acts against sulfhydryl enzymes and interferes with DNA-
synthesis by inhibiting the binding of substrates to the subunit of ribonucleotide reductase 
(Dobrogosz et al., 1989). 
 
6.6 Reutericyclin 
L. reuteri produces another antimicrobial substance, reutericyclin with a low molecular weight 
(349 Da), a negative charge and high hydrophobicity (Höltzel et al., 2000).  Only Gram-positive 
bacteria are sensitive to reutericyclin (Gänzle et al., 2000).  It works as a proton iophore, forming 
pores in the membranes of target cells.  Due to its hydrophobicity, it intercalates into the 
cytoplasmic membrane and selectively dissipates the transmembrane ∆pH (Gänzle et al., 2003). 
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6.7 2-Pyrrolidone-5-carboxylic acid 
Pyroglutamic acid (PCA) is present in fruits, vegetables and grasses and is produced by 
Lactobacillus casei subsp. casei, L. casei subsp. pseudoplantarum and Streptococcus bovis (Chen 
& Russell, 1989; Huttunen et al., 1995).  Pyroglutamic acid has a stronger antimicrobial activity 
than lactic acid and its mechanism of action is similar to that of organic acids and inhibits 
Bacillus subtilis, Enterobacter cloacae, Pseudomonas putida and Pseudomonas fluorescens 
(Yang et al., 1997). 
 
6.8 Bacteriocins 
Some bacteria produce antimicrobial peptides (namely bacteriocins) inhibitory to strains closely 
related to the producer strain (Klaenhammer, 1988; Tagg et al., 1976).  Since the discovery of 
bacteriocins the interest in such compounds as possible preservative agents for food, and 
potential supplements or as replacements for therapeutic  antibiotics has increased (Ouwehand & 
Vesterlund, 2004).  Consumer awareness of bacteriocins has increased as they are naturally 
produced and therefore more easily accepted than chemical preservatives (Ouwehand & 
Vesterlund, 2004).  Gram-positive bacteria, especially LAB, produce these small (2-6 kDa) 
peptides ribosomally as a defense mechanism against other organisms (Hansen et al., 1989).  
Gram-positive bacteria produce novel bacteriocins in competitive environments resulting in 
peptides bearing unique structural features and varied modes of action.  Bacteriocins are divided 
into three major classes (Table 11).  A fourth class (complex bacteriocins with carbohydrates or 
lipids) was suggested, but is not generally accepted (Ouwehand & Vesterlund, 2004).  Enterocins 
are produced by Enterococcus faecium, E. faecalis and E. mundtii and can also be grouped into 
one of these classes.  Enterocins such us enterocin A, enterocin CRL35, enterocin 31 and 
enterocin B with unusual structures or genetic characteristics can not be grouped into this 
classification scheme (Franz & Holzapfel, 2004).  
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Table 11 
Classes of bacteriocins produced by LAB (Ouwehand & Vesterlund, 2004) 
Class Subclass Description 
I (lantibiotics) A (1) 
 
 
 
A(2) 
 
 
B 
Elongated, cationic, 
membrane active, slight 
positive or negative net 
charge 
Elongated, cationic, 
membrane active, highly 
positive net charge 
Globular, inhibit enzyme 
activity.  
II  
 
 
 
 
IIa 
 
 
IIb 
IIc 
Small 9<10kDa), moderate 
(100°C) to high (121°C) heat 
stable, non-lanthionine-
containing membrane-active 
peptides. 
Listeria active peptides with 
–Y-G-N-G-V-X-C-near the 
amino terminus. 
Two peptide bacteriocins 
Other peptide bacteriocins 
III  Large (>10 kDa) heat-labile 
proteins 
IV  Complex bacteriocins: 
protein with lipid and/or 
carbohydrate. 
 
6.8.1 Class I 
Class I bacteriocins (lantibiotics) are small (< 5 kDa) peptides with dehydrated amino acids and 
unusual amino acids that are synthesized during posttranslational modifications (Jack & Sahl, 
1995).  The two groups of lantibiotics (types A and B) differ in structure and function. The 
elongated cation peptides of type A disrupt the membrane integrity of target organisms. Type A 
is further classified into two groups on the basis of size, charge, and sequence of the leader 
peptide (De Vos et al., 1995).  The globular type B disrupts enzyme function by inhibiting the 
biosynthesis of the cell wall (McAuliffe et al., 2001). A well-known and widely used commercial 
lantibiotic is nisin.  Nisin is produced by Lactococcus lactis, has a broad spectrum of activity 
against Gram-positive bacteria and is bactericidal to most LAB, Staphylococcus aureus, Listeria 
monocytogenes, vegative cells of Bacillus spp. and Clostridium spp. (Klaenhammer, 1993).  
Nisin forms pores in the cytoplasmic membrane of bacteria by using lipid II as a docking 
molecule (Breukink et al., 1999).  Small compounds, such as amino acids and ATP, diffuse 
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through these pores, resulting in disruption of the proton-motive force (PMF). The biosynthesis 
of macromolecules, e.g. DNA, RNA and proteins is inhibited (Hechard & Sahl, 2002).  In 
addition, nisin can lyse cells by releasing two strongly cationic cell wall-hydrolyzing enzymes 
(N-acetylmuramoyl-L-alanine amide and  
N-acetylglucosaminidase) through a cation exchange-like process (Hechard & Sahl, 2002).  
Cytolysin is the only known class I enterocin which has bacteriocin and haemolytic activity 
against eukaryotic cells and Gram-positive bacteria (Booth et al., 1996; Gilmore et al., 1994).  
 
6.8.2 Class II 
These small (<10 kDa) bacteriocins consist of heat-stable, non-lanthionine-containing, 
membrane-active peptides with a narrow inhibition spectrum (Ouwehand & Vesterlund, 2004).  
The three subclasses include Class IIa, the largest group with antilisterial activity. Class IIb 
includes the two peptide-bacteriocins and Class IIc the other non-lantibiotic bacteriocins (Eijsink 
et al., 2002; Hechard & Sahl, 2002).  These bacteriocins dissipitate the PMF of the target cell by 
forming pores at the surface of the sensitive cell (Hechard & Sahl, 2002).  Some class IIc 
bacteriocins can prevent septum formation (Matinez et al., 2000).  
 
Class IIa bacteriocins are used to improve food safety and reduce the prevalence of foodborne 
illnesses because they are highly active against Listeria spp.  Pediocin PA-1, produced by 
Pediococcus acidilactici, is the most extensively studied from this class and is encoded by an 
operon containing a structural gene (pedA), immunity gene (pedB) and secretion genes (pedC 
and pedD) (Ouwehand & Vesterlund, 2004).  Enterocin A (EntA) produced by E. faecium strains, 
is a class IIa enterocin as it is also active against L. moncytogenes.  Mundticin KS is another class 
IIa enterocin produced by Enterococcus mundtii NFRI 7393, active against L. monocytogenes, 
Lactobacillus spp. and Enterococcus spp. (Kawamoto et al., 2002).  Class IIb enterocins include 
enterocin 1071 and enterocin L50 produced by strains of E. faecalis and E. faecium, respectively, 
and have a broad range of antimicrobial activity (Balla et al., 2000; Franz et al., 2002; Nes et al., 
1996).  Enterocin P and enterocin 1071 produced by E. faecium, and bacteriocin 31 produced by 
E. faecalis, are classified as class IIc enterocins (Balla et al., 2000; Casaus et al., 1997; Tomita et 
al., 1996). 
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6.8.3 Class III 
Class III bacteriocins are large (>30kDa) heat-labile proteins and may include bacteriolytic 
extracellular enzymes (hemolysins and muramidases) which mimic the physiological activities of 
bacteriocins (Jack et al., 1994).  These bacteriocins were only isolated from lactobacilli and 
include acidophilucin A, caseicin, helveticin J, helveticin V-1829, lactacin A and lactacin B 
(Klaenhammer, 1993).  The only enterocin grouped in class III is enterolysin A produced by E. 
faecalis LMG 2333.  Enterolysin A has a molecular weight of 34 501 Da, is heat-labile and 
inhibits growth of Enterococcus, Pediococcus, Lactococcus and Lactobacillus spp. (Nilsen et al., 
2003). 
 
6.8.4 Class IV 
This class contains complex bacteriocins with lipid or carbohydrate moieties which are necessary 
for activity.  Limited data is available for this class and it is not discussed further (Klaenhammer, 
1993).  
 
Atypical enterocins cannot be grouped into any of the four classes.  Examples are enterocins B 
and Q, produced by E. faecium, and enterocin EJ97 and AS-48, produced by E. faecalis spp. 
(Aymerich et al., 1996; Casaus et al., 1997; Gálvez et al., 1986; Gálvez et al., 1998; Papadelli et 
al., 2003; Sánchez-Hidalgo et al., 2003). 
 
Some of the different methods used to determine antimicrobial activity of bacteria are 
summarized in Table 12.  The production of antimicrobial agents by lactobacilli to inhibit 
adhesion and infection of pathogens is illustrated in Figure 5.  
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Table 12  
Methods for studying antimicrobial activity 
Agar well diffusion assay (Cintas et al., 1995) 
Cell-free supernatants of bacteriocin producers with neutralized pH are used. 
The indicator strain is plated onto agar plates and the supernatant is spotted onto the agar or into 
wells in the agar.  Agar plates are screened for clear zones which indicate positive results. 
Cell lysis (Ouwehand & Vesterlund, 2004) 
Incubate target strain with cell-free culture supernatant. Determine cell density or viable cell 
numbers. 
Fluorescence (Budde & Rasch, 2001) 
Bacteriocins are stained with carboxyfluorescein diacetate and exposed to the target organism. 
Fluorescence is measured with flow cytometry.  A decrease in fluorescence indicates the effect of 
the bacteriocin. 
 
 
Fig. 5.  (a) The process whereby a pathogen, in this case uropathogenic Escherichia coli, adheres 
to the bladder surface using various mechanisms, and causes inflammation and infection.  (b) 
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Lactobacilli colonization of the vagina interferes with pathogen adhesion and infection.  The 
ability of E. coli to dominate the flora and ascend into the bladder is reduced by lactobacilli. In 
the case of a vaginal pathogen, such as Gardnerella vaginalis, lactobacilli interfere with the 
infectious process at the epithelial interface.  The signaling molecules produced by commensal or 
exogenously applied probiotic organisms activate the host (e.g. by stimulating mucus production) 
and/or inhibit the response of the pathogen (e.g. activation of their virulence genes).  
Abbreviations: ECM, extracellular matrix; IL, interleukin; slgA, secretory IgA (Reid et al., 2001).  
 
7. Safety of probiotic bacteria 
 
7.1 Lactobacillus spp. 
Lactic acid bacteria have a long history in the dairy industry and are generally regarded as safe 
(GRAS).  For more than 70 years, species such as L. acidophilus were used as probiotics 
(Salminen et al., 1998b).  Caution should be taken in the cases of immunosuppressed patients as 
individual cases of infection have been reported (Vesterlund et al., 2007).  Other cases of 
infection caused by non-probiotic lactobacilli were also reported (Table 13).  Cannon et al. 
(2005) reported 241 cases and Husni et al. (1997) 45 cases of infection.  Bacteremia was the most 
common infection associated with Lactobacillus, especially L. casei and L. rhamnosus, followed 
by endocarditis and localized infections (Cannon et al., 2005).  Safety of new potential probiotic 
species cannot be assumed and assessment of individual strains is important (Saxelin et al., 
2005). 
 
Safety assessment of a probiotic strain includes studies of the intrinsic properties and 
pharmacokinetics of the strain (survival and growth in the intestine, dose-response relationships, 
and fecal and mucosal recovery) and interactions between the strain and host (Salminen et al., 
1998b).  Enzymatic properties, e.g. excessive deconjugation of bile salts, degradation of mucus, 
platelet aggregating and enzymes favoring cardiac valve colonization are studied in vitro 
(Donohue et al., 1998; Korpela et al., 1997; Pelletier et al., 1996).  The pharmacokinetics of 
probiotics is measured in vivo using a fecal collection of intestinal intubation and colonic biopsy 
techniques (Alander et al., 1997; Johansson et al., 1993; Saxelin, 1996).  It is much more difficult 
to predict illness related to microbiological agents in  
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Table 13 
Classification of probiotic organisms (Donohue & Salminen, 1996; Gasser, 1994; Vesterlund et 
al., 2007) 
Organism Infection potential 
Lactobacillus Mainly non-pathogens, some opportunistic 
infections (usually in immunocompromised 
patients) 
Lactococcus Mainly non-pathogens 
Leuconostoc Mainly non-pathogens, some isolated cases 
of infection 
Streptococcus Oral streptococci mainly non-pathogens 
(including Streptococcus salivarius), some 
may cause opportunistic infections 
Enterococcus Some species are opportunistic pathogens 
with haemolytic activity and antibiotic 
resistance 
Bifidobacterium Mainly non-pathogens, some isolated cases 
of human infection 
Saccharomyces Mainly non-pathogens, some isolated cases 
of human infection 
 
food than illness caused by chemical agents (Tang et al., 1993).  Differences in microbial and 
host factors make it difficult to determine minimum dosages (Salminen et al., 1998a). 
The capacity of probiotic bacteria to invade epithelial cells is studied by culturing intestinal cells 
(Tang et al., 1993).  Translocation of probiotic bacteria, mucus degradation and immunological 
side-effects are determined in animal models (Salminen et al., 1998b).  Short-term human trials 
are also used to assess the safety of well-known probiotics.  This has been done for L. rhamnosus 
GG, L. johnsonii LC1, L. acidophilus NFCO 1748 and L. casei Shirota (Lidbeck et al., 1987, 
1988; Orrhage et al., 1994; Saxelin, 1997). 
 
Four types of side-effects exist, namely systemic infections, deleterious metabolic activity, 
excessive immune stimulation and risk of gene transfer (Salminen et al., 1998b).  Local or 
systemic infections, including septicemia and endocarditis, are rarely caused by lactobacilli and 
bifidobacteria and are mostly associated with the host’s own microflora (Salminen et al., 1998b).  
The most dominant bacteria colonizing the small intestine may induce diarrhea and cause 
intestinal lesions by deconjugation and dehydroxylation of bile salts (Donohue et al., 1998).  
Possible side-effects of probiotics with high BSH-activity are now being investigated (Salminen 
et al., 1998b).  Strains that metabolize glycoproteins and synthesize and lyse fibrin clots which 
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lead to enhanced infection risk of endocarditis, should not be considered for use as probiotics 
(Oakley et al., 1995).  No immunological side-effects of any probiotic were reported in humans 
(Salminen et al., 1998b).  Some strains of L. casei administrated parenterally induced side-effects 
such as fever, arthritis, and hepatobiliary lesions (Schwab, 1993).  Cell wall components, e.g. 
peptidoglycans, elicit cytokines which mediate these side-effects (Miettinen et al., 1996; 
Perdigon et al., 1991). 
 
Lactobacillus and Bifidobacteria prevent gastro-intestinal side effects after antibiotic 
administration by restoring the intestinal microflora (Courvalin, 2006).  The spread of antibiotic 
resistance genes to pathogenic bacteria has been discovered recently.  This has lead to the 
concern about the use of multidrug resistant probiotics and their impact on the antibiotic 
resistance patterns of bacteria causing diseases (Courvalin, 2006). 
 
Two types of bacterial resistance to antibiotics exist, namely intrinsic and acquired resistance 
(Courvalin & Trieu-Cuot, 2001).  Intrinsic, or natural, resistance, is present in all strains of a 
given genus or species.  It defines the spectrum of activity of an antibiotic and is chromosomal 
and not transferable to other bacteria.  Acquired resistance is present only in a certain number of 
bacteria belonging to a specific genus or species and is induced by mutations in indigenous 
(house keeping) genes.  Acquisition of an exogenous resistance determinant from another 
bacterium is conveyed by horizontal (lateral) gene transfer (Courvalin, 2006).  The genetic 
changes alter the defensive functions of the bacteria by changing the target of the drug, i.e. by 
changing the membrane permeability, enzymatic inactivation of antibiotics (e.g. h-lactamases, 
aminoglycoside acetyl-, nucleotidyl- and phosphoryl-transferases), active transport of antibiotics 
(e.g. by membrane inserted ATP-dependent efflux systems), target modification (e.g. methylation 
of 23S rRNA, mutation of amino acid sequence of topoisomerase) (Davies, 1997), or routing 
metabolic pathways around the disrupted point (Poole, 2002). 
 
Lactobacilli, pediococci and Leuconostoc spp. have a high natural resistance to vancomycin, 
which is different for other Gram-positive bacteria (Hamilton-Miller & Shah, 1998; Simpson et 
al., 1988).  Some lactobacilli have a high natural resistance to bacitracin, cefoxitin, ciprofloxacin, 
fusidic acid, kanamycin, gentamicin, metronidazole, nitrofurantoin, norfloxacin, streptomycin, 
sulphadiazine, teicoplanin, trimethoprim/sulphamethoxazole, and vancomycin (Danielsen & 
Wind, 2003).  In the case of Lactobacillus spp., susceptibility to antimicrobial agents is species-
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dependent (Danielsen & Wind, 2003).  The antibiotic resistance profile of 55 probiotics used in 
Europe revealed resistance against kanamycin (79% of the isolates), vancomycin (65 %), 
tetracycline (26 %), penicillin G (23 %), erythromycin (16 %) and chloramphenicol (11 %).  
Overall 68.4 % of the isolates showed resistance to multiple antibiotics (Temmerman et al., 
2002).  Growth of probiotic bacteria is inhibited by the majority of antibiotics.  In the case of 
multiresistance, the probiotic can be co-administrated with antibiotics.  The possible negative 
effects are firstly the transfer of genes encoding resistance, directly or indirectly via the 
commensal flora from the probiotic to human bacterial pathogens.  Secondly, only a limited 
number of antibiotics can be used to treat a patient when probiotics acquired resistance genes 
from human commensals or from multiresistant probiotics that caused infection in 
immunocompromised patients (Courvalin, 2006). 
 
Lactic acid bacteria, like all other bacteria, acquire genes to ensure their survival in antibiotic 
containing environments.  Food microbiologists should take care to avoid the distribution of 
bacteria with mobilizable antibiotic resistances (WHO, 1997).  Special purpose probiotics have 
been developed to use in combination with antibiotics through the introduction of multiple 
resistance to the bacteria.  However, probiotics should not carry genes other than those required 
to prevent the undesirable transfer of resistance or conferment of resistance to endogenous 
bacteria (Mathur & Singh, 2005).  
 
7.2 Enterococci 
Enterococcus spp. can also be used as probiotics and a few strains have been studied in clinical 
trials.  E. faecium SF68, produced in Switzerland, is effective in the prevention and treatment of 
diarrhea and can be used as an alternative to antibiotic treatment (Lewenstein et al., 1979; 
Bellomo et al., 1980).  A fermented milk product containing this strain is also sold in Denmark 
for its hypercholesterolomic effect (Agerbaek et al., 1995).  A fermented soymilk drink has been 
developed by using E. faecium CRL 183.  Cholesterol decreased by 43% in vitro (Rossi et al., 
1999).  The probiotic strain, E. faecium Fargo 688® alleviated the symptoms of irritable bowel 
syndrome in a clinical trial and was successfully used in the production of cheddar cheese (Allen 
et al., 1996; Gardiner et al., 1999).  The scientific committee on animal nutrition classified E. 
faecium DSM 7134, NCIMB 10415, CECT 4515, NCIMB 30098, NCIMB 1181, DSM 5464, 
DSM 3520, NCIMB 10415, DSM 4788, DSM 4789 and E. mundtii CNCM MA 27/4E safe to use 
as probiotics in animals (European commission, 2004). 
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Despite a few preliminary reports on the safety of Enterococcus spp. as probiotics, controversy 
still exists in the use of these organisms as probiotics (Lewenstein et al., 1979).  One of the main 
reasons for this is the association of enterococci with human diseases and multiple antibiotic 
resistances. Bacteremia, endocarditis, urinary tract and other infections, especially in 
immmunocompromised patients, or those with severe underlying disease, are among the human 
diseases caused by enterococci (Morrison et al., 1997; Murray, 1990; Linden & Miller, 1999).  E. 
faecalis is the most dominant enterococcus in human infections (more than 80 %).  E. faecium is 
associated with the majority of remaining infections (Jett et al., 1994) and is the causative agent 
in enterococcal bacteremia probably because of vancomycin- resistance (Mundy et al., 2000).  
 
Studies have shown that antimicrobial resistance genes and genes encoding virulence factors can 
be transferred to other bacteria in the gastro-intestinal tract (Franz & Holzapfel, 2004). 
Enterococci are resistant to a wide variety of antibiotics that contributes to pathogenesis 
(Landman & Quale, 1997; Leclercq, 1997; Murray, 1990).  Intrinsic resistance occurs to the 
cephalosporins, β-lactams, sulphonamides, and low levels of clindamycin and aminoglycosides 
(Leclercq, 1997; Moellering, 1990; Moellering, 1992; Morrison et al., 1997; Murray, 1990). 
Acquired resistance, based on acquisition of plasmids and transposons, include chloramphenicol, 
erythromycin, high levels of clindamycin, aminoglycosides, tetracycline, β-lactams (by β-
lactamase or penicillinase), fluoroquinolones and glycopeptides (Landman & Quale, 1997; 
Leclercq, 1997; Moellering, 1991; Morrison et al., 1997; Murray, 1990).  
 
Vancomycin is of special concern as it is used for treatment of multiple drug resistant infections.  
In the mid-1990s vancomycin-resistant enterococci (VRE) were isolated from farm animals.  This 
led to the transmission of VRE through food in hospitals and infections that cannot be treated 
with conventional antibiotic therapy (Franz et al., 2003).  Vancomycin resistant enterococci 
possess vanA, vanB, vanC1, vanC2, vanC3, vanD and vanE type resistance genes (Arthur & 
Courvalin, 1993; Leclercq, 1997).  
Glycopeptide resistant enterococci are phenotypically and genotypically heterogeneous.  VanA 
and VanB are the most frequently observed in two predominant enterococcal species (Arthur & 
Courvalin, 1993).  The VanA-type confers high level inducible resistance to vancomycin and 
teicoplanin and VanB-type displays variable levels of inducible resistance.  A third type, VanC, 
occurs in enterococci with low-level resistance to vancomycin.  The VanC-type is also an 
intrinsic property of the motile species E. gallinarum, E. casseliflavus and E. flavescens (Dutka-
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Malen et al., 1995; Leclercq, 1997; Vincent et al., 1991).  Only a few alternatives remain for 
successful treatment of VRE (Fraise, 1996) as they are highly resistant to all standard anti-
enterococcal drugs, including penicillin–aminoglycoside combinations (Landman & Quale, 
1997).  Therefore, VRE presently constitute a serious risk among bacterial nosocomial pathogens 
and their presence in hospitals is met with great concern (Franz et al., 1999).  
 
The virulence of enterococci involves more than antibiotic resistance and includes a number of 
events, e.g. colonization of and adhesion to host tissues, invasion of the tissue and resistance to 
both nonspecific and specific defense mechanisms mobilized by the host (Franz & Holzapfel, 
2004).  Pathological changes are produced by the pathogen by toxin production or indirectly by 
inflammation (Johnson, 1994).  Virulence traits have been determined in clinical isolates that 
may be associated with one or more stages of infection (Franz et al., 2003; Jett et al., 1994).  
 
7.3 Virulence factors 
7.3.1 Aggregation substance (AS) 
The production of aggregation substance (encoded by E. faecalis pheromone-responsive 
plasmids), is induced by small (7-8 amino acids) hydrophobic peptides, named sex pheromones 
(Franz et al., 2003).  Efficient enterococcal donor-recipient contact is mediated by AS to facilitate 
plasmid transfer (Clewell, 1993).  This might contribute to pathogenesis of infection by 
enterococci through different mechanisms (Foulquié Moreno et al., 2006).  Aggregation 
substance is also involved in binding to eukaryotic cells and extracellular matrix (ECM) proteins 
e.g. fibronectin, thrombospondin, vibronectin and collagen type I (Rozdzinski et al., 2001).  
Penetration of the intestinal or genitourinary epithelium to the lymphatic and/or vascular system 
by enterococci causes abdominal infection and bacteremia (Graninger and Ragette, 1992; Wells 
et al., 1988).  The translocation of enterococci through intact epithelial cell layers was reported in 
a few studies.  Aggregation substance is the only virulence factor which plays a role in 
translocation of enterococci.  The bacteria encounter the basal membrane and ECM. Adhesion to 
exposed extracellular proteins is promoted in cases of intestinal lesions which lead to the 
promotion of bacterial translocation (Franz et al., 2003).  Adhesion to ECM proteins might also 
play a role in wound infections and bacterial endocarditis (Benn et al., 1997; Rozdzinski et al., 
2001).  Aggregation substance plays a role in increased adhesion to human neutrophils (PMNs) 
and macrophages, leading to increased survival in immune cells. The phagosomes in activated 
human neutrophils contained AS-bearing enterococci which were much larger than phagosomes 
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containing opsonized E. faecalis.  Modification of phagosomal maturation is involved in AS-
induced resistance to killing (Rakita et al., 1999). 
 
7.3.2 Sex pheromones 
Sex pheromones are cleavage products of 21- to 22-amino-acid signal peptides which are 
associated with lipo-proteins and considered as virulence determinants (Clewell et al., 2000). 
These pheromones and their surface exclusion proteins cause pathological changes including 
acute inflammation.  They induce the production of superoxide, secretion of lysozyme enzymes 
and are chemotactic for human and rat PMNs in vitro.  
 
7.3.3 Cytolysin 
Cytolysin (Cyl) or β-haemolysin/bacteriocin is an enterococcal virulence factor which is a 
cellular toxin that increases virulence in animal models (Ike et al., 1984; Jett et al., 1992, 1994; 
Chow et al., 1993; Gilmore et al., 1994).  In Japan, the hemolytic phenotype was found in 60 % 
of clinical strains involved in parenteral infection in comparison to only 17 % of isolates from the 
feces of healthy individuals (Ike et al., 1987).  A study in the United States showed similar trends 
in E. faecalis strains isolated from blood (Huycke et al., 1991).  However, a study in Germany 
revealed haemolytic activity in only 16 % E. faecalis strains isolated from blood (Elsner et al., 
2000).  The production of Cyl may evade the host immune response by destroying cells of the 
immune system such as PMNs and macrophages (Miyazaki et al., 1993).  Enterococci with β-
hemolytic activity caused a fivefold increased risk of death in patients within 3 weeks of 
bacteremia in comparison to non- β-hemolytic strains.  The production of cytolysin is considered 
to be a major risk factor associated with pathogenic enterococci (Huycke et al., 1991). 
 
7.3.4 Enterococcus surface protein from E. faecalis (Espfs) and E. faecium (Espfm) 
Shankar and co-workers (1999) were the first to describe an extracellular surface protein (Esp) in 
a clinical strain of E. faecalis MMH594.  The Esp has a molecular mass of 202 kDa and is 
capable of encoding a primary translation product of 1873 amino acids (Foulquié Moreno et al., 
2006).  Enterococcus surface proteins are produced by E. faecalis (Espfs) and E. faecium (Espfm) 
and their genes are chromosomally encoded (Franz & Holzapfel, 2004).  The incidence of Espfs is 
higher among clinical strains of E. faecalis than strains isolated from healthy individuals and can 
play a role in pathogenicity (Franz & Holzapfel, 2004).  E. faecium Espfm was highly conserved 
in infection-derived isolates and environmental isolates, although absent in food and commensal 
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isolates (Eaton & Gasson, 2001).  Enterococcus surface proteins play a role in adhesion as their 
presence increases cell hydrophobicity, adhesion to abiotic surfaces and biofilm formation in 
vitro (Toledo-Arana et al., 2001).  The C-terminal regions of Esp contain a membrane-spanning 
hydrophobic domain and a cell wall anchor motif involved in anchoring the protein to the 
bacterial surface (Franz & Holzapfel, 2004).  E. faecalis Espfs exhibits characteristics of surface 
protein receptors, designated microbial surface components, recognizing adhesive matrix 
molecules (MSCRAMMs) that mediate binding to extracellular matrix proteins.  Colonization of 
host tissue by direct ligand-binding activity to the extracellular matrix in the human host is 
promoted by Espfs (Toledo-Arana et al., 2001).  Enterococcus surface proteins also play a role in 
evasion of the host’s immune response as the structures of both Esp’s aresimilar to that of 
MSCRAMMs (Eaton & Gasson, 2002; Hucke et al., 1991; Miyazaki et al., 1993). Both proteins 
are similar in sequence and global organization and contain a signal sequence followed by an N-
terminal region and a core region that consists of repeat units (Eaton & Gasson, 2002; Shankar et 
al., 1999).  The proteins and genes share 89 % identity (Eaton & Gasson, 2002). 
 
7.3.5 Adhesion to collagen from E. faecalis (Ace) and E. faecium (Acm) 
The proteins Ace and Acm contain an N-terminal signal sequence, followed by a collagen-
binding A domain, a B region consisting of repeat units and a cell wall domain with a 
characteristic LPKTS motif.  The LPKTS motif is a potential target for hydrophobic residues, 
namely sortase that may span the membrane.  Ace and Acm share 47 % amino acid sequence 
similarity (Nallapareddy et al., 2003).  These proteins might be involved in evasion of the 
immune response by mechanisms similar to Esp.  Ace binds to types I and IV collagen and 
laminin and plays an important role in enterococci pathogenesis (Nallapareddy et al., 2000a; 
Nallapareddy et al., 2000b).  This occurs especially during translocation and when the 
extracellular matrix proteins are exposed to damaged intestinal epidermal layer.  A similar 
mechanism exists for evading the immune system and adhesion.  The collagen-binding protein 
from E. faecium, Acm, binds to collagen types I and IV which is regarded as a virulence property 
(Nallapareddy et al., 2003).  
 
7.3.6 Enterococcus endocarditis antigen from E. faecalis (EfAfs) or E. faecium (EfaAfm) 
E. faecalis and E. faecium produce adhesion-like endocarditis antigens (EfaAfs and EfaAfm, 
respectively) which are considered to be potential virulence determinants (Franz & Holzapfel, 
2004).  Growth of E. faecalis in serum induced the expression of EfaA (Lowe et al., 1995).  
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EfaAfs plays a role in adhesion in endocarditis and only the efaAfs gene increases pathogenicity in 
animal models (Singh et al., 1998).  The efa operon consist of three genes (efaC, B and A) with 
homology to ABC-type metal ion transport systems (Low et al., 2003). The gene efaC encodes an 
ATP-binding protein, efaB a hydrophobic transmembrane protein, and efaA a solute-binding 
protein receptor for the ABC transport complex (Low et al., 2003). A manganese-regulated 
operon, EfaCBA, functions as a high-affinity manganes permease in E. faecalis.  These antigens 
play a role in the infection of human tissues, where the availability of Mn2+ is very low (Low et 
al., 2003). 
 
7.3.7 Gelatinase (Gel) 
Gelatinase is an extracellular metallo-endopeptidase involved in the hydrolysis of a variety of 
substrates, including gelatin, collagen, haemoglobin, and other bioactive peptides (Su et al., 
1991).  Enterococci isolated from patients with endocarditis and other nosocomial infections 
produced protease (Gold et al., 1975).  The gene for gelatinase, gelE, is located in an operon 
together with sprE encoding a serine protease (Qin et al., 2000).  GelE is a virulence factor of 
enterococci especially for peritonitis in mice and is commonly produced by nosocomial, fecal, 
and clinical enterococcal isolates (Singh et al., 1998).  Sixty-three percent of enterococci isolates 
and 54 % isolates from patients with endocarditis and other nosocomial infections were protease-
producing E. faecalis strains (Coque et al., 1995; Kühnen et al., 1988).  GelE cleaves fibrin.  The 
protease is secreted, damages host tissue and allows bacterial migration and spreading thereof 
(Franz & Holzapfel, 2004).  Enterococci, involved in blood infections and vegetations formed 
during endocarditis, are coated with polymerized fibrin (Waters et al., 2003).  The fibrin layer 
covering the bacteria is degraded after expression of gelE which leads to further dissemination of 
the organism.  GelE affects a variety of important housekeeping functions as it clears the 
bacterial cell surface of misfolded proteins and leads to activation of an autolysin (Waters et al., 
2003).  The function of this muramidase-1 autolysin is to reduce chain length (Waters et al., 
2003).  Sex pheromones and their inhibitors are also degraded by GelE and also it plays a crucial 
role in dissemination of the organism in a high-cell-density environment (Waters et al., 2003).  
Dissemination of fibrin leads to autolysin activation and reduction in chain length.  Degradation 
of sex pheromones decreases aggregation of enterococci which increases the potential for 
dissemination (Waters et al., 2003).   Another GelE-associated enterococcal virulence factor is 
the degradation of antimicrobial peptides which are part of the innate immune system 
(Schmidtchen et al., 2002).  The antibacterial peptide LL-37, isolated from epithelial cells, 
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neutrophils, and sub-populations of lymphocytes and monocytes, was inactivated by the 
supernatant from a gelatinase-expressing E. faecalis strain (Schmidtchen et al., 2002).  The 
presence of Gel is very high among food isolates of E. faecalis (Eaton & Gasson, 2001; Franz et 
al., 2001).   
 
7.3.8 Hyaluronidase 
Hyaluronidase degrades hyaluronic acid, a major component of the extracellular matrix of the 
endothelium.  The hyaluronidase gene (hylEfm) from a clinical E. faecium strain is 1659 bp long 
and encodes a putative protein of 533 amino acids with a molecular weight of 65, 051 Da (Franz 
& Holzapfel, 2004).  The production of hyaluronidase may play a role in enterococcal 
pathogenesis.  The genes espfm and hylEfm were found in vancomycin-resistant E. faecium isolates 
from patients in the United States (Rice et al., 2003).  Specific E. faecium strains may be enriched 
in determinants that render them more likely to cause clinical infections (Rice et al., 2003). 
 
7.3.9 Capsule 
The capsule that surrounds enterococci is a polysaccharide consisting of a repeat structure of 
kojibiose linked 1,2 to glycerolphosphate (Huebner et al., 1999).  The capsule of enterococcal 
strains protects the bacterial cell from the host’s defense mechanisms (Hancock & Gilmore, 
2002).  This was evident in a murine cutaneous infection model where a mutant was more readily 
cleared from a resulting abscess than the capsular polysaccharide-producing strains. 
 
7.3.10 Other virulence determinants 
An E. faecium strain was involved in a recent outbreak of sepsis in humans and pigs (Lu et al., 
2002).  The investigators believe that this particular strain may harbor gene(s) encoding toxin(s) 
similar to streptococcal pyrogenic exotoxins (spe) and should be studied in future (Lu et al., 
2002).  
 
All of the above contributes to the controversial safety issue of enterococci in foods and probiotic 
supplements.  However, they are associated with the human environment and gastro-intestinal 
tract and the chance of causing diseases in healthy humans is very limited. Conditions such as 
disturbed physiological condition, underlying disease and immunosuppression are the major 
causes of enterococcus infection (Franz & Holzapfel, 2004).  
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8. Health benefits 
8.1 Immune stimulation 
The benefits of consuming probiotics are well documented.  However, until recently the 
mechanisms by which probiotics exert their effects have been largely unknown (Heyman, 2000; 
Parvez et al., 2006).  Results obtained from in vitro systems, animal models and human trials 
suggest that probiotics enhance both specific and non-specific immune responses (Parvez et al., 
2006).  Stimulation of the host’s nonspecific and specific humoral immune responses to 
potentially harmful antigens has been documented for strains of Bifidobacteria bifidum, 
Bifidobacteria breve and Lactobacillus rhamnosus GG.  These effects are mediated through 
activating macrophages, increasing levels of cytokines, increasing natural killer cell activity, 
altering the balance of Th1 and Th2 and/or increasing levels of immunoglobulins (Fang et al., 
2000; Parvez et al., 2006).   The direct effects of probiotics in the gastro-intestinal tract include 
up-regulation of immunoglobulins such as IgA, down regulation of inflammatory cytokines and 
enhancement of gut barrier functions.  Microbes and antigens interact with components of the 
immune system along the mucosal surface of the gastro-intestinal tract.  Most importantly, these 
positive effects are exerted on the immune system without eliciting a harmful inflammatory 
response (Kopp-Hoolihan, 2001).  
 
The first line of host defense is directed toward the exclusion of antigens and regulation of 
antigen-specific immune responses.  As a result the gastro-intestinal barrier controls antigen 
transport and generation of immunologic phenomena in the gut.  These regulatory events 
constituting the intestinal immune response take place in organized lymph epithelial tissue and 
secretory sites.  The organized lymphoid tissue is composed of Peyer’s patches, lymphocytes and 
plasma cells that are distributed throughout the lamina propria.  Intra-epithelial lymphocytes are 
located above the basal lamina in the intestinal epithelium.  The lymphocyte maturation cycle 
involves antigen transport across Peyer’s patches and the presentation of antigens to T 
lymphocytes which proliferate and induce B cell response (Isolauri et al., 2001).  Although 
blood-borne and tissue immunity has a predominance of immunoglobulin (Ig) G antibodies, 
compared with IgA and IgM, IgA antibody production is abundant at mucosal surfaces.  IgA 
exists in the monomeric form in circulating human blood, whereas the dimeric form is expressed 
in secretions of mucosal surfaces including the intestine, saliva and tears (Pfeifer & Rosat, 1999).   
These secretory IgA antibodies in the gut form part of the common mucosal immune system, 
including the respiratory tract and lacrimal, salivary and mammary glands.  The common 
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mucosal immune system refers to the generalization of immune responses elicited at mucosal 
inductive sites and is accomplished by the migration of lymphocytes from the inductive site, via 
the mesenteric lymph nodes and circulation, to remote mucosal sites (Svennerholm & Quiding-
Järbrink, 2003).  Probiotics activate the dendritic cells within the Peyer’s patches.  Dendritic cells 
are the most potent cells to initiate a primary T-cell-dependent immune response (Clancy, 2003).  
The balance of the different T helper (Th) subsets is particularly important in mucosal immunity 
(Dugas et al., 1999).  After priming, memory B and T cells migrate to effector sites.  This is 
followed by active proliferation, local induction of certain cytokines and production of secretory 
antibodies (IgA).   Upon antigen exposure, immune cells respond with the release of a host of 
cytokines that then direct the subsequent immune responses.  One of the major mechanisms by 
which the gut associated lymphoid tissue (GALT) maintains homeostasis is via local cytokine 
regulation, particularly TGF-β-associated low-dose tolerance immunity (Dugas et al., 1999). 
 
IgA is resistant to intraluminal proteolysis and does not activate complement or inflammatory 
responses, which makes secretory IgA ideal for protecting mucosal surfaces.   Results obtained 
from experimental animal models suggested that the capacity to generate IgA-producing cells is 
initiated with the establishment of the gut microflora and that the secondary lymphoid organs, i.e. 
the spleen and lymph nodes, are poorly developed in germfree animals because of the lack of 
antigenic stimulation (Jiang et al., 2004).  The role of intestinal microflora in oral tolerance 
induction (i.e. the unresponsiveness to nonpathogenic antigens encountered at the mucosal 
surface) to the IgE response was investigated in germfree mice.  In contrast with control mice, 
germfree animals maintained their tendency to systemic immune response, e.g. the production of 
IgE antibodies, after oral administration of ovalbumin.  The aberrant IgE response in germfree 
mice could be corrected by reconstitution of the microflora at the neonatal stage but not later 
(Jiang et al., 2004).  These results suggest that the gut microflora direct the regulation of systemic 
and local immune responsiveness by affecting the development of GALT at an early age.  In 
humans, colonization was associated with the maturation of humoral immune mechanisms 
particularly of circulating IgA and IgM secreting cells.  The specific IgA response could 
contribute to the preventative potential of probiotics.  When antigens penetrate through the oral 
route, a secretory immune response is obtained which is mediated by secretory IgA or IgM (Jiang 
et al., 2004).  The mucus secreted by epithelial cells is the first layer of mucosal defense and 
consists of a combination of IgA, antimicrobial peptides, and a complex mixture of glycosylated 
proteins coded by several genes.  IgA is secreted by B lymphocytes (plasma cells) in the lamina 
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propria of the mucosa and is directed to specific antigens present in the lumen of the gastro-
intestinal tract and even to antigens from commensal bacteria (Saavedra & Frank, 2002).  The 
host makes a humoral mucosal response to all gut bacterial species characterized by an increase 
in IgA production in the gastro-intestinal tract.   Each bacterial species has a characteristic 
stimulation marked by a particular steady state level of gastro-intestinal tract IgA production and 
a ratio of specific IgA to general IgA production.  The best documented clinical application of 
probiotics is in the treatment of acute diarrhoea and as adjunct therapy in gut-related 
inflammatory conditions (Isolauri, 2001; Kaur et al., 2002).  
 
Diarrhoea results from disequilibrium in water movement across the intestinal epithelium.  
Multiple factors are responsible for regulating water and electrolyte absorption and secretion and 
therefore the beneficial effects of probiotics involve many different mechanisms. Saccharomyces 
boulardii and L. rhamnosus GG increase secretory IgA levels in the gastro-intestinal tract (Parvez 
et al., 2006).  L. rhamnosus GG is commonly used in commercial preparations and modulates 
intestinal immunity by increasing the levels of IgA and other immunoglobulin secreting cells in 
the intestinal mucosa (Kaur et al., 2002).  This strain increased the rotavirus-specific IgA 
response in children with rotavirus diarrhoea (Fang et al., 2000; Heyman, 2000; Isolauri et al., 
2001).  The increase in rotavirus-specific IgA was significantly higher with strain GG compared 
to a combination of Streptococcus thermophilus and Lactobacillus delbruckii subsp. bulgaricus.  
Consumption of L. rhamnosus GG shortened the phase of diarrhoea from an average of 3.5 days 
to 2.5 days in children being treated for rotavirus infection (Cross, 2002; De Roos & Katan, 
2000).  Both active and non-active preparations of strain GG reduced the duration of rotavirus 
diarrhoea, however only active forms increase the level of specific-IgA secreting cells to 
rotavirus (Fang et al., 2000).   Infants that received L. rhamnosus GG showed temporary 
increases in IgG, IgA and IgM levels and cells secreting specific-IgA were present at higher 
numbers compared to controls thereby providing protection against re-infection (De Roos & 
Katan, 2000). 
 
Volunteers that ingested Lactobacillus johnsonii La1 and milk fermented with bifidobacteria 
showed a 4-fold increase in specific IgA after ingesting an attenuated strain of Salmonella typhi, 
compared to a control group (De Roos & Katan, 2000; Heyman, 2000; Pfeifer & Rosat, 1999).  
When pre-feeding of probiotics was initiated 21 days before vaccination there was a significant 
increase in the pathogen-specific IgA response, while 7 days pre-feeding induced a non-
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significant trend toward an increase in the same parameter (Cross, 2002).   The specific IgA titer 
to S. typhi Ty21a in human volunteers was increased by fermented milk containing L. johnsonii 
La1 and bifidobacteria (Fang et al., 2000).  L. rhamnosus GG stimulated IgA antigen secreting 
cell responses against S. typhi Ty21a in greater numbers compared to Lactobacillus lactis and a 
placebo control.  L. rhamnosus GG increases antigen transfer across Peyer’s patches to 
underlying lymphoid cells.  This may explain the different responses observed (Kaur et al., 
2002).  In two groups of adult volunteers that received typoid vaccine, the antibody titers were 
significantly higher in the group that received L. rhamnosus GG (Young & Huffman, 2003).  
Strain GG also increased rotavirus-specific IgM secreting cells in infants that received an oral 
rotavirus vaccine (Cross, 2002; Heyman, 2000). Yoghurt supplemented with Lactobacillus 
acidophilus, Bifidobacterium bifidum and Bifidobacterium infantis enhanced mucosal and 
systemic IgA responses to cholera toxin immunogen in mice (Kaur et al., 2002).  Feeding mice 
with L. casei Shirota prior to influenza virus challenge also significantly increased protection of 
the upper respiratory tract (Cross, 2002).  L. casei Shirota and E. coli O157:H7 fed to infant 
rabbits exhibited a lower incidence of severe diarrhoea and lower levels of Shiga toxins 1 and 2 
were present in the gastro-intestinal tract compared to infant rabbits fed only with E. coli 
O157:H7 .  Anti-E. coli and anti-toxin IgA levels were higher in the gastro-intestinal tract tissue 
of the animals that were fed probiotics compared to control animals.  When mice were fed a 
combination of L. acidophilus/L. casei an increase in survival against pathogens was observed 
and both serum and gastro-intestinal tract mucosal anti-Salmonella antibody titers were elevated 
(Cross, 2002).  These results were also observed for anti-Shigella antibodies when mice were 
challenged with Shigella sonnei.  These results indicate that some LAB have the ability to persist 
in the intestinal tract and act as adjuvants to the humoral immune response (Cross, 2002). 
 
Macrophages, neutrophils, eosinphils, NK cells, epithelial cells and M cells monitor the sites of 
pathogen entry and coordinate early defense by the innate gastro-intestinal system (Dugas et al., 
1999).  Phagocytosis is responsible for early activation of the inflammatory response before 
antibody production.  Phagocytic activity results in the further recruitment of immunocompetent 
cells and the generation of inflammatory response.  Therefore, an increase in the number of 
activated phagocytes is indicative of non-specific immune stimulation and signals the 
strengthening of general defence mechanisms (Pfeifer & Rosat, 1999).  Oral introduction of 
Lactobacillus casei and Lactobacillus bulgaricus activates the production of macrophages and 
administration of L. casei and Lactobacillus acidophilus activates phagocytosis in mice (Isolauri 
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et al., 2001).  Enhanced phagocytosis was also reported in humans by L. johnsonii La1.  Probiotic 
bacteria modulate phagocytosis differently in healthy and allergic subjects.  An 
immunostimulatory effect was observed in healthy persons, whereas in allergic persons, down-
regulation of the inflammatory response was detected.  In a study of the immunomodulation 
following the consumption of milks fermented with B. bifidum or L. johnsonii LA1, human blood 
samples showed an increased phagocytosis of E. coli in vitro (Heyman, 2000).  When L. 
rhamnosus GG was given to volunteers the number of white blood cells with phagocytic activity 
doubled (De Roos & Katan, 2000).  L. acidophilus and B. bifidum had little effect on immunity in 
elderly volunteers, only B lymphocytes increased significantly.  This suggests that host 
characteristics also contribute to the different effects exerted by probiotics.  In a study to 
determine the effect of consuming different doses and different strains of LAB on immune 
indices, one group of volunteers consumed 1010 cfu B. bifidum Bb12 and a second group received 
7 x 1010 cfu L. johnsonii La1 daily for 3 weeks (Pfeifer & Rosat, 1999).  Two other groups each 
consumed either 109 cfu or 108 cfu of strain La1 daily.  The increase in leucocyte phagocytic 
activity was significant in both groups after the ingestion of LAB, but was more evident in the 
group ingesting bifidobacterium. Overall, phagocytic activity decreased 6 weeks after probiotic 
ingestion was stopped, but the group that consumed La1 retained the highest activity.  The 
respiratory burst and phagocytic activity were significantly enhanced in volunteers who 
consumed 109 cfu La1, but not in those who consumed a lower dose of 108 cfu.  In animals, LAB 
also exhibit immune stimulating capacity.  Different strains of Lactobacillus and Streptococcus 
thermophilus were capable of stimulating non-specific (macrophages) and specific (lymphocytes 
B and T) immunity in mice (Heyman, 2000). Lactobacillus acidophilus UFV-H2b20 stimulates a 
non-specific immune response in germ-free Swiss mice as indicated by stimulation of the host 
mononuclear phagocytic activity (Kaur et al., 2002).  There was a two-fold increase in the 
number of Kupffer cells, responsible for the clearance of circulating bacteria.  Enhanced 
phagocytosis was substantiated in humans by L. johnsonii La1 and L. rhamnosus GG (Isolauri, 
2001).  In addition to enhanced pathogen-specific antibody production, strains of Lactobacillus 
and Bifidobacterium spp. have also resulted in an increase in non-specific in vivo phagocytic 
activity or peritoneal macrophages and blood-borne neutrophils following pathogenic challenge 
(Cross, 2002).  This suggests that enhanced cell mediated immunity may also contribute to 
increased protection.  Rats fed with L. casei Shirota prior to oral challenge with Listeria 
monocytogenes showed reduced pathogen burdens in several excised GI tract tissues and lower 
pathogen translocation to the spleen and liver.  The probiotic-fed rats showed an increased level 
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of in vivo lymphocyte sensitization to microbial antigens.  Intestinal microorganisms could down-
regulate the allergic inflammation by counter-balancing T-helper cell Type-2 responses and by 
enhancing antigen exclusion through induction of an IgA response (Kaur et al., 2002).  L. 
rhamnosus GG and Propionibacterium freudenreichii spp. shermanii JS showed an 
immunomodulatory effect on the proliferate activity of murine B and T lymphocytes.  The oral 
administration of Lactobacillus casei CRL431 in mice stimulated type 1 helper T (Th1) cells, 
activated the cellular immune system and inhibited IgE production.  The cell wall of 
Lactobacillus casei CRL431 presents lectin-like surface molecules which stimulate the immune 
system.  Humans consuming fermented milk containing L. casei Shirota daily for 3 weeks 
showed increased levels of natural killer (NK) cell activity (Commane et al., 2005).  Natural 
killer activity returned to levels comparable with the controls 3 weeks after the feeding period 
had ended.  An increase in NK activity was also observed when L. casei strain Shirota was fed to 
mice.  
 
Specific strains of the normal, healthy gut microflora promote gut barrier functions, give 
maturational signals for the gut associated lymphoid tissues and balance the generation of pro- 
and anti-inflammatory cytokines thereby creating healthy interactions between the host and 
microbes in the gut that are needed to keep inflammatory responses regulated but concomitantly 
readily primed (Isolauri, 2001).  Even in the absence of inflammatory stimuli from the 
environment, the healthy and mature intestine is in a proinflammatory state, provoking many 
differentiated and activated lymphocytes that generate proinflammatory cytokines, a state called 
controlled inflammation (Isolauri, 2001).  When the gastro-intestinal tract becomes inflamed it 
becomes permeable and serves as a link between inflammatory disease in the gastro-intestinal 
tract and other disorders such as arthritis (Parvez et al., 2006).  An inflammatory immune 
response produces cytokine-activated monocytes and macrophages which release cytotoxic 
molecules and there is an increasing appreciation of the role of cytokines in regulating 
inflammatory responses at a local and systemic level.  Several strains of live LAB have been 
shown to induce in vitro the release of the proinflammatory cytokines TNF-α and IL-6, reflecting 
stimulation of nonspecific immunity (Isolauri et al., 2001).  Pro-inflammatory cytokines play a 
pivotal, yet paradoxical role, in inflammation.  Experiments in cytokine transgenic knockout mice 
show that a harmless immune response to commensal gut microflora becomes a harmful 
inflammatory state in the absence of IL-10, TGF-β and IL-2 and can lead to chronic gastro-
intestinal tract inflammatory diseases (Dugas et al., 1999).  This indicates that inflammation is 
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induced by an unbalanced local or systemic cytokine environment.  Probiotics may have an 
indirect impact on immunity by modulating inflammatory mediators such as cytokines.  The 
ingestion of probiotic bacteria can potentially stabilize the immunological barrier in the gut 
mucosa by reducing the generation of local proinflammatory cytokines.  The regulatory role of 
specific strains of the gut microflora was shown previously by a suppressive effect of immune 
responses to dietary antigens in allergic individuals partly attributable to enhanced production of 
anti-inflammatory cytokines IL-10 and TGF-β, whereas the capacity to stimulate nonspecific 
immune responses was retained.  Recently probiotics modulated the host’s immune responses to 
foreign antigens with a potential to dampen hypersensitivity reactions.  Unheated and heat-treated 
homogenates were prepared from probiotic strains, including L. rhamnosus GG, B. lactis, L. 
acidophilus, L. delbruckii subsp. bulgaricus and S. thermophilus.  The phytohemagglutinin-
induced proliferation of mononuclear cells was suppressed in these homogenates compared with 
controls with no homogenates, indicating that probiotic bacteria possess heat-stable, 
antiproliferative components, which could be therapeutically exploited in inflammatory 
conditions.  Probiotics play a role in down regulating inflammation associated with 
hypersensitivity reactions in patients with atopic eczema and food allergies (Kaur et al., 2002; 
Parvez et al., 2006; Young & Huffman, 2003).  Probiotics also showed up-regulation of anti-
inflammatory cytokines, such as IL-10, in atopic children.  In this way probiotics play a role both 
in immunostimulation in healthy individuals and down-regulation of immunoinflammatory 
responses in hypersensitive individuals. 
 
L. bulgaricus 100158 and S. thermophilus 001158 fed to rats increased lymphocyte proliferation 
in the spleen, peripheral blood and Peyer’s patches and elevated IFN-γ production in the Peyer’s 
patches and spleen (Commane et al., 2005).   Splenocytes cultured in vitro displayed an increase 
in the inflammatory immune response associated with IL-12 when given an oral application of L. 
casei strain Shirota.  Macrophage cell lines and murine cultures composed of peritoneal, spleen 
and Peyer’s patch cells were used to examine the effect of heat-killed cells, cell walls and 
cytoplasmic extracts of Bifidobacterium, Lactobacilllus acidophilus, L. bulgaricus, L. casei, L. 
gasseri, L. helveticus, L. reuteri and Streptococcus thermophilus effects on cell proliferation and 
cytokine and nitric oxide (NO) production (Kaur et al., 2002).  Both the cell wall and cytoplasmic 
fractions were able to stimulate cloned macrophages to produce significant amounts of TNF-α, 
IL-6 and NO.  Increased IFN-α activity was observed in virally-challenged peripheral blood 
samples from humans that consumed L. brevis subsp. coagulans (Commane et al., 2005).  A 
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decrease in TNF-α production was observed in human ileal specimens from Chrohn’s disease 
patients treated ex vivo with L. casei DN114001 and L. bulgaricus LB10.  TNF-α changes were 
not observed in non-inflamed mucosa indicating a down-regulation of Th1-like cytokines 
associated inflammation by probiotics.  L. rhamnosus GG significantly decreased the 
concentration of TNF-α in fecal samples from infants with dermatitis and cow milk allergy 
compared to a placebo control group (De Roos & Katan, 2000; Dugas et al., 1999; Isolauri et al., 
2001).  Paradoxically, ingestion of lactobacilli in fermented milk products or as live attenuated 
bacteria was shown to increase the IFN-γ production by peripheral blood mononuclear cells.  
IFN-γ can promote the uptake of antigens in Peyer’s patches where specific IgA-committed cells 
are generated.  An increase in systemic and mucosal IgA response to dietary antigens was shown 
after oral administration of lactobacilli.  Similarly, feeding an extensively hydrolysed whey 
formula supplemented with L. rhamnosus GG improved the clinical score of atopic dermatitis 
and decreased the intestinal excretion of α1-antitrypsin and TNF-α compared with children fed 
the extensively hydrolyzed formula alone (Heyman, 2000).  A mixture of bovine caseins, 
hydrolyzed with L. rhamnosus GG, derive enzymes that may induce a suppression of lymphocyte 
proliferation and a down regulation of IL-4 production in vitro.  Bacterial VSL#3 DNA has 
shown to down regulate proinflammatory cytokine secretion by attenuation of the nuclear factor-
κB pathway in intestinal an epithelial cell chemically induced colitis model in mice (Marteau & 
Shanahan, 2003).  The beneficial effect of the probiotic mixture VSL#3 on the immune system 
was derived from its DNA as VSL#3 genomic unmethylated DNA was effective whereas VSL#3 
methylated DNA and calf thymus DNA were ineffective.  The stimulation of dendritic cells by 
CpG DNA is associated with the production of T-helper type 1 (Th1)-like cytokines such as IL-
12.  Immune responses are different in mice given oral preparations of B. breve YIT4064 
compared to mice given L. casei.  Bifidobacterium sp. raised a Th-2 type response that is 
characterized by increased IgG activity against oral infection with an influenza strain.  
Lactobacillus sp. induced the expression of the type-1 helper T-cell associated cytokines IFN-γ 
and IL-2 (Commane et al., 2005). 
The host is able to distinguish signals from pathogens and commensals by pattern recognition 
receptors or Toll-like receptors (TLRs) which are differentially expressed between immune cells 
and by intestinal epithelial cells (Marteau & Shanahan, 2003).  TLRs are transmembrane proteins 
that respond to different microbial antigens and are able to discriminate between different 
microbes by detecting several features of a microorganism simultaneously (Clancy, 2003).   
Ligand-specific binding promotes interaction of the cytoplasmic domain with adaptor proteins 
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followed by the recruitment of kinases and activation of downstream target effector systems, 
including MAPK as well as the NF- κB transcriptional system.  The transcription factor nuclear 
factor NF- κB transcriptionally regulates the expression of TLRs as well as a wide range of 
chemoattractant and inflammatory cytokines (Ruiz et al., 2005).   
 
Regular consumption of probiotics allows their interaction with immune components of the 
gastro-intestinal tract.  This interaction results in the stimulation and modulation of the immune 
system of the host.  Most probiotic effects on the immune system are a result of regulating the 
balance between pro- and anti-inflammatory cytokine production.  The most well documented 
immunological effects are the modulation of the inflammatory response and use as an adjuvant.  
However, the way in which the immune system is modulated depends on a number of factors 
including the immunologic state of the host and the specific strain/strains of probiotics used.  
Different microorganisms produce different effects on the immune system.  Cytokine secretion 
patterns and the specific immunomodulatory effect of the probiotic is a strain-dependent 
characteristic and therefore the effects of each strain need to be evaluated individually and 
specific strains can be used in the treatment of specific diseases. 
 
8.2 Infectious diseases 
One of the biggest problems yet to solve in the 21st century is infectious diseases in humans. 
Pathogenic microorganisms which cause these diseases and subsequently lead to death in 
developing countries include Shigella, Vibrio cholera, pathogenic Escherichia coli, 
Campylobacter, and rotavirus.  Even in developed countries many cases of diarrhoea in children 
as well as food borne infection still occurr.  Probiotic bacteria have shown to be effective in the 
prevention of infections such as acute diarrhoea, Helicobacter pylori-infections, necrotinizing 
enterocolitis, Campylobacter-induced enteritis and infections in the urinary tract in double-blind 
placebo-controlled randomized studies (Alvarez-Olmos & Oberhelman, 2001; Bengmark, 2003; 
Gill, 2003; Reid et al., 2003).  
 
Rotaviral diarrhoea is identified by vomiting and subsequent rapid watery diarrhoea and occurs 
mainly in infants aged 6 months to 2 years.  The impaired mucosa leads to unbalanced microflora 
and subsequently osmotic diarrhoea and diarrhoea caused by bacterial overgrowth (Isolauri et al., 
1994).  Clinical trials showed that probiotics may treat rotaviral infection by reducing diarrhoea 
and frequency and that efficacy improves with increased dosages (Kaila et al., 1992; Szajewska 
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& Mrukowicz, 2001; Van Niel et al., 2002).  In a multi-centre study in Europe, a significantly 
lower duration of diarrhoea in 1 to 3 month old neonates was observed compared to the placebo 
group (Guandalini et al., 2000).  Children aged 6 to 36 months, of whom 75 % were infected with 
rotavirus, ingested L. reuteri SD 2222. Watery diarrhoea was shortened to five days (Shornikova 
et al., 1997).  Two other placebo-controlled studies with L. rhamnosus GG showed reduction of 
nosocomial rotavirus gastroenteritis and protective effects against bacterial and viral pathogens in 
undernourished children (Oberhelman et al., 1999; Szajewska et al., 2001). 
 
Antibiotics such as clindamycin, cephalosporin and penicillin might induce diarrhoea due to 
disturbance of the normal microflora and the increased growth of endogenous C. difficile in the 
intestine (Nomoto, 2005; Sullivan & Nord, 2002).  The probiotic S. boulardii produces a 
proteolytic enzyme which digests toxin A or B of C. difficile and receptors of these toxins in the 
epithelium of the intestine.  In two clinical trials diarrhoea decreased by 11 % and 18 % 
respectively in children on antibiotic therapy treated with L. rhamnosus GG (Arvola et al., 1999; 
Vanderhoof et al., 1999).  Results of other double-blind placebo-controlled studies on antibiotic-
induced diarrhoea also showed significant effects of probiotics (D’Souza et al., 2002).  Traveler’s 
diarrhoea caused mainly by E. coli, shigella and salmonellae occurs in 10 – 60 % of people 
traveling from developed countries to subtropical and tropical zones (DuPont & Ericsson, 1993).  
Diarrhoea was significantly decreased with the ingestion of L. rhamnosus GG by travelers to one 
region (Oksanen et al., 1990).  In other studies there were no significant effects with probiotics 
and more studies are needed to confirm the effect of probiotics on traveler’s diarrhoea (Katelaris 
et al., 1995; Oksanen et al., 1990).  
 
Necrotizing enterocolitis, occurring in neonates, shows increased intestinal bacterial flora such as 
Enterococcus, E. coli, Staphylococcus, and Clostridium perfringens which aggrevate the 
symptoms of this disease (Nomoto, 2005).  Probiotic administration showed a 60 % decrease of 
necrotizing colitis (Hoyos, 1999). However, not a significant difference was found in other 
studies (Dani et al., 2002; Millar et al., 1993). 
 
Probiotics together with prebiotics (non-digestible food ingredients) have been used in the 
prevention of infectious diseases after surgery in the gastro-intestinal tract.  Administration of L. 
plantarum 299 decreased the incidence of postoperative infectious disease from 48 % to 13 % 
and improved recovery of immunity (Rayes et al., 2002a).  The development of sepsis after 
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surgery in the abdominal cavity was also significantly decreased (Rayes et al., 2002b). Kanazawa 
and co-workers (2005) concluded that postoperative enteral nutrition supplemented with L. casei 
Shirota strain, B. breve Yakult strain and galactooligosaccharides improved the intestinal 
microflora and the concentration of intestinal organic acid was normalized in patients.  Infectious 
complications were significantly decreased and the stay in hospital and need for antibiotic 
administration were shortened.  Bacterial translocation (BT) is defined as ‘the passage of viable 
enteric bacteria from the intestinal lumen through the epithelial mucosa into the lamina propria 
and then into mesenteric lymph nodes (MLNs) and possibly other organs (Wiest & Rath, 2003).  
Probiotics and their production of organic acid might improve the resistance of the host against 
the factors causing BT in infectious diseases after operation of digestive organs (Nomoto, 2005). 
 
The microaerophilic Gram-negative Helicobacter pylori is strongly associated with gastritis, 
peptic ulcer and possibly gastric cancer.  Clinical studies with L. acidophilus (viable and heat-
killed) and L. johnsonii La1 significantly decreased the symptoms of H. pylori in patients. The 
mechanism of the probiotic bacteria is not clear.  However, it was hypothesized that the killed L. 
acidophilus bacteria improved the host immune system and prevented adsorption of H. pylori to 
glycolipid receptors (Canducci et al., 2000; Felley et al., 2001; Michetti et al., 1999; Sakamento 
et al., 2001).  The infection-preventing effects of probiotics possibly include the activation of the 
innate immune system and/or inhibiting the adhesion of pathogenic bacteria to the epithelium by 
competitive antagonism (Nomoto, 2002). 
 
High numbers of Lactobacillus bacteria form part of the normal bacterial flora in the vagina and 
ensure a reduced risk of bacterial vaginosis and urinary tract infections (Nomoto, 2005; Reid & 
Burton, 2002).  Lactobacilli inhibited the growth and attachment of uropathogenic E. coli in vitro 
(McGroarty & Reid, 1988; Reid et al., 1987; Velraeds et al., 1998).  L. rhamnosus GR-1, L. 
fermentum B-54 and Lactobacillus strains with high adhesion and hydrogen peroxide production 
were weekly administered as a vaginal suppository (Reid & Bruce, 1995; 2001; Reid et al. 1987; 
1995a; 1995b).  Urinary tract infection was significantly decreased.  Orally administered L. 
rhamnosus GR-1 and L. fermentum RC-14 decreased E. coli and fungi in the vagina.  Future 
studies should include the inhibition of STBs by probiotics taken orally or as vaginal 
suppositories (Reid et al., 2003; Sewankambo et al., 1997).  A proposed mechanism is the 
inducing of an immune response via the urethra or vagina which is functional in the bladder 
(Reid & Burton, 2002).  Probiotic colonization in the vagina might prevent infection by 
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competition for nutrients and mannose and hydrophobic adhesion to receptors (Braun, 1999; 
Masuoka & Hazen, 1999) and possibly bacteriocin production with fungistatic activity (Okkers et 
al., 1999).  
 
8.3 Prevention and treatment of inflammatory bowel disease 
Inflammatory bowel disease (IBD) is a group term for the intestinal disorders Crohn’s disease 
and ulcerative colitis caused by three interactive pathogenic factors, namely genetic 
susceptibility, environmental factors and immune dysregulation (Shanahan, 2001; 2002; 2003).  
Therapeutic and preventative strategies are implemented to target the immune response 
(Shanahan, 2003).  However, these immunomodulatory drugs are expensive, toxic and not always 
effective.  A new strategy emerged to improve the beneficial microflora of the host as a way of 
limiting the development of IBD.  However, several clinical studies do not support the use of 
probiotics in the maintenance therapy of ulcerative colitis (Ishikawa et al., 2000; Kruis et al., 
1997; Kruis et al., 2001; Rembacken et al., 1999).  Treatment of active ulcerative colitis by 
probiotics is not performed because of the possibility of sepsis.  Future research is therefore 
needed to determine the effective use of probiotics in maintenance therapy (Tambioli et al., 
2003).  Chronic pouchitis is defined as ‘a non-specific inflammation of the ileal reservoir 
following the surgical creation of an ileal-anal anastomosis with a pouch reservoir, in the setting 
of ulcerative colitis.  The symptoms include abdominal pain, diarrhoea, urgency, rectal bleeding 
and possibly fever.  The lyophilized bacterial combination, VSL#3, which includes strains of 
Lactobacillus spp., Bifidobacterium spp. and one Streptococcus sp., reduced the rate of relapse of 
chronic pouchitis. The therapeutic effect was not maintained after treatment because the strains in 
VSL#3 did not stay viable in the colon (Gionchetti et al., 1999; 2000a; 2000b; Mimura et al., 
2002).  The lactobacilli, bifidobacteria and streptococci increased concentrations in the faeces 
and the tissue levels of IL-10 that might relate to the therapeutic efficacy (Tamboli et al., 2003).  
Treatment of Crohn’s disease with the probiotics Mutaflor (E. coli Nissle strain 1917, serotype 
06K5HI), Saccharomyces boulardii and L. rhamnosus GG showed no significant effect in 
controlled studies (Guslandi et al., 2000; Malin et al., 1996; Malchow, 1997; Prantera et al., 
2002).  Future application of probiotics in IBD might include genetically modified (GM) strains. 
L. lactis was used as a vector in an animal model of colitis to deliver active interleukin (IL) 10. 
The GM treatment showed similar results to other conventional IBD treatments (Steidler et al., 
2000). However, the applicability, safety, and economic feasibility for humans should be studied 
first. 
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8.4 Treatment of irritable bowel syndrome (IBS) 
This relapsing chronic disorder is characterized by recurrent abdominal pain and altered bowel 
function.  One fifth of the general population suffers from these clinical symptoms but only a few 
seek medical therapy (Carlson, 1998; Jones et al., 2000; Olden, 2002; Thompson & Gick, 1996).  
Irritable bowel syndrome increases health-care costs as it leads to disability, absence from work 
or school.  In the few probiotic studies using Lactobacillus spp. and VSL#3 abdominal bloating 
and gastro-intestinal function were significantly improved (Kim et al., 2003; Kim et al., 2005).  
Colonic transit was also retarded by VSL#3 (Kim et al., 2005). Mechanisms of the probiotic 
therapeutic effect include anti-inflammatory effects, modulating of intestinal flora and increased 
motility.  The anti-inflammatory effects summarized in Table 14 show in general a decreased 
release of TNF-α in ileal tissues, reduction of IL-8 production and an increased IL-10 production.  
Colonic bacteria which produce gas and short chain fatty acids might be reduced by probiotic 
bacteria and therefore inhibit propulsive contractions (Kamath et al., 1990).  Probiotic bacteria 
may also reduce the bile acid load in patients with diarrhoea causing secretion of colonic mucin 
and fluid and colonic contractions (Bampton et al., 2002; Chadwick et al., 1979).  This leads to a 
reduction in the reflex motor responses of the colon and therefore retardation of stool transit 
(Bazzocchi et al., 2002). 
 
8.5 Anticarcinogenic activity 
Probiotic intake may prevent colon and bladder cancer (Gibson & Macfarlane, 1994, Morotomi et 
al., 1990).  Researchers believe that microflora in the colon play an important role in the 
development of colon cancer (Rowland, 1988).  Several species of bacteria found in the colon 
produce carcinogens and tumor promoters from food components that reach the colon.  Many of 
these microorganisms also synthesize enzymes that generate toxic products (Table 15). 
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Table 14                                                                                                                           
Summary of literature on effects of bacterial species on inflammatory responsesa       
Species Cytokines Present 
in VSL#3
Reference(s) 
L. bulgaricus ↓ TNF-α + Borruel et al. (2003) 
L. casei ↓ TNF-α + Borruel et al. (2003) 
L. salivarius ↓ IFN-γ  McCarthy et al. (2003) 
L. reuteri ↓ IL-8 - Ma et al. (2004) 
B. breve ↓ TNF-α; ↑ IL-10 + Menard et al. (2004) 
S. thermophilus ↓ TNF-α + Menard et al. (2004) 
L. plantarum ↑  IL-10 + Pathmakanthan et al. (2004) 
B. infantis ↓ TNF-α; ↓IL-12, ↑IL-
10/ IL-12 ratio 
+ McCarthy et al. (2003), 
O’Mahony et al. (2005) 
↑ = increase, ↓ = decrease 
 
Table 15 
Toxic products produced by colonic bacteria (obtained from Rastall & Gibson, 2002) 
Enzyme Toxic products 
β-glycosidase 
Azoreductase 
Nitroreductase 
β -glucuronidase 
IQ hydrase-dehydrogenase 
 
Nitrate/nitrite reductase 
Plant glycosides, e.g. rutin, cycasin 
Azo compounds, e.g. benzidines 
Nitro-compounds, e.g. nitrochrysene 
Bilary glucuronides, e.g. benzidine 
2-amino-3-methyl-3H-imidazo-4,5-
ƒ.quinolineIQ 
Nitrate, nitrite 
 
Antimutagenic mechanisms proposed for probiotics include the following: Binding of micro-
organisms that produce (pro) carcinogens, production of antimutagenic compounds by viable 
probiotic cells, modulation of procarcinogenic enzymes in the gut, alteration of colonic transit 
time to remove faecal mutagens more effectively, reduction of the intestinal pH, thereby altering 
microflora activity and bile solubility and suppression of tumors by enhancing defense immune 
mechanisms (Hirayama & Rafter, 1999; McIntosh, 1996).  Evidence for the possible role of 
probiotics in the prevention/treatment of colon cancer has come from in vitro, animal and human 
studies (Tables 16 – 20).   
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Table 16 
Bacterial enzyme activities modified by probiotic treatment 
Probiotic Subjects Treatment Effect Reference(s) 
L. acidophilus 
A1, B. bifidum 
B1, S. lactis, S. 
cremoris 
9 males and 
females 
100 g fermented 
milk product, 3 
times daily/ 3 
weeks (wks) 
↓ faecal nitroreductase, 
azoreductase, β-
glucuronidase 
Marteau et 
al.(1990) 
L. rhamnosus 
GG (LGG), L. 
casei strain 
Shirota 
Human 
volunteers 
- ↓ fecal β-glucuronidase, 
nitroreductase and 
glycoeholic acid 
hydrolase activities 
Lidbeck et 
al. (1992) 
LGG Elderly 
volunteers 
20 ml 
fermented whey 
preparation  for 
2 wks 
↓ activity of glycolic acid 
hydrolase, β-
glucuronidase, urease 
Ling et al. 
(1992) 
LGG 64 female 
adults 
- ↓ activity of 
nitroreductase, β-
glucuronidase, glycolic 
acid hydrolase, ↓ levels 
ρ-cresol in faeces 
Ling et al. 
(1994) 
↓ = decrease 
 
Table 17 
Anti-genotoxic activity of probiotics in vitro 
Probiotic In vitro test Effect Reference(s) 
L. casei S. typhimurium 
Ames assay 
Anti-mutagenicity effect 
against mutagenic nitrosated 
beef extract. 
Renner & Musner 
(1991) 
Omniflora (B. 
longum, L. 
gasseri, E. coli) 
S. typhimurium 
Ames assay 
Anti-mutagenicity effect 
against mutagenic nitrosated 
beef extract. 
Renner & Musner 
(1991) 
LAB Binding to food 
borne 
carcinogens 
Binding of 3-amino-1-methyl 
5 h pyrido[4,3-b]indole acetate 
(TrpP2), 2-amino-3-
methylimidazo[4,5-f]quinoline 
(IQ), 2-amino-3,8-
demethylimidazo[4,5-
f]quinoxaline and 2-amino-1-
methyl-6-phenylimidazo[4,5-
b]pyridine by LAB 
Orrhage et al. 
(1994) 
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Table 18 
Probiotic effect on promotion phase of carcinogenesis in rats and anti-genotoxic activity of 
probiotics in rats 
Probiotic Treatment Effect Reference(s) 
LGG Exposure to 1,2 
dimethyl hydrazine 
(DMH) which induce 
tumors 
↓ colonic tumors Goldin et al. (1996) 
L. plantarum 299 Interleukin 10 knock-
out 
Stabilized gut 
mucosal barrier 
Kennedy et al. (2000) 
L. brevis 
 
- ↓ take-up of 
radioloabelled 
mannitol and 
improved barrier 
function 
Garcia Lafuente et al. 
(2001) 
L. casei Shirota Exposure to N-
methyl-N-nitro, N-
nitroso-guanidine 
Inhibited DNA 
damage in colon 
Pool-Zobel et al. (1993) 
Different lactobacilli 
species 
Colon carcinogen 
1,2-dimethyl 
hydrazine 
Anti-genotoxic 
effect was species 
specific. 
Pool-Zobel et al. (1996) 
 
 
Table 19 
Stimulation of immune system in humans by probiotic treatment 
Probiotic Subjects Treatment Effect Reference(s) 
L. casei 
preparations 
Double blind 
study, cancer 
patients 
- Suppressed 
recurrence of 
bladder tumors 
Aso & Akazan 
(1992), Aso et 
al. (1995) 
L. casei Shirota - - Inhibition of 
methyl-
cholanthrecene-
induced 
sarcomas 
Yokokura 
(1994) 
L. brevis subsp. 
coagulans 
Human 
volunteers 
- ↑ IFN-α activity 
in peripheral 
blood 
Kishi et al. 
(1996) 
L. casei Shirota 
(Yakult 400) 
Human 
volunteers  
Consumed 
fermented milk 
↑ NK cell 
activity  
Nagao et al. 
(2000) 
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Table 20 
Stimulation of immune system in mice by probiotic treatment 
Probiotic Treatment Effect Reference(s) 
L. salivarius 
UCC118 
IL-10 knockout mice ↓ colonic 
inflammation 
↓ tumor 
development 
O’Mahony et al. 
(2001) 
L. casei strain 
Shirota 
Inhibition of 
methylcholanthracene-
induced tumor 
development 
↑ NK cell activity; 
delayed development 
of tumors 
Takagi et al. (2001) 
L. bulgaricus 
100158, S. 
thermophilus 001158 
Yoghurt feeding ↑ lymphocyte 
proliferation in 
spleen, peripheral 
blood, Peyer's 
patches 
↑ IFN- γ production 
in Peyer’s patches, 
spleen 
Aatouri et al. (2002) 
LGG Implanted bladder 
tumor cell line 
Subcutaneous 
development was 
inhibited 
Lim et al. (2002) 
 
The anti-carcinogenic effects of probiotics are supported by the above-mentioned studies and the 
effects involve specific strains/species and a combination of mechanisms.  For the use of 
probiotics as cancer prophylactics in humans, specific strains with the most benefit should be 
selected and their mechanism(s) identified (Commane et al., 2005). 
 
8.6 Prevention and treatment of allergies 
Allergic diseases increased in Western countries during the past few years (Yazdanbakhsh et al., 
2002). A possible reason is improved hygienic conditions and therefore a reduced exposure to 
microbes during childhood (Yazdanbakhsh et al., 2002).  Gut microflora differs in children with 
allergic diseases to healthy children.  High numbers of lactobacilli and bifidobacteria are found in 
the non-allergic and Staphylococcus aureus and coliforms are more common in allergic children 
(Bjorksten et al., 1999). Antiallergenic processes are promoted by the gastro-intestinal microflora 
and include enhancement of systemic T-helper-1-type responses and IgA production (Gaskins, 
1997; Martinez and Holt, 1999), generation of transforming growth factor β (Isolauri et al., 2000; 
Sanfilippo et al., 2000) which plays an essential role in suppression of T-helper-2-induced 
allergic inflammation (Hansen et al., 2000) and induction of oral tolerance (Sudo et al., 1997).  
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The gut microflora might therefore reduce the risk of T-helper-2-mediated allergic responses in 
fetuses and neonates (Kalliomaki et al., 2001). Microbes and their antigens interact directly after 
birth and therefore stimulate the early development of gut-associated lymphoid tissue (Salminen 
et al., 1998a). Atopic disease includes initially atopic dermatitis which is followed by the 
development of asthma and allergic rhinitis.  Atopic disease is believed to be the cause of all 
allergic diseases (Spergel & Paller, 2003). An abnormal immune response leads to an IgE 
response to common environmental allergens and therefore Th2-type cytokines are over produced 
(Miraglia del Giudice et al., 2003).  Several clinical trials showed that probiotics can be used in 
the treatment of clinical conditions related to atopic disease (Table 21).  
 
In conclusion these studies showed that probiotic administration reduced atopic inflammation and 
enhanced anti-inflammatory markers.  However, these are only the studies with positive results.  
Possible explanations for different results could be the use of different probiotic strains and 
dosages.  Microbial responsiveness and the tendency of allergic reactions are influenced by host 
factors and environmental factors influence colonization and the development of immunity 
(Prescott & Björkstén, 2007).  Probiotic consumption during late pregnancy also reduced 
allergies in infants (Kalliomäki et al., 2001, Kukkonen et al., 2007). Insufficient data exists for 
probiotic treatment of allergic diseases (Prescott & Björkstén, 2007).  Although positive results 
were observed for atopic disease, more clinical studies are needed to confirm this.  
 
8.7 Reduction of cholesterol 
Cardiovascular disease is a major problem in Western countries and elevated total serum 
cholesterol (hypercholesteremia), mainly the low density lipidprotein (LDL)-cholesterol, and 
elevated fasting triglycerides are high risk factors (Hokanson & Austin, 1996).  Drug therapy for 
the management of serum cholesterol and triglycerides levels is expensive and a low fat/low-
saturated fat diet is used as an alternative (Taylor & Williams, 1998).  Diets are, however, 
difficult to maintain and new dietary therapies including soluble fibers, soy protein, plant sterols, 
probiotics and prebiotics are of great interest (Taylor & Williams, 1998).  The serum cholesterol 
levels of Maasai warriors in Africa are low and it was noticed that large amounts of Lactobacillus 
fermented milk are regularly consumed (Mann, 1974, Sharper et al., 1963).  Since then, many 
researchers investigated the effect of fermented milk products containing Lactobacillus spp. 
and/or Bifidobacterium spp. on hypercholesteremia (Tables 22-25).  
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Table 21 
Clinical trials of probiotic treatment of atopic dermatitis  
Probiotics Subjects Treatment Effect Reference(s) 
L. 
rhamnosus 
GG (LGG) 
Infants with cow 
milk allergy  
Administration 
of hydrolyzed 
whey formula 
during first 
month 
↓ atopic eczema 
↓ fecal concentration 
of α1-antitrypsin and 
tumor necrosis facto-
α (anti-inflammatory 
properties) 
Majamaa & 
Isolauri (1997) 
LGG, B. 
lactis Bb-12 
27 infants, atopic 
eczema during 
breast-feeding 
Administration 
of hydrolyzed 
whey formula 
during first 
month 
↓ SCORADa-score 
↓ eosinophil protein 
x in urine 
Isolauri et al. 
(2000) 
LGG 9 children with 
AD and cow 
milk allergy 
Supplementation 
to diet for 4 wks 
↑ IL-10 Pessi et al. 
(2000) 
LGG Mother with 
family history of 
atopic eczema, 
their infants after 
birth for 6 mo. 
2 capsules per 
day for 2-4 wks, 
human milk 
↓ atopic eczema vs. 
placebo 
Kalliomäki et al. 
(2001) 
LGG Infants with 
atopic dermatitis 
Administration 
for 4 wks 
↑ Th1-IFN-γ 
responses 
Pohjavuori et al. 
(2004) 
L. 
paracasei-
33 
80 children with 
perennial allergic 
rhinitis 
Administration 
of fermented 
milk for 30 days 
↑quality of life Wang et al. 
(2004) 
L. 
fermentum 
PCC 
Infants with 
atopic dermatitis 
Administration 
for 4 wks 
↑ Th1-IFN-γ 
responses 
Prescott et al. 
(2005) 
LGG 6 months old IgE 
sensitized infants 
with atopic 
dermatitis 
Administration 
for 4 wks 
↓ SCORADa-score 
 
Viljanen et al. 
(2005) 
LGG and 
LC705 
Infants with 1 or 
both parents with 
allergic disease 
Administration 
twice daily, 6 
mo after birth 
↓ atopic eczema Kukkonen et al. 
(2007) 
aSCORAD index = Scoring Atopic Dermatitis, ↑ = increase, ↓ = decrease 
 
Reports from the in vivo trials show that total serum cholesterol, triglyceride levels, LDL- 
cholesterol, LDL/HDL ratio and blood pressure were reduced and HDL-cholesterol increased. 
Possible mechanisms include the production of short-chain fatty acids in the gut after 
fermentation of indigestible carbohydrates by probiotic bacteria. The synthesis of hepatic 
cholesterol and redistribution of cholesterol from plasma to the liver are inhibited leading to a 
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decrease in systematic levels of blood levels (Pereira & Gibson, 2002).  Probiotic bacteria can 
also interfere with cholesterol absorption. Cholesterol is not taken up by the bacteria and 
deconjugated bile acids co-precipitate with cholesterol at a pH of less than 5.5.  This affects the 
metabolism of cholesterol as the liver will convert cholesterol into new bile acids to compensate 
for the loss of bile acids (Brashears et al., 1998).  The mechanisms are strain dependent and the 
exact mechanisms for cholesterol reduction is still unclear (De Roos & Katan, 2000). 
 
Table 22 
In vitro tests to study the effect of probiotic bacteria on cholesterol levels 
Probiotic In vitro test Effect Reference(s) 
L. acidophilus RP32 Removal of 
cholesterol from 
culture medium 
Cholesterol was 
removed by 
deconjugation of bile 
salts 
Klaver & van der 
Meer (1993) 
L. casei N19, L. casei 
E5, L. acidophilus L1 
L. acidophilus ATCC 
43121 
Deconjugating bile 
salts; removing 
cholesterol from 
MRS at pH 6 or 
without pH control 
60 to 90 % bile salts 
were deconjugated by 
all 4 strains. 
Little cholesterol was 
removed by the 2 L. 
acidophilus strains. 
L. casei strains 
removed up to 60 µg 
of cholesterol/ml at 
no pH control. 
Brashears et al. 
(1998) 
L. acidophilus strains Removal of 
cholesterol from 
culture medium 
supplemented with 
bile acids 
57 % removal of 
cholesterol 
Lin & Chen (2000) 
L. plantarum PH04 Bile salt hydrolase 
activity 
Activity in stationary 
phase 
Nguyen et al. (2007) 
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Table 23 
In vivo trails with rats to study the effect of probiotic bacteria on cholesterol 
Probiotic Treatment Effect Reference(s) 
L. reuteri CRL 1098 Probiotic 
supplementation to 
feeding of Swiss 
albino rats 
↓ 40 % triglycerides 
↑ 20 % in ratio of 
high density 
lipoprotein (HDL) to 
LDL 
Taranto et al. (1998) 
Lactobacillus casei 
TMC0409, 
Streptococcus 
thermophilus TMC 
1543 
Fermented milk 
supplemented with 
whey protein 
concentrate; daily 
intake 
↓ total serum 
cholesterol 
Kawase et al. (2000) 
L. plantarum PH04 12 male mice; 
probiotic 
supplementation for 
2wks 
↓ 7 % serum total 
cholesterol 
↓ 10 % triglycerides 
Nguyen et al. (2007) 
↑ = increase, ↓ = decrease 
 
 
Table 24 
In vivo trials with pigs to study the effect of probiotic bacteria on cholesterol 
Probiotic Treatment Effect Reference(s) 
L. acidophilus ATCC 
43121  
33 Yorkshire barrows 
(92 kg). Feeding 
supplemented with 
probiotic plus 0.7 % 
/1.4 % calcium) for 
15 days 
↓ 11.8 % total 
cholesterol and ↓ 
23.9 % in serum bile 
acids 
De Rodas et al. 
(1996) 
L. johnsonii BFE 
1059 and BFE 1061 
and L. reuteri BFE 
1058 
6 male Göttingen 
minipigs between 3 
and 6 years (55.3 kg). 
Probiotic 
supplementation for 
5 wks 
↓ serum cholesterol Du Toit et al. (1998) 
↑ = increase, ↓ = decrease 
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Table 25 
Clinical trials with human adults to study the effect of probiotic bacteria on cholesterol 
Probiotic Subjects Treatment Effect Reference(s) 
E. faecium, S. 
thermophilus 
(Gaio) 
58 males 200 ml 
fermented milk 
for 6 wks 
↓ 6 %  
triglyceride  
↓ 10 % LDL 
Agerbaek et al. 
(1995) 
L. acidophilus 
(Actimel 
Cholesterol 
Control 
yoghurt) 
30 males 3 x 125 ml 
fermented milk 
for 2 x 3 wks 
↓ 4.4 %  
triglyceride  
↓ 5.4 % LDL 
↓ 5.3 % 
LDL/HDL ratio 
Schaafsma et al. 
(1998) 
E. faecium, S. 
thermophilus 
(Gaio) 
11 males, 21 
females 
200 g fermented 
milk for 8 wks 
↓ 5.3 % 
triglyceride 
↓ 6.15 % LDL 
Bertolami et al. 
(1999) 
Lactobacillus 
casei TMC0409, 
Streptococcus 
thermophilus 
TMC 1543 
20 males Fermented milk 
twice daily for 8 
wks 
↑ HDL 
↓ triglyceride 
level ↓ systolic 
blood pressure  
Kawase et al. 
(2000) 
E. faecium, S. 
thermophilus 
(Gaio) 
20 males, 50 
females 
450 ml 
fermented milk 
for 8 wks 
↓ 8.4 % LDL Larsen et al. 
(2000) 
L. acidophilus, 
B. longum 
29 females 300g yoghurt for 
51 days 
↓ 50 % LDL Schaarmann et 
al. (2001) 
↑ = increase, ↓ = decrease 
 
8.8 Alleviation of lactose intolerance 
The enzyme, beta-galactosidase (lactase), hydrolyses lactose to glucose and galactose (Savaiano 
& Levitt, 1987).  The enzyme is produced in the gastro-intestinal tract for the first years of life.  
In specific ethnic groups, including blacks, Asians and South Americans, the levels of this 
enzyme decrease with age, resulting in lactose intolerance (inability to hydrolyze lactose) 
(Andersson et al., 2001).  Lactose intolerance can also develop secondary to an infection of the 
small intestine or destruction of mucosal cells due to other causes or other infections or 
conditions, such as diarrhoea, AIDS or giardiasis, especially in children.  Small bowel surgery or 
prolonged disuse of the gastro-intestinal tract may also affect lactase activity (Tyrus, 1996).  The 
symptoms of lactose intolerance include abdominal pain, flatulence, or diarrhoea because the 
lactose behaves like an osmotic and non-digestible carbohydrate (Pfeifer & Rosat, 1999, 
Roberfroid, 2000).  Probiotic bacteria used to produce fermented milk or yoghurt products 
produce bacterial β-galactosidase in the intestine and stomach where lactose is degraded (Kopp-
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Hoolihan, 2001).  Although lower concentrates are produced in the gastro-intestinal tract than in 
the yoghurt starter cultures of L. bulgaricus and S. thermophilus, the resulting β-galactosidase 
levels are present in the gastro-intestinal tract for longer time periods, facilitating lactose 
hydrolysis (Sanders, 1993).  Lactose from yoghurt and milk containing the probiotic L. 
acidophilus was better absorbed by subjects with low β-galactosidase activity.  The symptoms of 
lactose intolerance were fewer and bacterial fermentation of undigested lactose was also evident 
in breath hydrogen concentrations (Table 26). Dairy products or other products containing the 
mentioned probiotic bacteria can be included in the diet of people suffering from lactose 
intolerance to prevent/reduce the symptoms. 
 
9. Conclusion and future perspectives 
Different techniques were described and proposed to evaluate lactic acid bacteria for probiotic 
properties. Several bacterial strains were well studied in the different assays and clinical trials and 
can be defined as reliable probiotics.  From the scientific data it is also evident that probiotic 
properties are strain specific and that these strains do not meet all the probiotic criteria. In vitro 
assays can give an indication of probiotic properties and can be the first part of the selection 
process.  This process might be refined in future by using genomic analysis. However, clinical 
trials are the most reliable method to ensure probiotic validity.  This will reduce uncertainties 
about the use of probiotics as health supplements and functional foods. Until these regulations are 
strictly followed, probiotics will battle to be fully recognized in promoting human health. 
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CHAPTER 3 
 
Evaluation of Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 as 
probiotics and growth studies in a model simulating an infant gastro-intestinal 
tract  
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Abstract 
Enterococcus mundtii ST4SA produces a broad-spectrum antimicrobial peptide with activity 
against Gram-positive and Gram-negative bacteria.  Lactobacillus plantarum 423 produces a 
bacteriocin active against a number of Gram-positive bacteria.  Survival of the two strains was 
studied in a model simulating an infant gastro-intestinal tract (GIM) and was compared to 
commercial probiotic strains.  Infant milk formulations were used as substrate.  Changes in pH 
were controlled by the addition of 0.5 M HCl or 0.5 M NaOH.  Bile salt and pancreatic juice 
were added to the duodenum vessel.  Intestinal flow was controlled by peristaltic pumps 
receiving signals from a computer program.  Strains ST4SA and 423 withstood low pH and 
elevated bile salts. Both strains are resistant to amoxicillin, cefadroxil, roxithromycin, meloxicam 
doxycycline, novobiocin, and ibuprofen, and painkillers codeine terprim hydrate aminobenzoic 
acid, metamizole aspirin and paracetamol.  Strain 423 is sensitive to vancomycin and does not 
contain genes encoding gelatinase, cell aggregation, enterococcus surface protein, hemolysin, 
non-cytolysin β-hemolysin and enterococcus endocarditis antigen.  Genes encoding cytolysin, 
non-cytolysin β-hemolysin III and cell aggregation were detected on the genome of strain 
ST4SA, but they were not expressed.  The reason for the latter is unknown.  Both strains 
inhibited the growth of Listeria monocytogenes ScottA in the GIM. Survival of the strains 
improved when used in combination and compared well with the survival of commercially 
available probiotics.  
 
Keywords: Enterococcus mundtii ST4SA, Lactobacillus plantarum 423, Probiotics, GIM 
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1. Introduction 
A number of lactic acid bacteria have been classified as probiotics and are either incorporated 
into functional foods or marketed as lyophilized cells in capsules (Fuller, 1989; Svensson, 1999).  
Health benefits described for probiotics include prevention or treatment of infectious diseases, 
irritable bowel syndrome, allergies, lactose intolerance, colon cancer and reduction of serum 
cholesterol levels (Andersson et al., 2001). 
 
Criteria for selection of a probiotic vary, but usually includes the ability to adhere to mucus and 
epithelial cells (Gorbach, 2002), and survival at low pH (1.0 to 3.0) and bile salts of 
approximately 0.3 % (Mainville et al., 2005).  Recent reports of lactic acid bacteria, especially E. 
faecalis and E. faecium, associated with nosocomial infections (Jones et al., 1997; Cannon et al., 
2005; Salminen et al., 1998) have alerted scientists to screen potential probiotic strains for 
virulence factors (Edwards, 2000; Mundy et al., 2000; Routsi et al., 2000). 
 
Most probiotic tests were performed in vitro (Alander et al., 1997; Isolauri et al., 1994; 
Matsumura et al., 1999; Minekus et. al., 1995; Sarem-Damerdji et al., 1995).  Models have been 
developed to simulate gastro-intestinal conditions. The simulated human intestinal microbial 
ecosystem (SHIME), developed by Molly and co-workers (1993) was a five-stage reactor with a 
two-step “fill and draw” system that represented the small intestine and a three-step reactor 
representing the large intestine.  The medium in each vessel was kept in suspension by a 
magnetic stirrer and the pH controlled by probes linked to control units.  Minekus and co-workers 
(1995) developed an upper gastro-intestinal model with four compartments, representing the 
stomach, duodenum, jejunum and ileum.  Each compartment consisted of a glass exterior with 
flexible inner silicon tubing, connected by peristaltic valves which regulated the flow of nutrients 
to each compartment.  Macfarlane and co-workers (1998) developed a three-stage compound 
continuous culture system simulating the proximal colon.  The pH was automatically controlled 
and each vessel was flushed with CO2.  The most recent gastro-intestinal model developed by 
Mainville et al. (2005) simulated the stomach and duodenum.  Each vessel was equipped with pH 
and temperature probes and entry ports for medium, HCl, NaOH and ox-bile.  The medium in 
each reactor was kept in suspension by a magnetic stirrer and the temperature maintained at 37ºC 
with a circulating water bath. 
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In this study, Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 were evaluated as 
probiotics by studying their growth in infant milk formulations, inhibition of Listeria 
monocytogenes, growth at low pH and in the presence of elevated bile salts, susceptibility to 
antibiotics, anti-inflammatory drugs and painkillers, and presence of virulence factors.  Survival 
of the strains in the gastro-intestinal tract (GIT) was studied by using infant milk formulations as 
substrate in a computerized gastro-intestinal model (GIM) designed to simulate nutrient flow 
through the GIT of an infant.  
 
2. Materials and Methods 
2.1 Bacterial strains and growth conditions 
Enterococcus mundtii ST4SA, isolated from soybeans (Knoetze, 2006), and Lactobacillus 
plantarum 423 isolated from sorghum beer (Van Reenen et al. 1998), were cultured in De Man 
Rogosa Sharpe (MRS) broth (Biolab, Biolab Diagnostics, Midrand, SA) for 18 h at 37°C.  
Lactobacillus rhamnosus R-11 and Lactobacillus acidophilus La5, isolated from functional dairy 
products, Lactobacillus reuteri isolated from a probiotic supplement, and Lactobacillus johnsonii 
La1, Lactobacillus rhamnosus GG and Lactobacillus casei Shirota (received from W.H. 
Holzapfel, Institute of Hygiene and Toxicology, Karlsruhe, Germany) were cultured in MRS 
broth (Biolab) at 37°C for 18 h.  Listeria monocytogenes ScottA, cultured in Brain Heart Infusion 
(BHI) (Biolab) served as a model of a pathogen and as target strain for determination of 
antimicrobial activity. 
 
2.2 Growth of E. mundtii ST4SA and L. plantarum 423 in infant milk formulations 
E. mundtii ST4SA and L. plantarum 423 were inoculated, separately, into 10 ml MRS broth and 
incubated at 37°C for 18 h.  The cultures were washed (8000 x g, 15 min, 18ºC) with sterile 
saline (0.75 %, w/v, NaCl) and the pellets resuspended into 200 ml N1 (57.8 % maltodextrin, 6 % 
demineralised whey, 6 % skimmed milk, 25.9 % vegetable fat, vitamins and minerals) and 200 
ml L1 2 (54.7 % maltodextrin, 1.7 % fructo-oligosaccharides, 18.3 % skimmed milk, 18.2 % milk 
fat, vitamins and minerals), respectively.  Incubation was at 37ºC.  Samples were taken every two 
hours for 21 h and plated onto MRS agar (Biolab).  Antimicrobial activity was determined using 
the agar spot method, as described by Uhlman et al. (1992).  Aliquots of 10 µl cell-free culture 
supernatant fluid were spotted onto an agar plate (0.7 % w/v agar) seeded with active growing 
cells of L. monocytogenes ScottA (approximately 106 cells ml-1).  Plates were incubated at 37°C 
for 18 h.  A clear zone of inhibition of at least 2 mm in diameter was recorded as positive. 
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2.3 Design of the infant gastro-intestinal model 
The gastro-intestinal model (GIM), shown in Fig. 1, was developed to simulate nutrient flow 
through an infant gastro-intestinal tract, aged between 6 and 12 months, and was a combination 
of the models described by Molly et al. (1993) and Mainville et al. (2005).  The GIM consists of 
four vessels, representing the stomach, duodenum, jejunum, and ileum.  Pancreatic juice and bile 
salts [2.4 g NaHCO3, 0.18 g pancreatin (Sigma-Aldrich Chemie GmbH, Steinheim, Germany), 
1.2 g Ox-bile (Oxoid Ltd, Hampshire, England)] were kept in a separate vessel (Fig. 1).  The 
reservoir vessel contained 400 ml sterile saliva buffer (1.24 g NaCl, 0.44 g KCl, 0.04 g CaCl2, 
0.24 g NaHCO3).  Vessels were connected with autoclavable Nalgene tubing (Fig. 1).  Peristaltic 
pumps were linked to a LabPro Interface system (Vernier Software & Technology, Beaverton, 
USA), controlled by a computer program designed by J. Kistner and R. Kistner (Information 
Technology, University of Stellenbosch).  All components, except the computer, were housed in 
a 37°C room. 
 
The substrate was pumped from the reservoir to the stomach, and then to the duodenum, jejunum 
and ileum at specific time intervals (Table 1).  The pancreatic juice and bile salts (200 ml) were 
injected into the duodenum after 2.5 h.  The flow speed of the peristaltic pumps was controlled at 
104 ml min-1 (Van den Driessche et al., 1999).  The pH in the stomach was gradually decreased to 
3.7 with the addition of 0.5 M HCl to simulate milk digestion in infants.  The pH in the ileum 
vessels was kept at 6.0 with the addition of 0.5 M HCl and the pH in the duodenum and jejunum 
vessels kept at 6.5 with the addition of 0.5 M NaOH.  Changes in pH were recorded with pH 
probes (Vernier Software & Technology, Beaverton, OR), linked to peristaltic pumps (Fig. 1).  
 
2.4 Preparation of starter cultures and operation of the GIM 
E. mundtii ST4SA and L. plantarum 423 were inoculated, separately, into 10 ml MRS broth 
(Biolab) and incubated at 37°C for 18 h.  The cultures were then transferred to 200 ml MRS broth 
(Biolab) and incubated at 37°C to OD600 = 1.5.  The cells were harvested (8000 x g, 15 min, 
18°C), washed with half-strength saliva buffer (Marteau et al., 1997) and the pellets resuspended 
in 10 ml of the same buffer.  These cell suspensions were used to inoculate the reservoir (400 ml 
saliva buffer), supplemented with either 58.2 g N1 or 65.3 g L1 2.  Final cell numbers in the 
reservoir were 1.0 x 108 cfu/ml and the pH adjusted to approximately 6.8 with sterile 0.5 M 
NaOH.  In a separate experiment, the reservoir was inoculated with a combination (1:1) of strains 
ST4SA and 423 (total = 1 x 108 cfu/ml).  Conditions were the same. 
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Samples were collected with sterile tubing (1 mm diameter) connected to a 1 ml sterile syringe.  
Viable cell numbers of strains ST4SA and 423 were determined by plating onto Enterococcus 
Specific Agar (Difco, Becton, Dickinson and Company, Le Pont de Claix, France) and MRS agar 
(Biolab), respectively.  All plates were incubated at 37 ºC for 48 h.  Antimicrobial activity was 
determined using the agar spot method, as described before.  
 
The experiment was repeated by using L. rhamnosus R-11, L. acidophilus La5, L. reuteri, L. 
johnsonii La1, L. rhamnosus GG and L. casei Shirota as probiotics.  Conditions were the same, 
except that only N1 was used as substrate.  Viable cell numbers were determined by plating onto 
MRS agar (Biolab) and antimicrobial activity determined as before.  Each experiment was 
conducted in triplicate. 
 
In a separate experiment, the GIM colonized with ST4SA, 423 or a combination of the two 
strains (1.0 x 108 cfu/ml), was contaminated with L. monocytogenes ScottA (1.0 x 104 cfu/ml).  
The experiment was conducted as described before.  Cell counts of L. monocytogenes ScottA 
were determined by plating onto Listeria agar (Merck).  The control was L. monocytogenes 
ScottA grown in the absence of E. mundtii ST4SA and L. plantarum 423. 
 
2.5 Screening for bile-salt hydrolase (BSH) activity 
E. mundtii ST4SA, L. plantarum 423, Lactobacillus rhamnosus R-11, L.acidophilus La5, L. 
reuteri, L. casei Shirota, L. rhamnosus GG and L. johnsonii La1 were screened for BSH activity 
by spotting 10 µl of cultures (OD600 = 1.5) onto MRS agar (Biolab), supplemented with 0.5% 
(w/v) taurodeoxycholic acid (Sigma) and 0.37 g L-1 CaCl2.  Plates were incubated for 72 h at 
37°C in an anaerobic jar with a gas generating kit (Oxoid).  Formation of a precipitation zone 
surrounding the colonies was regarded BSH positive. 
2.6 Susceptibility to antibiotics, anti-inflammatory drugs and painkillers 
Strains ST4SA and 423 were tested for susceptibility to ampicillin, bacitracin, caphazolin, 
chloramphenicol, ciprofloxacin, compound sulphonamides, cloxacillan, erythromycin, 
metronidazole, methicillin, neomycin, novobiocin, nystatin, oflaxacin and oxacillan (Oxoid) by 
using the disc diffusion method (Charteris et al., 1998).  The susceptibility of E. mundtii ST4SA, 
L. plantarum 423, L. casei Shirota, L. rhamnosus GG and L. johnsonii La1 to commercially 
available antibiotics, anti-inflammatory medicaments and painkillers was also determined (see 
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Table 2).  Strains were inoculated, separately, into 10 ml MRS broth (Biolab) and incubated at 
37°C for 18 h and imbedded into MRS soft agar (1.0 %, w/v) (Biolab) at 106 cfu/ml.  Ten µl of 
each medicament was spotted onto the surface of the agar and the plates incubated for 18 h. 
 
2.7 Screening for the presence of virulence factors 
E. mundtii ST4SA, L. plantarum 423, L. casei Shirota, L. johnsonii La1, L. rhamnosus GG, E. 
faecium T8 and E. faecium ST311LD were cultured in MRS broth (Biolab) at 37°C to OD600 = 
1.5.  DNA was isolated according to Archimbaud et al. (2002).  Plasmid DNA of E. mundtii 
ST4SA was isolated by using the Qiagen plasmid midi kit (Qiagen, Inc., Valencia, USA).   
Primers designed from genes encoding virulence (Table 3) were used to amplify the genomic and 
plasmid DNA.  Amplified DNA fragments of expected sizes were isolated from the gels (Omar et 
al., 2004), sequenced on an ABI Genetic Analyzer 3130XL Sequencer (Applied Biosystem, 
South Africa, Pty, Ltd.) by using BigDye Terminator Cycle Chemistry (Biosystems, Warrington, 
UK), and searched for homologous sequences in GenBank using BLAST 
(www.ncbi.nlm.nih.gov). 
 
Production of gelatinase was determined by streaking single colonies of each strain onto MRS 
agar, supplemented with 3 % (w/v) gelatin (BDH Laboratory Supplies, Poole, England). Plates 
were incubated at 37 °C for 24 h followed by incubation at 4 °C for 5 h.  Colonies with 
surrounding opaque zones were regarded gelatinase positive (Eaton & Gasson, 2002). 
 
Production of an aggregation substance was determined as described by Franz et al. (2001). 
Enterococcus faecalis OGIX, producer of a pheromone, was cultured in Todd Hewitt broth 
(Difco, Becton Dickinson, Le Pont de Claix, France) at 37 °C for 18 h.  Cell-free culture 
supernatant (200 µl) of E. faecalis OGIX was added (0.5 % v/v) to each of the test strains and 
microscopically examined for cell clumping after 2, 4, 8 and 24 h.  
 
Production of haemolysin was determined by streaking the strains onto Columbia Agar (Merck, 
Merck Chemicals, Gauteng, SA), supplemented with 5% (v/v) sheep blood. Plates were 
incubated for 72 h at 37 °C in anaerobic jars with gas generating kits (Oxoid).  The presence of 
zones surrounding the colonies indicated β-haemolysis.  The absence of zones was interpreted as 
no haemolysis (Semedo et al., 2003). 
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3. Results  
3.1 Growth of E. mundtii ST4SA and L. plantarum 423 in infant milk formulations 
E. mundtii ST4SA reached 3.5 x 109 cfu/ml after 12 h in N1 and 18 h in L1 2.  Highest activity of 
peptide ST4SA (25 600 AU/ml) was recorded between 8 and 15 h in N1 and between 8  and 21 h 
in L1 2, followed by a decrease to 12 800 AU/ml after 18 h in N1.  The culture pH decreased 
from 6.8 to 4.2 in N1 and from 6.8 to 4.4 in L1 2 after 21 h of growth (Fig. 2).  L. plantarum 423 
reached highest cell numbers (4.0 x 1010 cfu/ml) after 12 h in N1 and 15 h in L1 2 (1.4 x 
1010cfu/ml).  Plantaricin 423 activity of 1600 AU/ml was recorded after 12 h in N1. Highest 
activity (6400 AU/ml) was recorded between 10 and 18 h in L1 2, followed by a decrease to 3200 
AU/ml in the same substrate.  The pH decreased from 6.8 to 4.3 after 21 h in N1 and from pH 6.8 
to 5.6 in L1 2 (Fig. 3). 
 
3.2 Growth and survival of E. mundtii ST4SA and L. plantarum 423 in the model  
Cell numbers of E. mundtii ST4SA decreased from 1.0 x 108 cfu/ml to 7.5 x 106 cfu/ml after 2.5 
h in the stomach vessel filled with N1 and to 8.5 x 107 cfu/ml over the same period in the 
presence of L1 2 (Fig. 4).  Addition of bile and pancreatin to the duodenum and jejunum led to a 
further decrease in cell numbers of E. mundtii ST4SA after 4 h (1.6 x 106 in N1 and 9.9 x 106 in 
L1 2).  Cell numbers increased by one log in the ileum (to 3.1 x 107 cfu/ml in N1 and 8.4 x 107 in 
L1 2).  Peptide ST4SA activity decreased from 25 600 AU/ml to 12 800 AU/ml in the stomach, 
duodenum and jejunum, but increased to 25 600 AU/ml in the ileum in both substrates.  
 
L. plantarum 423 decreased from 1.0 x 108 cfu/ml to 2.2 x 107 cfu/ml in the stomach vessel filled 
with N1 and to 1.0 x 107 cfu/ml when filled with L1 2.  Bile and pancreatin stimulated the growth 
of L. plantarum 423 (from 2.2 x 107 to 3.6 x 107 cfu/ml in N1 and from 1.0 x 107 to 8.0 x 108 
cfu/ml in L1).  In N1, cell numbers increased to 1.5 x 108 cfu/ml in the jejunum and decreased to 
2.4 x 107 cfu/ml in the ileum.  In L1 2, cell numbers decreased to 5.4 x 108 cfu/ml in the jejunum 
and to 2.8 x 108 cfu/ml in the ileum.  Plantaricin 423 activity decreased from 800 AU/ml to 400 
AU/ml in the stomach and duodenum with N1 as substrate.  Activity increased to 800 AU/ml in 
the jejunum and decreased to 400 AU/ml in the ileum.  With L1 2 as substrate, the activity of 
bacteriocin 423 remained at 800 AU/ml in the stomach, duodenum and jejunum, but increased to 
1600 AU/ml in the ileum. 
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Less fluctuation in cell numbers was observed when E. mundtii ST4SA and L. plantarum 423 
were used in combination, irrespective of the substrate.  E. mundtii ST4SA increased from 1.0 x 
108 cfu/ml to 2.0 x 108 cfu/ml after 8.5 h in the presence of L. plantarum 423.  L. plantarum 423 
increased from 1.0 x 108 cfu/ml to 3.6 x 108 cfu/ml and to 4.8 x 108 cfu/ml in the presence of E. 
mundtii ST4SA over the same period (Fig. 4).  
 
L. rhamnosus GG produced the highest cell numbers in the stomach (5.0 x 108 cfu/ml), the 
duodenum (9.0 x 108 cfu/ml) and jejunum (5.0 x 108 cfu/ml) after 2.5, 4.5 and 6.5 h, respectively.  
Growth of L. reuteri was slower and reached 1.3 x 108 cfu/ml in the ileum after 8.5 h.  Cell 
numbers of L. johnsonii La1 decreased from 1.0 x 108 cfu/ml to 3.0 x 107 cfu/ml in the stomach 
and increased to 7.0 x 108 cfu/ml after 6 h in the duodenum, jejunum and ileum.  L. casei Shirota 
decreased from from 1.0 x 108 cfu/ml to 1.5 x 107 cfu/ml in the stomach, but increased to 1.0 x 
108 cfu/ml after a further 6 h in the duodenum, jejunum and ileum. L. acidophilus La5 and L. 
rhamnosus R-11 decreased by two log cycles in the presence of acid and bile (Fig. 5). 
 
L. monocytogenes ScottA remained at 1.0 x 104 cfu/ml in the stomach, but increased to 1.0 x 106 
cfu/ml in the duodenum.  Growth of ScottA was repressed by E. mundtii ST4SA and cell 
numbers remained at 1.0 x 104 cfu/ml.  In the presence of L. plantarum 423, cell numbers of 
ScottA decreased from 1.0 x 104 cfu/ml to 2.5 x 103cfu/ml in the duodenum and jejunum, but 
increased to 8.0 x 103 cfu/ml in the ileum (results not shown). 
 
3.3 Screening of bile-salt hydrolase (BSH) activity 
No bile-salt hydrolase activity was detected in any of the strains.  
 
3.4 Susceptibility to antibiotics, anti-inflammatory drugs and painkillers 
Growth of E. mundtii ST4SA was inhibited by ampicillin, bacitracin, cephazolin, 
chloramphenicol, ciprofloxzcin, erythromycin, novobiocin, oflaxacin, oxacillan, rifampicin and 
tetracycline (Table 2).  Growth of L. plantarum 423 was inhibited by ampicillin, bacitracin, 
cephazolin, chloramphenicol, compound sulphonamides, erythromycin, novobiocin, oflaxacin, 
oxacillan, rifampicin and tetracycline (Table 2).  E. mundtii ST4SA and L. plantarum 423 were 
resistant to commercially available β-lactam penicillins (Promoxil and Cipadur) and macrolides 
(Roxibidd and Doximal).  Similar results were recorded for L. casei Shirota, L. rhamnosus GG 
and L. johnsonii La1.  L. plantarum 423 was the only strain resistant to Ciprofloxacin. 
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3.5 Screening for the presence of virulence factors 
E. mundtii ST4SA contained the genes encoding cytolysin (β-hemolysin), non-cytolysin (beta 
hemolysin III), and cell aggregation (Table 3).  No virulence genes were recorded for L. 
plantarum 423, L. casei Shirota, L. rhamnosus GG and L. johnsonii La1.  Aggregation substances 
(AS) and gelatinase were not produced and no haemolytic activity was detected in any of these 
strains.  E. faecium T8 and ST311LD contained the E. faecium endocarditis antigen, E. faecalis 
endocarditis antigen, cytolysin (β-hemolysin) and non-cytolysin (beta hemolysin III).  None of 
the strains contained genes encoding vancomycin resistance, gelatinase, adhesin to collagen or 
the enterococcus surface protein. 
 
4. Discussion 
Infant milk formulations N1 and L1 2 provided sufficient growth factor requirements for E. 
mundtii ST4SA and L. plantarum 423.  However, both strains preferred L1 2 (maltodextrin, 
fructo-oligosaccharides and skimmed milk) as substrate.  This corresponded to results obtained 
for strain 423 in MRS broth supplemented with 1 % (w/v) inulin and 1 % (w/v) fructo-
oligosaccharides (Brink et al., 2006).  Medium supplemented with these oligosaccharides also 
supported growth of strain 423 at low pH and at high bile concentrations.  Similar results were 
recorded for Lactobacillus curvatus DF38, Lactobacillus salivarius 241, L. casei LHS and 
Pediococcus pentosaceus 34 grown in the presence of 1 % inulin and 1 % (w/v) fructo-
oligosaccharides (Brink et al., 2006).  This phenomenon has also been reported for other lactic 
acid bacteria (Kontula et al., 1998).  The high activity levels recorded for peptide ST4SA and 
plantaricin 423 in L1 2 may be due to the metabolism of fructo-oligosaccharides that may 
stimulate the production of bacteriocins.  
 
Sensitivity of E. mundtii ST4SA to low pH, elevated bile levels and pancreatin suggests that only 
a few cells will survive conditions in the stomach and duodenum, but that the cells will recover in 
the ileum.  Acidic conditions repressed the growth of L. plantarum 423 and it is safe to assume 
that these bacteria will not survive the conditions in the stomach.  Growth will, however, 
commence in the duodenum, irrespective of the presence of bile and pancreatin.  High cell 
numbers recorded for both strains in the ileum suggests that they may survive conditions in the 
colon.  Increased survival recorded when strains ST4SA and 423 were used in combination 
suggests symbiotic growth, possibly the fermentation of complex sugars to fermentable 
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carbohydrates.  It is well known that multispecies probiotics create their own niche to improve 
survival under conditions of stress (Timmerman et al., 2004).   
 
Food-borne pathogens tolerate 500 to 1000 ml bile secreted from the gallbladder (Hofmann, 
1994).   Growth of L. monocytogenes ScottA was not inhibited by pH 3.7 and 0.6 % (w/v) bile in 
the GIM.  This corresponds to previous studies that showed L. monocytogenes is not affected by 
0.3 % to 30 % (v/v) bile from human, bovine or porcine (De Boever & Verstraete, 1999; 
Hofmann et al., 1983).  Genes encoding for capsule formation (capA), transcriptional regulation 
(ZurR), isoprenoid biosynthesis (lytB), a membrane protein (YxiO) and a amino acid transporter 
with a putative role in pH homeostasis (gadE) have been described for L. monocytogenes LO28, 
which explains the high tolerance to bile (Begley et al., 2002).  
 
Growth inhibition of L. monocytogenes ScottA is ascribed to the production of antimicrobial 
peptide ST4SA and plantaricin 423.  The mode of action and structure of the peptides have been 
described in previous papers (de Kwaadsteniet et al., 2005; Granger et al., 2005; Todorov et al., 
2005; Van Reenen et al., 1998). Both peptides act by dissipating the proton motive force of the 
target cell.  
 
Growth of  E. mundtii ST4SA and L. plantarum 423 in the GIM superseded that recorded for L. 
acidophilus La5 and L. rhamnosus R-11, suggesting that they will colonize the GIT at higher 
levels.  Mainville et al. (2004) has shown that only 0.1 % of cells of L. rhamnosus GG survived 
in a stomach reactor, whereas L. johnsonii La1 showed 76 % survival.  However, previous 
studies showed thathigh cell numbers of L rhamnosus GG reached the colon in vivo (Goldin et 
al., 1992; Mainville et al., 2004; Siitonen et al., 1990).  Furthermore, in human trial studies L. 
casei Shirota and L. johnsonii La1 survived conditions in the GIT the best (Holzapfel et al., 2001; 
Mainville et al., 2004; Salminen et al., 1998; Spanhaak et al., 1998).  From these results, it is 
clear that in vitro studies have to be substantiated with in vivo studies. 
 
Possible mechanisms contributing to the acid and bile resistance of the strains include proton 
pumps, amino acid decarboxylation and transport (putative role in pH homogenesis), electrogenic 
transport systems, chaperones involved in repair/degradation of damaged proteins, incremental 
expression of regulators promoting local or global responses, elements involved in the 
maintenance of the cell envelope, energy metabolism, and fatty acid or isoprenoid biosynthesis 
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(Begley et al., 2002; Breton et al., 2002; Cotter & Hill, 2003).  The cell could be protected from 
harsh conditions by alterations in the cell wall (Bron, Hoffer et al., 2004). 
 
The correlation of BSH activity and high tolerance to bile salts is debatable (Pinto et al., 2006).  
Lactobacillus spp. may use deconjugation of bile salts as a detoxification mechanism (De Smet et 
al., 1995; Tannock et al., 1989).  Superior toxicity of the deconjugated salts may also affect the 
viability of cells (Grill et al., 2000).  Resistance of E. mundtii ST4SA and L. plantarum 423 to 
ox-bile cannot be correlated with BSH activity and confirms recent studies on bile-salt hydrolase 
(Moser & Savage, 2001; Schmidt et al., 2001). 
 
Enterococci are resistant to a broad range of antibiotics (Landman & Quale, 1997; Leclercq, 
1997; Murray, 1990).  E. mundtii ST4SA showed resistance to beta-lactam penicillins, 
macrolides, tetracyclines, quinolones and anti-inflammatory medicaments.  No inhibition by 
norfloxacin, an antibiotic for urinary tract infections, the anti-inflammatory medicaments, 
diclofenak, Na+-hydrogen carbonate, benzoic acid and painkillers, metamizole codeine terprim 
hydrate amino benzoic acid and paracetamol was detected.  The antibiotic susceptibility profile of 
L. plantarum 423 correlates with that reported for other lactobacilli and is similar to E. mundtii 
ST4SA.  L. plantarum 423 is the only strain resistant to the quinolone ciprofloxacin.  Some 
lactobacilli have a high natural resistance to bacitracin, cefoxitin, ciprofloxacin, fusidic acid, 
kanamycin, gentamicin, metronidazole, nitrofurantoin, norfloxacin, streptomycin, sulphadiazine, 
teicoplanin, trimethoprim/sulphamethoxazole, and vancomycin (Danielsen & Wind, 2003).  
However, the levels of susceptibility of Lactobacillus spp. to various antimicrobial agents are 
species-dependant (Danielsen & Wind, 2003). The antibiotic resistance profile of 55 European 
probiotic strains revealed resistance to kanamycin (79 % of the isolates), vancomycin (65 %), 
tetracycline (26 %), penicillin G (23 %), erythromycin (16 %) and chloramphenicol (11 %).  
Overall 68.4 % of the isolates showed resistance against multiple antibiotics, including intrinsic 
resistance (Temmerman et al., 2002).  Growth of probiotic bacteria is either inhibited by the 
majority of antibiotics or they are multi-resistant. In the case of multi-resistance the probiotic can 
be co-administrated with antibiotics. The possible negative effects are resistance transfer directly 
or indirectly via the commensal flora from probiotic strains to pathogenic bacteria.  Probiotics 
could acquire resistance genes from human commensals and when these probiotics cause 
infection mainly in immunocompromised patients, only a limited number of antibiotics could be 
used to treat the patient (Courvalin, 2006). 
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The virulence of lactic acid bacteria involves more than multi-drug antibiotic resistance (Franz 
and Holzapfel, 2004).  Virulence traits determined in clinical isolates may be associated with one 
or more stages of infection (Franz et al., 2003; Jett et al., 1994).  Three virulence factors were 
found in E. mundtii ST4SA, although no functional homology of the genes was detected which 
indicate low virulence potential.  The AS found in the plasmid of E. mundtii ST4SA is encoded 
on pheromone-responsive plasmids.  These pheromone-responsive plasmids may contribute to 
pathogenesis of infection by enterococci through different mechanisms (Foulquié Moreno et al., 
2006; Franz et al., 2003).  No clumping response was detected in E. mundtii ST4SA and the AS 
gene is therefore not expressed.  No virulence factors were found in L. plantarum 423.  The 
safety of both strains was confirmed in rat studies (unpublished data). 
 
The GIM proved useful to predict the survival of E. mundtii ST4SA and L. plantarum 423 in the 
GIT of infants and provided an indication as to the area where each strain would colonize.  Both 
strains inhibited the growth of L. monocytogenes ScottA in the GIM.  These characteristics, and 
the absence of virulence factors, render E. mundtii ST4SA and L. plantarum 423 good candidates 
as probiotics.  Future modifications of the GIM may include the incorporation of more enzymes 
involved in food digestion and the use of different food matrixes. 
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Table 1 
Residence time of substrates N1 and L1 in each vessel 
Vessel Working volume (ml) Residence time (h)
1. Stomach 400 2.5 
2. Duodenum 600 2.0 
3. Jejunum 600 2.0 
4. Ileum 600 2.0 
 
 
 
 
 
 
 
 
 
 
Fig. 1. In vitro model simulating the human gastro-intestinal tract 
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Table 2 
Effect of commercially available medicaments on the growth of selected lactic acid bacteria  
Commercial 
name 
Active substance Concen-
tration 
(mg/ml) 
E. mundtii 
ST4SA 
L. plantarum 
423 
L. salivarius 
241 
E. faecium T8 L. johnsonii  
La1 
L. casei 
Shirota 
L. rhamnosus 
GG 
Antibiotics          
Ciprofloxacin Ciprofloxacin 100  +++ - +++ +++ ++ ++ +++ 
Promoxil Amoxicillin 100 ++++ ++++ ++++ ++++ ++++ ++++ ++++ 
Cipadur Cefadroxil 50 +++ +++ +++ +++ ++ +++ +++ 
Roxxibid Roxithromycin 30 +++ +++ + + +++ +++ ++ 
Doximal  Doxycycline 20 +++ +++ ++++ ++++ ++++ ++++ +++ 
Utin Norfloxacin 80 - - ++ ++ - - - 
       
Anti-inflammatory medicaments       
Analgin 
Codterpin 
 
 
 
Metamizole 
Codeine terprim 
hydrate 
aminobenzoic 
acid 
100 
50  
 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Coxflam Meloxicam 1.5 ++ ++ ++++ + ++ ++ ++ 
Dolocyl Ibuprofen 40  ++ + - + - - ++ 
Adco-
Ibuprofen 
Ibuprofen 40 ++ + - - - + ++ 
K-fenak Diclofenac 5 - - - - - - - 
Cataflam Na+-diklofenak 5 ++ + + + + + + 
Mefenacid 
 
Na-hydrogen 
carbonate 
100 - - - - - - - 
Preflam 
(Prednisolone) 
Benzoic acid, 
alcohol 
3 - - - - - + +++ 
Rheogesic Piroxicam 4 + - +++ - - - - 
          
Painkillers          
Disprin  Aspirin  60 + - - - - -  
Paracetamol Paracetamol 
2-(2,3-
dimethylphenyl) 
100 - - - - - - - 
Pynmed 5 ml contains: 
paracetamol (120 mg), 
codeine phosphate (5 mg), 
promethazine HCl (6·5 mg), 
alcohol (12·5%, v/v) 
++ + + + - + + 
- = no growth inhibition, + = inhibition zones of 1 - 11 mm in diameter, ++ = inhibition zones of 12 - 16 mm in diameter, +++ = inhibition zones of 17 – 20 mm in 
diameter, ++++ = inhibition zones larger than 21mm.             
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Table 3 
Primers used in the amplification of certain virulence genes 
 Virulence property References Primer set Presence of virulence genes 
Aggregation substance (AS) Omar et al., 2004 f: AAG AAA AAG AAG TAG ACC AAC 
r: AAA CGG CAA GAC AAG TAA ATA 
E. mundtii ST4SA  
Adhesin to collagen (Ace) Omar et al. (2004) f: GAA TTG AGC AAA AGT TCA ATC 
r: GTC TGT CTT TTC ACT TGT TTC 
- 
Enterococcus surface 
protein (Esp) 
Omar et al. (2004) f: TTG CTA ATG CTA GTC CAC GAC 
r: GCG TCA ACA CTT GCA TTG CCG 
E. faecium T8, E. faecium ST 311 LD 
Enterococus faecalis 
endocarditis antigen 
(EfaAfs) 
Omar et al.  
(2004) 
f: GAC AGA CCC TCA CGA ATA 
r: AGT TCA TCA TGC TGT AGT 
E. faecium T8, E. faecium ST 311 LD 
Cytolysin (Cyl) Omar et al. (2004) f: TGG GTT GGT GGC GGT ATT TT 
r: TAA TGC ACC TAC TCC TAA GCC 
E. mundtii ST4SA, E. faecium T8, 
E. faecium ST 311 LD 
Non-cytolysin beta β 
hemolysin (hemolysin)  
Unpublished - E. mundtii ST4SA, E. faecium T8, 
E. faecium ST 311 LD 
Vacomycin (vanA) Lemcke & Bülte, 
(2000) 
f: TCT GCA ATA GAG ATA GCC GC 
r: TCT GCA ATA GAG ATA GCC GC 
- 
Vancomycin (vanB) Lemcke & Bülte 
(2000) 
f: GCT CCG CAG CCT GCA TGG ACA 
r:  ACG ATG CCG CCA TCC TCC TGC 
- 
Vancomycin (vanC1) Clark et al. (1998) f: GAA AGA CAA AGG AGG ACC GC 
r: TCG CAT CAC AAG CAC CAA TC 
- 
Vancomycin (vanC2) Satake et al. 
(1997) 
f: CGG GGA AGA TGG CAG TAT 
r: CGC AGG GAC GGT ATT TT 
- 
Vancomycin (vanC3) Clark et al. (1998) f: GCC TTT ACT TAT TGT TCC 
r: GCT TGT TCT TTG ACC TTA 
- 
f = forward primer, r = reverse primer, - = virulence genes absent. 
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Fig. 2. Viable count of E. mundtii ST4SA in N1 and L1 2 for 21 h 
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Fig. 3. Viable count of L. plantarum 423 in N1 and L1 2 for 21 h 
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Fig. 4. Survival of E. mundtii ST4SA and L. plantarum 423 in a) N1 and b) L1 2 in the GIM for 
8.5 h 
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Fig. 5. Survival and growth of E. mundtii ST4SA and L. plantarum 423, L. johnsonii La1, L. 
reuteri, L. casei Shirota, L. rhamnosus R-11 and L. acidophilus La-5 for 8.5 h in the GIM with 
N1 as substrate. 
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CHAPTER 4 
 
Adhesion of Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to 
Caco-2 cells 
 
 
 
Prepared for publication in Applied and Environmental Microbiology 
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Adhesion of Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to 
Caco-2 cells 
MARELIZE BOTES1, BEN LOOS2, CAROL A. VAN REENEN1 AND LEON M.T. DICKS1. 
Department of Microbiology1 and Department of Physiological Sciences2, University of 
Stellenbosch, Stellenbosch, 7600, South Africa. 
 
Adhesion of Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to Caco-2 
(human carcinoma epithelial) cells was visualized by fluorescent staining.  Both strains 
showed good adhesion compared to Lactobacillus casei MB1, L. casei Shirota, Lactobacillus 
johnsonii La1 and Lactobacillus rhamnosus GG.  No correlation was found between 
hydrophobicity, aggregation and adhesion to Caco-2 cells.  Presence of antibiotics and anti-
inflammatory medicaments reduced adhesion of bacterial strains to Caco-2 cells.  Proteins 
sensitive to pepsin, trypsin and pronase are involved in the adhesion of E. mundtii ST4SA 
and L. plantarum 423 to Caco-2 cells.  Adhesion of Listeria monocytogenes ScottA to Caco-2 
cells was not prevented by ST4SA and 423.  Cell-free culture supernatants of strains ST4SA 
and 423 prevented the invasion of L. monocytogenes ScottA into Caco-2 cells.   
 
One of the prerequisites of a good probiotic is adhesion to mucus and epithelial cells (45).  
Adhesion to the mucosa is, however, influenced by the flow rate, competition for nutrients, 
adhesion sites and specific physico-chemical properties of the probiotic (20, 48, 55).  Adhesion to 
epithelial cells is facilitated by cell surface carbohydrates, proteins (including S-layer proteins) 
hemagglutins and lipoteichoic acids (2, 4, 6, 19, 25, 26, 42, 44, 54). 
 
A number of in vitro models have been used to study the adhesion of probiotic cells to epithelial 
cells.  Of these, the colon adenocarcinoma cells Caco-2 and HT-29 are the most popular choice 
(24, 29, 38, 43, 51).  Adherence is strain-specific and is not defined to specific levels in any 
species.  Lactobacillus rhamnosus GG, one of the best studied probiotics, adheres at a relatively 
high level (9.7 %) to Caco-2 cells (17, 51).  Strains of Lactobacillus casei, Lactobacillus 
paracasei, Lactobacillus acidophilus and dairy strains of Lactobacillus rhamnosus, on the other 
hand, adhered to Caco-2 cells at levels ranging from 3 to 14 % (5, 8, 18, 24, 39, 48).  In general, 
much higher levels of adhesion (20 to 40 %) have been recorded to mucus producing HT29 MTX 
cells (48). 
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Cell lines have also been used to study microbial interactions (1, 47, 56), e.g. endocytosis of L. 
monocytogenes (11, 14, 22, 23, 28, 31, 52).  Adhesion of bacteria to epithelial cells is usually 
studied by subtracting the number of cells that did not adhere to the epithelial cells from the 
original number of cells before adhesion, by visualizing the cells with Gram-staining (51) or 
Giemsa staining (18), or by radioactive labeling of the bacteria (12).  More recently, fluorescent 
dyes with specific binding to nucleic acids have been used (21).  
 
In this study, the adhesion of E. mundtii ST4SA and L. plantarum 423 to Caco-2 cells and the 
ability to compete with L. monocytogenes ScottA were studied.  Fluorescent dyes which bind 
specific to DNA were used.  Adhesion of the two strains has been compared to the adhesion of 
commercially available probiotics.  The effect of antibiotics, medicaments, bile, pancreatin, 
proteolytic enzymes and periodate on adhesion of E. mundtii ST4SA and L. plantarum 423 were 
determined.   
 
MATERIALS AND METHODS 
Bacterial strains and growth conditions. Lactic acid bacteria (LAB) listed in Table 1 were 
cultured in De Man Rogosa Sharpe (MRS) broth (Biolab, Biolab Diagnostics, Midrand, SA) at 
37°C for 18 h.  Listeria monocytogenes ScottA, used as target strain in competitive exclusion 
assays, was cultured in Brain Heart Infusion (BHI)  (Biolab) at 37°C for 18 h. Escherichia coli 
ATCC 25922 and Salmonella sp., used in auto-aggregation and co-aggregation assays, were 
cultured in BHI at 37°C for 18 h. 
 
Adhesion of bacterial strains to Caco-2 cells.  Caco-2 cells (Highveld Biological PTY LTD, 
Kelvin, Johannesburg, SA) were grown in Minimal Essential Medium (MEM) Earle’s Base 
(Highveld Biological), supplemented with 10 % (v/v) fetal bovine serum (FBS) (Sigma, St. 
Louis, USA), 100 U ml-1 penicillin (Sigma) and 100 U ml-1 streptomycin (Sigma).  Incubation 
was at 37°C in the presence of 5 % CO2.  The media was changed every second day. Adhesion 
assays were performed with cells at late post-confluence (15 d in culture).  Caco-2 cells were 
seeded at 1 x 105 cells per well in 12-well microtitre plates (MultiwellTM, Becton Dickinson 
Labware, NJ, USA) to obtain confluence.  Incubation was at 37°C in the presence of 5 % CO2.  
Before the adherence assay, Caco-2 cells were washed twice with sterile phosphate-buffered 
saline (PBS, 6.0 mM Na2HPO4, 1.5 mM KH2PO4, 0.14 M NaCl, 3.0 mM KCl, pH 7.3). 
Stellenbosch University  http://scholar.sun.ac.za
 143
Cultures of strains listed in Table 1 were harvested (10 000 g, 10 min, 4oC), the cells washed 
twice with sterile PBS, and diluted in MEM (without FBS, penicillin and streptomycin) to OD600 
= 0.5 i.e. approximately 1.0 x 106 CFU ml-1.  Wells with Caco-2 cells were inoculated with 1 x 
105 viable cells of each bacterial cell suspension and incubated at 37°C for 2 h.  Non-adhering 
bacterial cells were then withdrawn from the wells and the Caco-2 cells washed twice with 1 ml 
sterile PBS, followed by 1 ml 0.5% (v/v) Triton X-100 (Sigma).  Bacterial cells were plated onto 
MRS agar (Biolab) and Listeria Enrichment agar (LEB; Merck, Darmstadt, Germany), 
respectively.  The experiment was conducted in triplicate and the average viable cell numbers 
determined. The percentage adherence was calculated as described by Shillinger et al. (48): 
% Adhesion = (cfu/ml120 / cfu/ml0) x 100, where cfu/ml0 refers to the initial number of viable 
cells and cfu/ml120 to adhesion of viable bacterial cells after 2 h. 
 
Determination of cell surface hydrophobicity.  LAB listed in Table 1 were cultured in MRS 
broth (Biolab) at 37°C for 18 h, harvested (10 000 g, 10 min, 4oC) and washed twice with 
quarter-strength Ringer’s solution (1.5 g NaCl, 0.02 g KCl, 0.03 g CaCl2 and 0.03 g NaHCO3). 
Optical density readings were recorded at 580 nm (reading 1). To each cell suspension an equal 
volume n-hexadecane was added and mixed for 2 min. The two phases were allowed to separate 
for 30 min at 25°C, after which 1 ml of the top phase was removed and the optical density 
determined (reading 2).  The optical density reading was recorded and used to calculate the 
percentage hydrophobicity according to the equation used by Doyle and Rosenberg (16): 
% Hydrophobicity = [(OD580nm reading1 – OD580nm reading 2)/OD580nm reading1] x 100.  The 
experiment was repeated and the average hydrophobicity of each strain calculated. 
 
Auto-aggregation and co-aggregation.  Eighteen-hour-old cultures of bacteria (Table 1), were 
harvested (10 000 g, 10 min, 18°C) and washed with sterile saline (0.75 %, w/v, NaCl).  The cells 
were resuspended in saline, adjusted to OD660 = 0.3, and 1 ml of the suspension transferred to a 
sterile 2 ml plastic cuvette.  The cell suspension was centrifuged at 2000 rpm for 2 min.  The 
optical density (OD660) of the supernatant was immediately measured (OD0) and after 60 min 
(OD60). 
The percentage auto-aggregation was determined according to Malik et al. (34):  
% Autoaggregation = [(OD0 – OD60 )/  OD0] x 100        
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To investigate co-aggregation of LAB with potential pathogenic organisms, strains of LAB, L. 
monocytogenes ScottA, E. coli ATCC 25922 and Salmonella sp. (Table 1), were inoculated into 
the respective growth media and grown to mid-log phase.  The cells were harvested (10 000 g, 
10min, 18°C) and washed with sterile saline.  Equal volumes of cell suspensions of LAB and 
pathogens were combined.  Optical density (OD660nm) readings of cells were recorded.  The cells 
were harvested (2000 g, 2 min, 18°C) and the OD660 of the supernatant determined. The 
supernatant was discarded.  To determine the number of viable cells present in each co-
aggregation, serial dilutions of the bottom phase were made, plated onto MRS and BHI agar 
(Biolab), and the plates incubated at 37°C for 18 h.  The percentage co-aggregation was 
calculated using the equation of Malik et al. (34): 
% Co-aggregation = [(ODTot – ODs )/  ODTot] x 100  
ODTot = initial OD, taken immediately after the strains were paired and ODs = OD of the cell-free 
supernatant. 
 
Effect of commercially available medicaments on adhesion of strains.  Caco-2 cells were 
grown in MEM, supplemented with 10 % (v/v) FBS, 100 U ml-1 penicillin and 100 U ml-1 
streptomycin.  Incubation was at 37°C in the presence of 5 % CO2.  Caco-2 cells were seeded at 
1.0 x 105 cells per well in 12-well microtitre plates, as described previously.  Before the 
adherence assay, the Caco-2 cells were washed with sterile PBS.  LAB (Table 1) were cultured in 
MRS (Biolab) to OD600 = 1.5, harvested (10 000 g, 10 min, 4oC), washed twice with sterile PBS 
and diluted to OD600 = 0.5, i.e. equivalent to approximately 1.0 x 105 CFU ml-1 in MEM (without 
FBS, penicillin and streptomycin).  One capsule or tablet of each medicament (Table 3) was 
diluted in 5 ml sterile water.  Tubes with 1 ml MEM (without FBS, penicillin and streptomycin), 
each supplemented with 100 µl of the eight medicament suspensions, were inoculated into 
separate microtitre wells, together with each LAB listed in Table 1.  In a subsequent study, the 
concentrations of Cefasyn and Utin were increased 5-fold.  Non-adhering bacteria were 
withdrawn from the wells after 2 h of incubation at 37°C.  The Caco-2 cells were washed twice 
with 1 ml sterile PBS, and then lysed with 1 ml 0.5% (v/v) Triton X-100.  Appropriate dilutions 
were made of the released cells and plated onto MRS agar (Biolab) and incubated at 37°C for 18 
h.  Controls were adhesion of bacterial strains, inoculated in MEM, without supplementation of 
antibiotics or medicaments.   
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The effect of proteolytic enzymes, ox-bile and pancreatin on adhesion of E. mundtii ST4SA 
and L. plantarum 423 to Caco-2 cells.  E. mundtii ST4SA and L. plantarum 423 were cultured 
in MRS broth (Biolab) at 37°C for 18 h, washed in 0.8 ml sterile PBS and resuspended in 500 µl 
of one of the following solutions: 0.1 mol l-1 citrate-phosphate-0.1 mol l-1 NaCl, pH 4.5 (buffer 
A), 0.05 mol l-1 sodium periodate in buffer A, 0.05 mol l-1 Tris-HCl-0.1 mol l-1 NaCl, pH 8.0 
(buffer B), 5.0 mg ml-1 trypsin (Roche Diagnostics GmbH, Mannheim, Germany) in buffer B, 5.0 
mg ml-1 pronase (Roche) in PBS and 5 mg ml-1 pepsin (Roche) in PBS. The cells were incubated 
at 37 °C for 1 h, centrifuged (14 000 g, 10 min, 4oC) washed twice in 0.8 ml PBS and 
resuspended in 1.0 ml of PBS prior to adhesion assays. 
 
Adhesion of E. mundtii ST4SA and L. plantarum 423 to Caco-2 cells was repeated in the 
presence of ox-bile (Oxoid Ltd, Hampshire, England) and pancreatin (Sigma) 0.5 % (v/v), 1.0 % 
(v/v), 1.5 % (v/v) and 2.0 % (v/v), respectively, for 2 h. Adhesion was determined by plate counts 
as described before. Controls were adhesion of untreated E. mundtii ST4SA and L. plantarum 
423 to Caco-2 cells. 
 
Competitive exclusion of L. monocytogenes ScottA. Competition for adherence of E. mundtii 
ST4SA and L. plantarum 423 to Caco-2 cells was studied by inoculating each well (1.0 x 105 
Caco-2 cells) with 100 µl (approximately 1.0 x 105 cfu) of each strain and 100 µl (approximately 
1.0 x 105 cfu) of L. monocytogenes ScottA.  After 2 h of incubation at 37°C, non-adhering 
bacterial cells were withdrawn from the wells. The Caco-2 cells were washed twice with 1 ml 
sterile PBS, followed by 1 ml 0.5% (v/v) Triton X-100 and plated onto MRS (Biolab) and LEB 
agar (Merck). 
 
To determine if strains ST4SA and 423 could prevent adherence of L. monocytogenes ScottA to 
Caco-2 cells, each well (1.0 x 105 Caco-2 cells) was inoculated with 100 µl of E. mundtii ST4SA 
or L. plantarum 423 (approximately 1.0 x 105 cfu) and incubated at 37oC for 1 h.  Non-adhering 
cells were removed by washing Caco-2 cells twice with sterile PBS and then incubated for a 
further 1 h in the presence of approximately 1.0 x 105 cfu L. monocytogenes ScottA. 
 
In a separate experiment, the ability of strains ST4SA and 423 to displace L. monocytogenes 
ScottA from Caco-2 cells was determined by first incubating the cells (1.0 x 105 per well) in the 
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presence of L. monocytogenes ScottA (approximately 1.0 x 105 cfu) at 37oC for 1 h, followed by 
removal of the bacterial cells as described before, and incubation in the presence of E. mundtii 
ST4SA or L. plantarum 423 (approximately 1.0 x 105 cfu) for a further 1 h.  The wells were 
washed and the number of viable E. mundtii ST4SA and L. plantarum 423 released from Caco-2 
cells determined by plating onto MRS agar (Biolab) and L. monocytogenes ScottA determined by 
plating onto LEB agar (Merck), respectively. 
 
The competitive exclusion assay was repeated by supplementing MEM (1 ml, without FBS, 
penicillin and streptomycin) with 5.0 % (v/v), 10 % (v/v), 25 % (v/v), 75 % (v/v) and 100 % (v/v) 
pH-neutralized cell-free culture supernatants of E. mundtii ST4SA and L. plantarum 423, 
respectively.  Each well was inoculated with L. monocytogenes ScottA (approximately 1.0 x 105 
cfu).  The wells were treated as described before and the number of viable L. monocytogenes 
ScottA released from Caco-2 cells determined by plate counts. 
 
Cell invasion of L. monocytogenes ScottA. Cell invasion of Caco-2 cells by L. monocytogenes 
ScottA was determined by the aminoglycoside antibiotic assay described by Isberg and Leong 
(1990).  Caco-2 cells were prepared as before and inoculated with 100 µl (approximately 1.0 x 
105 cfu) L. monocytogenes ScottA and incubating at 37oC for 2 h. Non-adhering cells were 
removed by washing twice with sterile PBS and then incubated for a further 2 h at 37oC in the 
presence of 40 µg/ml gentamicin (Sigma).  The wells were washed twice with PBS, followed by 
treatment with 1 ml 0.5 % (v/v) Triton X-100 and the number of viable intracellular L. 
monocytogenes ScottA released from the wells determined by plating onto LEB agar (Merck). 
 
To determine the effect of E. mundtii ST4SA and L. plantarum 423 cell-free culture supernatant 
on cell invasion of L. monocytogenes ScottA, Caco-2 cells were prepared in 12-well microtitre 
plates as described before.  MEM (without FBS, penicillin and streptomycin) was supplemented 
with 5.0 % (v/v), 10 % (v/v), 25 % (v/v), 75 % (v/v) and 100 % (v/v) pH-neutralized cell-free 
culture supernatant of both strains, respectively, and inoculated with 100 µl L. monocytogenes 
ScottA (approximately 1.0 x 105 cfu).  Cell invasion was determined as described before. 
 
Adhesion of bacterial cells to Caco-2 cells visualized by fluorescent staining.   E. mundtii 
ST4SA, L. plantarum 423 and L. monocytogenes ScottA were grown to (OD600nm = 1.5) and 200 
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µl of each cell suspension added to 1 ml filter-sterilized water in separate micro-centrifuge tubes.  
The cells were harvested (10 000 g, 5 min, 18 oC) and the pellet resuspended in 1 ml filter-
sterilized water.  Three µl hexidium iodide (HI; Molecular probes, Inc., Midrand, SA) from a 
stock solution (5mg/ml) was added to 1 ml of cell suspension, mixed thoroughly and incubated at 
25oC for 15 min in the dark.  Caco-2 cells were prepared in eight-chamber slides (Nalge Nunc 
International, Rochester, NY, USA) as previously described and inoculated with 100 µl MEM 
(without FBS, penicillin and streptomycin), 0.5 µl Hoechst 33342 (10mg/ml stock solution, 
Sigma) and stained cells of E. mundtii ST4SA and L. plantarum 423 (approximately 1.0 x 104 
viable cells of each strain) in combination and individually.   In a separate experiment, Caco-2 
cells were inoculated with stained cells of L. monocytogenes ScottA (approximately 1.0 x 103 
viable cells) and in combination with E. mundtii ST4SA and L. plantarum 423. 
 
Cells were observed on an Olympus cell^R system attached to an IX-81 inverted fluorescence 
microscope equipped with a F-view-II cooled CCD camera (Soft Imaging Systems).  Cell^R 
imaging software was used for image acquisition and analysis. For three dimensional imaging, 
cells were photographed with a step width of 0.26 µm represented in fence view using the cell^R 
software and a 60 x (Olympus PlanApo N) or 100 x (UPlanApo N) oil immersion objective.   
 
For z stack analysis, a defined experiment was set up.  Image acquisition parameters such as 
exposure time, illumination settings and emission filter cube selection were kept constant for all 
groups and ensured appropriate selection of parameters.  The DAPI 360 nm excitation 
wavelength was used for setting the focal plane, avoiding unnecessary photo-bleaching.  For the 
experiment setting a combined multi color image frame was selected, using 360 nm DAPI for 
Hoechst, 492 nm and FITC for HI as multiple excitation settings.  Through the z-stack frame the 
top and bottom focus position parameter were selected, indicating the upper and lower 
dimensions of the cell and a step width of 0.26 µm between the image frames was chosen.  For 
the time-lapse bacterial cells were inoculated to the wells and left to settle for 30 min after which 
images were taken every five seconds for 20 minutes. 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 148
RESULTS 
Adhesion of E. mundtii ST4SA and L. plantarum 423 to Caco-2 cells.  Adhesion of strains 
ST4SA and 423 to Caco-2 cells is expressed as a percentage of the inoculum.  Only 6 % cells of 
E. mundtii ST4SA and 8 % cells of L. plantarum 423 adhered to Caco-2 cells (Fig. 1).  E. 
faecium T8 and L. rhamnosus GG adhered slightly stronger at 10.0 % and 9.2 %, respectively.  L. 
johnsonii La1, L. salivarius 241, L. casei MB1 and L. casei Shirota adhered at 7.0 %, 6.0 %, 4.5 
% and 3.2 %, respectively.  L. monocytogenes ScottA adhered at 6 % to Caco-2 cells. 
 
Determination of cell surface hydrophobicity.  No cell surface hydrophobicity was recorded 
for E. mundtii ST4SA (Fig. 2).  A hydrophobicity of 50 % was recorded for L. plantarum 423, 13 
% for L. casei Shirota, 28 % for L. johnsonii La1, 45 % for L. casei MB1 and 54 % for L. 
rhamnosus GG.  E. faecium T8 and L. salivarius 241 revealed the highest hydrophobicity (80 % 
and 95 %), respectively. 
 
Auto-aggregation and co-aggregation.  Auto-aggregation ranged from 52 % to 64 % for E. 
mundtii ST4SA, L. plantarum 423, L. salivarius 241, E. faecium T8, L. casei Shirota, L. johnsonii 
La1, L. casei MB1 and L. rhamnosus GG (Fig. 3).  Auto-aggregation values between 22 % and 
39 % were recorded for L. monocytogenes ScottA, E. coli ATCC 25922 and Salmonella sp. (Fig. 
3).  The same number cells of E. mundtii ST4SA, L. plantarum 423, L. salivarius 241, E. faecium 
T8, L. casei MB1 and L. rhamnosus GG cells (1.0 x 107cfu/ml) co-aggregated with 1.0 x 
107cfu/ml L. monocytogenes ScottA (Table 2).  No cells of L. casei Shirota and L. johnsonii La1 
co-aggregated with L. monocytogenes ScottA.  Co-aggregation with E. coli ATCC 25922 yielded 
lower cell numbers of E. mundtii ST4SA, L. plantarum 423, L. salivarius 241, E. faecium T8, L. 
johnsonii La1 and L. rhamnosus GG (Table 2).  L. casei Shirota and L. casei MB1 did not co-
aggregate with E. coli ATCC 25922.  Cells of E. mundtii ST4SA, L. plantarum 423, L. salivarius 
241 and E. faecium T8 (1.0 x 104 cfu/ml co-aggregated with 1.0 x 107cfu/ml Salmonella sp.  
Cells of L. johnsonii La1 and L. rhamnosus GG (1.0 x 108cfu/ml) co-aggregated with 1.0 x 
107cfu/ml Salmonella sp.  L. casei Shirota and L. casei MB1 did not co-aggregate with 
Salmonella sp. (Table 2). 
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Effect of commercially available medicaments on adhesion to Caco-2 cells. E. mundtii 
ST4SA, L. plantarum 423, L. salivarius 241, E. faecium T8 L. casei MB1, L. casei Shirota, L. 
johnsonii La1 and L. rhamnosus GG were sensitive to amoxicillin (8 mg/ml), cefadroxil (5 
mg/ml), doxycycline (2 mg/ml) and roxithromycin (10 mg/ml) and adhesion to Caco-2 cells 
decreased in the presence of these antibiotics  (Table 3).  Diclofenac (0.5 mg/ml) had the least 
inhibitory effect on the adhesion of E. mundtii ST4SA, L. plantarum 423, L. salivarius 241 and 
E. faecium T8 to Caco-2 cells.  However, adhesion of L. casei MB1, L. casei Shirota, L. 
rhamnosus GG and L. johnsonii La1 to Caco-2 cells decreased significantly in the presence of 
diclofenac (0.5 mg/ml). Norfloxacin (8 mg/ml) had no affect on adhesion of E. mundtii ST4SA 
and L. salivarius 241 to Caco-2 cells. Very low adhesion of all the strains was reported in the 
presence of a five-fold increase in cefuroxime and norfloxacin, except for L. salivarius 241 and 
L. johnsonii La1, respectively.  Of all strains, L. salivarius 241 and L. johnsonii La1 showed the 
highest resistance to antibiotics and anti-inflammatory medicaments in the adhesion assay.  L. 
rhamnosus GG was not resistant to any of the antibiotics or anti-inflammatory medicaments 
(Table 3). 
 
The effect of proteolytic enzymes, ox-bile and pancreatin on adhesion of E. mundtii ST4SA 
and L. plantarum 423 to Caco-2 cells.  Treatment of E. mundtii ST4SA and L. plantarum 423 
with trypsin decreased their adhesion to Caco-2 cells by 3.0 %.  Treatment of E. mundtii ST4SA 
with pepsin reduced adhesion by 0.7 %.  L. plantarum 423 treated with pepsin resulted in a 3.2 % 
loss in adhesion.  Pronase decreased adhesion of strain ST4SA by 4.0 % and strain 423 by 7.5 %, 
whereas periodate oxidation had no effect on adhesion (Fig. 4).  The presence of ox-bile almost 
completely prevented the adhesion of ST4SA and 423 cells to Caco-2 cells.  Pancreatin reduced 
adhesion by 2.0 to 3.0 %, depending on the concentration (Fig. 4). 
 
Competitive exclusion of L. monocytogenes ScottA.  L. monocytogenes ScottA adhered at a rate 
of 5 % to Caco-2 cells.  E. mundtii ST4SA did not have an effect on the adhesion of L. 
monocytogenes ScottA, irrespective of the strain being added before, during or after incubation 
with the pathogen.  Adhesion of L. plantarum 423 to Caco-2 cells decreased by 1.0 % when L. 
monocytogenes ScottA was added prior to incubation. Cell-free culture supernatant of E. mundtii 
ST4SA and L. plantarum 423 had no effect on the adhesion of L. monocytogenes ScottA.  
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Cell invasion of L. monocytogenes ScottA.   Plate counts revealed that from each well an 
average of 3 x 101 cfu/ml viable cells of L. monocytogenes ScottA invaded Caco-2 cells.  In the 
presence of 5 % cell-free culture supernatant, both strains did, however, decrease cell invasion of 
L. monocytogenes ScottA by 33%.  An increase to 10 % totally inhibited cell invasion.  
 
Adhesion of bacterial cells to Caco-2 cells visualized by fluorescent staining.  Bacterial cells 
stained with HI and Hoechst dyes in the absence of Caco-2 cells are shown in Fig. 5.  The nuclei 
of epithelial cells were brightly stained with HI and Hoechst against a uniformly dark background 
(Figs. 6 - 8).   E. mundtii ST4SA stained with Hoechst and HI appeared as blue and green cocci 
in pairs or short chains. Cells of L. plantarum 423 stained with HI and Hoechst were single or 
arranged in chains or, clusters.  L. monocytogenes ScottA was observed as small and single blue 
and green rods.  Cells of E. mundtii ST4SA and L. plantarum 423 adhered to Caco-2 cells within 
10 min and increased in numbers after an additional 10 min (Fig. 6).  L. monocytogenes ScottA 
adhered 30 min later than E. mundtii ST4SA and L. plantarum 423 to Caco-2 cells (not shown).  
Z-stack and fence view images (Figs 7 and 8) clearly showed how cells of ST4SA and 423 
adhered to the edges, surface and centre of epithelial cells.   In the absence of strains ST4SA and 
423, L. monocytogenes ScottA adhered as a cluster of cells to the surface of and in-between 
Caco-2 cells, which were clearly malformed (Fig. 7 and 8).  However, Caco-2 cells appeared 
normal when strains ST4SA and 423 were present in combination with L. monocytogenes ScottA 
(Fig. 8). 
 
DISCUSSION 
Adhesion of E. mundtii ST4SA and L. plantarum 423 to Caco-2 cells (6 % and 8 %, respectively) 
compared well to that recorded for the probiotic L. rhamnosus GG (9.2 %).  Adhesion of E. 
faecium T8, L. salivarius 241, L. casei MB1, L. casei Shirota and L. johnsonii La1 to Caco-2 
cells ranged between 3.2 % and 10 % and corresponded to results obtained for other 
Lactobacillus spp. (5, 8, 18, 24, 39, 48, 51).  The best adhesion (14 %) to Caco-2 cells was 
reported for L. casei (Fyos®) (51).  The ability to adhere to Caco-2 cells is important in the 
calculation of dosages. If these results are directly comparable with the in vivo situation, 
approximately 1010 cfu/ml of each strain should be incorporated in a supplement to ensure the 
required probiotic dosage of 1 x 108 cfu/ml.  
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The hydrophobicity potential of strains differed considerably.  Hydrophobicity plays a key role in 
first contact between a bacterial cell and mucus or epithelial cells (48, 55).  No correlation existed 
between hydrophobicity potential and adhesion to Caco-2 cells.  E. mundtii ST4SA with no 
hydrophobicity and L. plantarum 423 with 50 % hydrophobicity adhered well to Caco-2 cells.  
Lactobacillus salivarius 241 and E. faecium T8, on the other hand, revealed high levels of 
hydrophobicity and adhesion to Caco-2 cells.  This is contradictory to the findings of Wadström 
et al. (55).  Lactobacillus strains showing high cell surface hydrophobicity adhered in high 
numbers to porcine enterocytes (55). However, in other studies (38, 45, 48) no correlation was 
found between hydrophobicity and adhesion to mucus or epithelial cells.  These discrepancies 
may be ascribed to the differences in methods.  
 
Auto-aggregation and co-aggregation are important in the formation of biofilms to protect the 
host from colonization by pathogens (3, 10, 35, 37).  Both strains (ST4SA and 423) formed 
strong aggregates which may increase adhesion to epithelial cells.  The two strains also showed 
good co-aggregation with L. monocytogenes ScottA, E. coli ATCC 25922 and Salmonella sp. Co-
aggregation with a potential pathogen allows the probiotic strain to produce antimicrobial 
substances in a very close proximity of them which may inhibit the growth of pathogenic strains 
in the gastrointestinal and urogenital tracts (41).  Similar results were recorded with E. faecium 
T8, L. salivarius 241, L. johnsonii La1 and L. rhamnosus GG.  L. casei Shirota did not co-
aggregate with L. monocytogenes ScottA, E. coli ATCC 25922 and Salmonella sp. and no co-
aggregation of L. casei MB1 with E. coli ATCC 25922 and Salmonella sp. was observed. 
 
Prolonged treatment with antibiotics may lead to strain or species selection and cause an 
imbalance in the intestinal microflora (16).  Probiotic bacteria resistant to antibiotics restore the 
microbial balance and prevent antibiotic side effects (30). Enterococcus spp. are known to be 
resistant to cephalosporins, low levels of amino-glycoside and clindamycin (36, 50). 
Lactobacillus, Pediococcus and Leuconostoc spp. have a high natural resistance to vancomycin 
(27, 49).  Our results have shown that the effect of antibiotics and anti-inflammatory 
medicaments on bacterial adhesion is strain specific. Adhesion to Caco-2 cells decreased, 
especially in the presence of cefuroxime and norfloxacin. To our knowledge, this is the first 
evidence of adhesion being influenced by antibiotics or anti-inflammatory medicaments and 
should therefore be carefully selected when used in combination with probiotics. 
Stellenbosch University  http://scholar.sun.ac.za
 152
A significant proportion ST4SA and 423 cells remained attached to Caco-2 cells after extensive 
washing.  This suggests that adhesion may entail more than non-specific physical entrapment of 
cells.  Treatment with trypsin and pepsin decreased the adhesion of both E. mundtii ST4SA and 
L. plantarum 423 by 0.7 % and 3.0 % respectively and it may be assumed that the protein 
adhesins in the cell membranes were not as sensitive to these proteolytic enzymes. The adhesins 
in the cell membrane of L. plantarum 423 appeared more sensitive to pronase than those of E. 
mundtii ST4SA.  Treatment with periodate did not affect adhesion, suggesting that carbohydrates 
do not play a role in adhesion of E. mundtii ST4SA and L. plantarum 423.  Ox-bile had a 
detrimental effect on the adhesion of both strains, whilst pancreatin decreased adhesion only 
slightly.  Adsorption of bile to the surface of LAB may induce metabolic changes, leading to 
altered carbohydrate compositions and changes in adhesion properties (57). 
 
E. mundtii ST4SA and L. plantarum 423 had no affect on the adhesion of L. monocytogenes 
ScottA to Caco-2 cells.  The reason for this phenomenon is not known.  Strains ST4SA and 423 
may bind to receptors on epithelial cells that are not recognised by L. monocytogenes ScottA.  
The supernatants of E. mundtii ST4SA and L. plantarum 423 did however prevent L. 
monocytogenes ScottA from invading Caco-2 cells.  However, the supernatants had no inhibitory 
effect on L. monocytogenes ScottA during the 2 h adhesion assay and may be due to time 
restriction.  In this assay gentamycin was used to kill cells of L. monocytogenes ScottA adhering 
to intestinal brush border and not those invading Caco-2 cells (9).  Cell-free supernatants may 
interfere with the interaction between pathogens and epithelial cells and prevent the cell-entry 
process (6, 7, 12, 32, 33).  One such example is L. acidophilus LB, which produced extracellular 
components that inhibited signal-dependant cell damage induced by S. enterica serovar 
Typhimurium in Caco-2 cells (32).  
 
The first step of listeriosis is an association of L. monocytogenes with microvilli on the plasma 
membrane and entering of the epithelium from the apical side to invade enterocytes (40).  
Infection of Caco-2 cells with L. monocytogenes ATCC 7644 led to 70% apoptosis and 30% cell 
lysis after 48 h (53).   In this study the cell structure and nuclei of Caco-2 cells changed in the 
presence of L. monocytogenes ScottA, which suggested the initiation of invasion.  Caco-2 cells 
appeared normal in the presence of E. mundtii ST4SA and L. plantarum 423 despite an increase 
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in bacterial cells attaching to Caco-2 cells.  The cell structure of Caco-2 cells remained normal in 
the presence of L. monocytogenes ScottA, E. mundtii ST4SA and L. plantarum 423.  It is 
suggested that strains ST4SA and 423 inhibited the deformation of Caco-2 cells by preventing the 
L. monocytogenes ScottA from entering the Caco-2 cells. 
 
Caco-2 cells are useful to collect background information on the adhesion and competitive 
exclusion abilities of potential probiotic strains.  The use of fluorescent proteins i.e. GFP and 
YFP to distinguish between bacterial cells in the adhesion process is recommended in the future. 
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TABLE 1. Bacterial strains used in adhesion, hydrophobicity, aggregation and antibiotic 
resistance assays 
Strain Origin 
Enterococcus mundtii ST4SAa Soybeans 
Lactobacillus plantarum 423a Sorghum beer 
Enterococcus faecium T8a Faeces of infants 
Lactobacillus salivarius 241a Intestinal tract of pigs 
Lactobacillus casei MB1b Probiotic yoghurt drink 
Lactobacillus casei Shirotac Human intestine 
Lactobacillus johnsonii La1c Human intestine 
Lactobacillus rhamnosus GGc Human intestine 
Listeria monocytogenes ScottAc Human intestine 
Escherichia coli ATCC 25922a Human intestine 
Salmonella sp.d Human intestine 
a Culture collection, Department of Microbiology, University of Stellenbosch 
b Isolated from a probiotic yoghurt drink as L. casei defenses 
c Received from W.H. Holzapfel (Institute of Hygiene and Toxicology, Karlsruhe, Germany) 
d Obtained from Red Cross Children’s Hospital, SA 
 
TABLE 2. Co-aggregation of LAB with L. monocytogenes ScottA, E. coli ATCC 25922 and 
Salmonella sp. 
Strain Co-aggregation with 
L. monocytogenes 
ScottA (%) 
Co-aggregation with 
E. coli ATCC 25922 
(%) 
Co-aggregation with 
Salmonella sp. (%) 
E. mundtii ST4SA 53.8 45.8 12.7 
L. plantarum 423 51.3 43.6 12.9 
L. salivarius 241 49.2 49.2 13.3 
E. faecium T8 48.8 44.4 12.8 
L. casei MB1 42.4 29b 12.2c 
L. casei Shirota 41.7a 35.0b 19.9c 
L. johnsonii La1 49.2a 53.1 56.8 
L. rhamnosus GG 48.3            55.6        60.3 
a Values obtained for L. monocytogenes (no LAB aggregated) 
b Values obtained for E. coli ATCC 25922 (no LAB aggregated) 
c Values obtained for Salmonella sp. (no LAB aggregated) 
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TABLE 3. The effect of commercially available antibiotics and anti-inflammatory medicaments on the adhesion of lactic acid bacteria to 
Caco-2 cells, expressed as percentage values. 
Medica-
ment 
Active 
substance 
Concen-
tration 
mg/ml 
E. mundtii
ST4SA 
L. 
plantarum 
423 
E. 
faecium 
T8 
L. 
salivarius
241 
L. casei L. 
casei 
Shirota
L. 
rhamnosus 
GG 
L. 
johnsonii 
La1 
Control - - 6.0 8.0 10 6.0 4.5 3.2 9.2 3.3 
Cefacyn Cefuroxime 10 2.4 0.8 1.5 6.0 0 3.0 1.0 3.3 
Cefacyn Cefuroxime 50 0.14 0.004 0.225 6.0 0 0.04 0.05 0.1 
Utin Norfloxacin 8 6.0 0.68 0.45 6.0 4.5 3.2 0.05 3.3 
Utin Norfloxacin 40 0.6 1.2 1.5 2.25 0.1 0.32 0.003 3.3 
Cipadur Cefadroxil 5 1.2 0.32 0.5 1.5 1.0 1.0 0.33 0.7 
Roxibudd Roxithromycin 10 0.6 0.56 0.5 2.25 3.5 2.0 0.05 0.1 
Promoxil Amoxicillin 8 2.5 0.4 3.5 0.36 0.7 2.1 0.33 0.3 
Doximal Doxycycline 2 2.0 0.64 1.0 3.75 0.7 1.2 0.33 1.3 
Ibuprofen Ibuprofen 2 0.16 1.0 1.5 4.5 4.5 3.0 0.83 0 
K-fenak Diclofenac 0.5 6.0 8.0 10 6.0 0.7 1.6 1.0 3.0 
Adhesion of bacteria not affected by antibiotics and anti-inflammatory medicaments is printed in bold.   
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FIG. 1. Adhesion of bacteria to Caco-2 cells.  
 
 
FIG. 2. Hydrophobicity of bacteria, expressed as the mean percentage. 
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FIG. 3. Auto-aggregation of bacteria expressed as the mean percentage. 
 
 
FIG. 4.  Adhesion of E. mundtii ST4SA and L. plantarum 423 to Caco-2 cells after treatment 
with Na+-periodate, trypsin, pronase, pepsin, ox-bile and pancreatin. 
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Hoechst-staining HI-staining Phase Phase overlayed with 
HI-staining 
E. mundtii ST4SA 
 
L. plantarum 423 
 
L. monocytogenes ScottA 
 
FIG. 5.  Images of E. mundtii ST4SA, L. plantarum 423 and L. monocytogenes ScottA stained 
with HI and Hoechst dyes, in the absence of Caco-2 cells.  
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0 min 10 min 20 min 
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FIG. 6. Adhesion of E. mundtii ST4SA and L. plantarum 423 to Caco-2 cells, stained with HI 
and Hoechst, and recorded after 0 min, 10 min and 20 min.  
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Z-stack 0 min Z-stack 20 min Z-stack 20 min Phase Z-stack 20 min Phase 
overlayed with HI and 
Hoechst dyes 
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FIG. 7. Z-stack images of E. mundtii ST4SA, L. plantarum 423 and L. monocytogens ScottA 
adhering to Caco-2 cells before and after 20 min. 
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FIG. 8.  Fence view images of E. mundtii ST4SA, L. plantarum 423 and L. monocytogenes 
ScottA adhering to Caco-2 cells. 
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Chapter 5 
 
General discussion and conclusions 
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General discussion 
The probiotic concept, developed in recent years, involves the selection of lactic acid bacteria 
for probiotic supplements and functional foods (Gibson & Fuller, 2000).  In vitro assessment 
forms part of the initial screening process and may include resistance to gastric and bile acid, 
adhesion to mucus and/or human epithelial cells, competitive exclusion of pathogenic bacteria 
and safety (Conway et al., 1987; Floch, 2002; Lin et al., 2006; Saarela et al., 2000).  In vitro 
models, simulating the gastrointestinal tract in humans, have been developed to represent in 
vivo conditions (Mainville et al., 2005). 
 
In this study the GIM, simulating the upper gastrointestinal tract of the human infant, was 
developed.  Enterococcus mundtii ST4SA (isolated from soy beans) and Lactobacillus 
plantarum 423 (isolated from sorghum beer), active against various Gram-positive and Gram-
negative bacteria, were compared to the survival of commercial probiotics.  Two infant milk 
formulas were used as growth media.  Strain ST4SA was sensitive to the low pH conditions, 
bile and pancreatin in the GIM.  Cell numbers of L. plantarum 423 decreased in low pH 
conditions and this strain was resistant to bile and pancreatin, despite the absence of bile-salt 
hydrolase activity. Both strains showed high viability in the ileum component of the GIM and 
it is considered to increase in cell numbers in the colon. Combination of the two strains 
improved their survival in the GIM.  L. rhamnosus GG showed the highest survival of the 
commercial probiotics tested and strains ST4SA and 423 compared well to this probiotic.  
Growth of L. monocytogenes ScottA in the GIM was inhibited in the presence of strains 
ST4SA and 423.  The production of antimicrobial peptides is the possible explanation for 
their antimicrobial activity against L. monocytogenes ScottA. Previous studies have shown 
that peptide ST4SA and plantaricin 423 inhibit the growth of Listeria spp. (de Kwaadsteniet 
et al., 2005; Van Reenen et al., 1998). 
 
Although lactic acid bacteria have GRAS status, safety criteria such as antibiotic resistance 
and inheritance of virulence factors of all potential probiotic strains should be determined.  
Antibiotic resistance of E. mundtii ST4SA and L. plantarum 423 correlated to lactobacilli and 
enterococci in previous studies (Danielsen & Wind, 2003; Landman & Quale, 1997; Leclercq, 
1997; Murray, 1990).  Strains ST4SA and 423 showed resistance to beta-lactams penicillin, 
macrolides, tetracycline, quinolones and anti-inflammatory medicaments.  L. plantarum 423 
was the only strain resistant to the quinolone, ciprofloxacin of these tested.  Three virulence 
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factors were found in E. mundtii ST4SA, although the genes were not expressed..  No 
virulence factors were found in L. plantarum 423.  
 
Adhesion and colonization of probiotic bacteria in the gastro-intestinal tract of the host is 
believed to be one of the essential features required for delivering health benefits (Bernet et 
al., 1994). Caco-2 cells exhibit characteristics of epithelial cells in the small intestine and 
were used as an adhesion model in this study (Gopal et al., 2001).  Adhesion of E. mundtii 
ST4SA and L. plantarum 423 compared well to the commercial probiotic strain, L. rhamnosus 
GG.  Factors involved in their attachment to Caco-2 cells include auto-aggregation and 
protein factors sensitive to pepsin, trypsin and pronase, present on the surface of their 
bacterial cell walls. No carbohydrate factors are involved and hydrophobicity was reported 
only for strain 423.  Bile and antibiotics may change the surface and adhesion properties of 
bacterial strains and therefore reduced adhesion of strains ST4SA and 423 to Caco-2 cells 
(Zavaglia et al., 2002).  Adhesion of both strains and L. monocytogenes ScottA was visualized 
by fluorescent staining.  Cell of strains ST4SA and 423 adhered on the surface and nucleus of 
the Caco-2 cells and increased in adhesion over time.  Cells of L. monocytogenes ScottA took 
longer to adhere to Caco-2 cells than strains ST4SA and 423.  A large number of cells 
attached to the surface and in between the Caco-2 cells. 
 
An important aspect of probiotic bacteria is the protection of the gastro-intestinal micro-
environment from invading pathogens (Gopal et al., 2001).  The competitive exclusion 
abilities of E. mundtii ST4SA and L. plantarum 423 may include co-aggregation and the 
production of antimicrobial substances.  Both strains co-aggregated with L. monocytogenes 
ScottA, E. coli ATCC 25922 and Salmonella sp.  Cells of L. monocytogenes ScottA invaded 
Caco-2 cells and images of Caco-2 cells in the presence of L. monocytogenes ScottA 
confirmed these results.  Cell-free culture supernatants of strains ST4SA and 423 did however 
inhibit the invasion of L. monocytogenes ScottA.  E. mundtii ST4, L. plantarum 423 and L. 
monocytogenes ScottA adhering to Caco-2 cells revealed no change in the cell structure of 
Caco-2 cells. We predict that strains ST4SA and 423 may inhibit the invasiveness and cell 
association characteristics of L. monocytogenes ScottA and prevent Caco-2 cells from 
listeriosis. 
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Concluding remarks and future perspectives 
The GIM and Caco-2 cells were useful to predict survival and adhesion of E. mundtii ST4SA 
and L. plantarum 423 in the gastro-intestinal tract.  E. mundtii ST4SA and L. plantarum 423 
exhibit characteristics generally considered essential for probiotic organisms. Both strains 
proved to survive GIM transit and will most probably colonize in the ileum and colon. 
 
Strains ST4SA and 423 compared well to the reference strain L. rhamnosus GG in terms of 
survival and adhesion.  This probiotic strain is effective in preventing and treating acute 
diarrhoea in infants (Isolauri et al., 2001).  A few studies indicate a relationship between in 
vitro adhesion and in vivo colonization (Cesena et al., 2001; Castagliuolo et al., 2005) or 
modulating the immune system (Schiffrin et al., 1997).  Therefore strains ST4SA and 423 
may modulate the intestinal immunity in a similar way.  E. mundtii ST4SA and L. plantarum 
423 may also be used to prevent gastro-intestinal infection of L. monocytogenes ScottA and 
possibly other pathogens. 
 
Fluorescent staining of bacterial cells was useful in the visualization of adhesion to Caco-2 
cells however differentiation between the strains was difficult.  Expression of fluorescent 
reporter genes i.e. lux genes in the genome of bacteria may address this problem.  In vivo 
fluorescent imaging may identify specific adhesion sites for bacteria in the gastrointestinal 
tract and the ability to compete with pathogens.  
 
It is recommended that E. mundtii ST4SA and L. plantarum 423 should be combined when 
commercialized.  Application of both strains as probiotics may include supplementation of 
infant milk formulations or encapsulated for use as a probiotic supplement.  Dosage of each 
strain should be calculated according to adhesion rates.  Strains ST4SA and 423 should not be 
administrated in combination with antibiotics and anti-inflammatory medicaments, with the 
exeption of diclofenak. 
 
However, prior to commercialization, human clinical studies are compulsory to evaluate 
survival and colonization of E. mundtii ST4SA and L. plantarum 423 in the gastro-intestinal 
tract and to identify possible health benefits of each strain.   
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